2,4,5-Trisubstituted 1,2,4-triazolones as DHODH inhibitors
The 2,4,5-trisubstituted 1,2,4-triazolone compound of general formula (I) has solved the challenges of the lack of DHODH and the treatment of diseases such as AML in the prior art, and achieved the goal of Effective interventions for hyperproliferative and inflammatory diseases.
Patent Information
- Application Number
- CN202210811374.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2017-10-06
- Filing Date
- 2017-10-25
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2037-10-25
AI Technical Summary
The prior art lacks effective DHODH inhibitors to treat or prevent hyperproliferative and inflammatory diseases, especially in AML and other cancers, and existing compounds fail to effectively inhibit dihydroorate dehydrogenase.
A 2,4,5-trisubstituted 1,2,4-triazolone compound of general formula (I) is provided, which effectively inhibits DHODH by its structural properties, and is used to treat or prevent hyperproliferative and inflammatory diseases.
The compound exhibits surprising DHODH inhibitory effects, with potential ability to treat or prevent hyperproliferative and inflammatory diseases, especially in AML and other cancers, providing new therapeutic options.
Smart Images

Figure CN115557907B_ABST
Abstract
Description
[0001] The present application is a divisional application of the Chinese invention patent application (filing date: October 25, 2017, application number: 201780066589.7 (PCT application number: PCT / EP2017 / 077252), and the invention name: “2,4,5-trisubstituted 1,2,4-triazolones as DHODH inhibitors”). Technical Field
[0002] The present invention provides 2,4,5-trisubstituted 1,2,4-triazolone compounds of the general formula (I) as described and defined herein, methods for preparing the compounds, intermediate compounds for preparing the compounds, pharmaceutical compositions and combinations comprising the compounds, and the use of the compounds in the preparation of pharmaceutical compositions for the treatment or prevention of diseases, in particular hyperproliferative and / or inflammatory diseases, as sole agents or in combination with other active ingredients. Background Art
[0003] The present invention provides 2,4,5-trisubstituted 1,2,4-triazolone compounds of the general formula (I) that inhibit dihydroorotate dehydrogenase (DHODH).
[0004] Acute myeloid leukemia (AML) is the most common acute leukemia in humans, with a 5-year survival rate of only about 30%. AML is a malignant tumor of the myeloid blood cell line. The incidence and chance of cure are highly dependent on age. The chemotherapy standard of care for AML has not changed significantly in the past few decades, and new therapies are urgently needed. The main hallmark of AML is the differentiation arrest of leukemic cells at the early stages of cell differentiation. With the success of ATRA or arsenic trioxide-induced differentiation of acute promyelocytic leukemia (APL), the potential of leukemia differentiation therapy can be seen. Approximately 10% of AML belongs to the APL subtype, in which leukemic cells carry chromosomal translocations that lead to oncoprotein fusions involving retinoic acid receptors. Although treatment with ATRA or arsenic trioxide has resulted in a significant increase in patient survival, with an overall survival rate exceeding 70%, unfortunately, there is a lack of comparable non-APL AML differentiation therapies (Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet, Sanz MA et al., Blood 2009, 113(9), 1875-1891). Therefore, new therapies that induce AML cell differentiation are of great interest and medical need.
[0005] Dihydroorotate dehydrogenase (DHODH)
[0006] DHODH is located in the mitochondria. This enzyme is responsible for the second and rate-limiting step of de novo pyrimidine synthesis, converting dihydroorotate into orotic acid. M. et al., Molecular and Cellular Biochemistry 1997, 174, 125-129).
[0007] Because pyrimidine production is essential for DNA and RNA synthesis, DHODH is very important for cell proliferation. The enzyme is considered an attractive drug target for cancer, immunology, parasitic and viral diseases, and DHODH small molecule inhibitors such as leflunomide / teriflunomide and brequinar have been approved for clinical use in rheumatoid arthritis and multiple sclerosis. In addition, preclinical studies have shown that DHODH inhibitors can be used to treat hematological cancer indications, for the treatment of solid tumors (such as neuroblastoma, melanoma, colon cancer, breast cancer and lung cancer), for the treatment of parasitic diseases (such as malaria), and for the treatment of viral diseases.
[0008] US 6444613 B1 relates to the field of defoliants, in particular mixtures containing thidiazuron, and their use in cotton crops. These mixtures include 2,4,5-trisubstituted 1,2,4-triazolone compounds as herbicides, which also inhibit protoporphyrinogen-(IX) oxidase (PPO inhibitors).
[0009] WO199802422 describes substituted aromatic carbonyl compounds, among which 2,4,5-trisubstituted 1,2,4-triazolone compounds, as herbicides.
[0010] From CN106543139 it is known that some triazolone compounds are used as agricultural chemicals.
[0011] US 2016 / 0251341 A1 describes triazole compounds as serine protease inhibitors, which can be used to inhibit thrombin and / or kallikrein.
[0012] WO2010 / 077686A1 describes sirtuin-modulating compounds, such as isoindolinones and related compounds, and uses thereof. Sirtuin-modulating compounds can be used to increase the lifespan of cells and to treat and / or prevent a variety of diseases and conditions, including, for example, diseases or conditions associated with aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood coagulation disorders, inflammation, cancer, and / or flushing, as well as diseases or conditions that would benefit from increased mitochondrial activity.
[0013] WO 2013 / 186692 A1 describes triazolone compounds as mPGES-1 inhibitors, which are useful for treating pain and / or inflammation from various diseases or conditions, such as asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain, and neurodegenerative diseases.
[0014] However, the prior art does not describe the specific 2,4,5-trisubstituted 1,2,4-triazolone compounds of the present invention of general formula (I) as described and defined herein. Summary of the Invention
[0015] It has now been found, which partly forms the basis of the present invention, that the compounds of the invention (eg compounds of general formula (I)) have surprising and advantageous properties.
[0016] In particular, it has surprisingly been found that the compounds of the present invention are effective in inhibiting DHODH and are therefore useful in treating or preventing hyperproliferative and / or inflammatory diseases, such as cancer.
[0017] According to one aspect, the present invention provides a compound of formula (I)
[0018]
[0019] in
[0020] R 1 represents a group selected from the following:
[0021] C5-C8-alkyl,
[0022] C2-C8-haloalkyl,
[0023] C4-C8-cycloalkyl,
[0024] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0025] and wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0026] C1-C6-alkyl, which is substituted by C3-C8-cycloalkyl,
[0027] C2-C6-alkyl, which is substituted by cyano, hydroxy, C3-C8-heterocycloalkyl or phenyl,
[0028] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[0029] (C2-C6-hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[0030] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[0031] -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[0032] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[0033] 4- to 7-membered heterocycloalkyl, 5- to 7-membered heterocycloalkenyl,
[0034] wherein the 4- to 7-membered heterocycloalkyl and the 5- to 7-membered heterocycloalkenyl are attached to the rest of the molecule via carbon atoms and are optionally substituted once or twice, each substituent being independently selected from the group consisting of: C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[0035] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice
[0036] or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[0037] C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy, phenyl,
[0038] which are optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), hydroxyl, cyano, C1-C6-hydroxyalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 ), -OC(=O)-(C1-C6-alkyl)-, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2N(R 7 )(R 8 ), -S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -S(=O)(=NR 11 )(C1-C3-alkyl), -N(O)2, -P(=O)(C1-C3-alkyl)2 and SF5,
[0039] or
[0040] wherein the two ortho substituents may together form a 5- or 6-membered optionally heterocyclic, aromatic or non-aromatic ring, which optionally has 1-3 independently selected from -N=, -NH-, -N(R 7)-, -O-, -S- heteroatoms, and optionally contains a C(═O) group, and wherein the ring so formed is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[0041] Bicyclic aryl,
[0042] partially saturated monocyclic or bicyclic aryl or heteroaryl, and
[0043] a monocyclic or bicyclic heteroaryl group,
[0044] which is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -O(C2-C6-alkenyl), C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, C(=O)OR 6 , hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -N(O)2 and -N(R 7 )(R 8 ),
[0045] R 2 represents a hydrogen atom or a halogen atom,
[0046] R 3 represents a group selected from the following,
[0047] C1-C6-alkyl,
[0048] which are optionally replaced by C3-C8-cycloalkyl or NR 7 R 8 Group substitution,
[0049] C3-C8-cycloalkyl,
[0050] C1-C6-haloalkyl,
[0051] C1-C6-hydroxyalkyl,
[0052] C2-C6-alkenyl,
[0053] C2-C6-alkynyl,
[0054] C4-C8-cycloalkenyl,
[0055] (C1-C6-alkyl)-N(R 7 )R 8 Group,
[0056] -(C1-C6-alkyl)-(4- to 7-membered nitrogen-containing heterocycloalkyl) group,
[0057] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0058] and which are optionally substituted by C1-C3-alkyl, and
[0059] Phenyl,
[0060] which is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -N(O)2 and -N(R 7 )(R 8 ),
[0061] R 4 represents a group selected from the following,
[0062] C1-C6-alkyl,
[0063] which are optionally substituted by a group selected from the group consisting of C3-C8-cycloalkyl and phenyl,
[0064] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(=O)OR 6 , hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -N(O)2 and -N(R 7 )(R 8 ),
[0065] C2-C6-alkenyl,
[0066] C3-C8-cycloalkyl,
[0067] C2-C6-haloalkyl,
[0068] C2-C6-hydroxyalkyl,
[0069] -(C2-C6-alkyl)-N(R 7 )(R 8 ) group,
[0070] -C(=O)OR 6 Group,
[0071] -C(=O)NR 7 R 8 Groups and
[0072] -S(=O)(=NR 11 )(C1-C3-alkyl) group,
[0073] R 5 represents a halogen atom or a group selected from the following:
[0074] C1-C6-alkyl,
[0075] C3-C8-cycloalkyl,
[0076] C1-C6-haloalkyl,
[0077] C1-C6-hydroxyalkyl,
[0078] -(C1-C6-alkyl)-N(R 7 )(R 8 ) group,
[0079] -(C1-C6-alkyl)-O-(C1-C6-alkyl) group,
[0080] C2-C6-alkenyl,
[0081] C2-C6-alkynyl,
[0082] C1-C6-alkoxy groups,
[0083] C1-C6-alkylthio and
[0084] -N(R 7 )(R 8 ) group,
[0085] -C(=O)OR 6 Group,
[0086] -C(=O)N(R 7 )(R 8 ) group,
[0087] -S(=O)(=NR 11 )(C1-C3-alkyl) groups, and
[0088] Phenyl,
[0089] which is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(=O)OR 6 , hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -N(O)2 and -N(R 7 )(R 8 ),
[0090] R 6 represents a hydrogen atom or a group selected from the group consisting of C1-C6-alkyl and benzyl,
[0091] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from the group consisting of C1-C6-alkyl, C2-C6-hydroxyalkyl, C3-C6-cycloalkyl and -(C2-C6-alkyl)-N(R 9 )(R10 ) group,
[0092] or
[0093] R 7 and R 8 Together with the nitrogen to which they are attached, they represent a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0094] which are optionally substituted by a group selected from the group consisting of C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0095] R 9 and R 10 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group,
[0096] or
[0097] R 9 and R 10 Together with the nitrogen to which they are attached, they represent a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0098] R 11 represents a hydrogen atom or a group selected from the group consisting of a cyano group and a -C(=O)(C1-C3-haloalkyl) group, or a tautomer, an N-oxide, a salt, a salt of a tautomer or a salt of an N-oxide thereof. Detailed Description of the Invention
[0099] definition
[0100] The term "substituted" means that one or more hydrogen atoms on the designated atom or group are replaced with a group selected from the indicated group, provided that the normal valence of the designated atom in its current state is not exceeded. Combinations of substituents and / or variables are permitted.
[0101] The term "optionally substituted" means that the number of substituents may be equal to or different from zero. Unless otherwise indicated, an optionally substituted group may be substituted with a plurality of optional substituents, which may be placed by replacing a hydrogen atom with a non-hydrogen substituent on any available carbon or nitrogen atom. Typically, when present, the number of optional substituents may be 1, 2, 3, 4, or 5, specifically 1, 2, or 3.
[0102] As used herein, the term "one or more", for example in the definition of substituents of the compounds of general formula (I) of the present invention, means "1, 2, 3, 4 or 5, specifically 1, 2, 3 or 4, more specifically 1, 2 or 3, even more specifically 1 or 2".
[0103] As used herein, an oxo substituent refers to an oxygen atom that is bonded to a carbon atom or a sulfur atom through a double bond.
[0104] The term "ring substituent" refers to a substituent attached to an aromatic or non-aromatic ring that replaces an available hydrogen on the ring.
[0105] If a composite substituent consists of more than one part, for example (C 1- C 3- Alkoxy)-(C 1- In the case of a (C1-C3-alkoxy)-(C1-C6-alkyl)-group, the position of the given moiety may be at any suitable position of the composite substituent, i.e. the C1-C3-alkoxy moiety may be attached to any carbon atom of the C1-C6-alkyl portion of the (C1-C3-alkoxy)-(C1-C6-alkyl)-group. A hyphen at the beginning or end of such a composite substituent indicates the point of attachment of the composite substituent to the rest of the molecule. If a ring comprising carbon atoms and optionally one or more heteroatoms (e.g. nitrogen, oxygen or sulfur atoms) is substituted by a substituent, the substituent may be attached at any suitable position of the ring, to a suitable carbon atom and / or a suitable heteroatom.
[0106] When used in the specification, the term "comprising" includes "consisting of.
[0107] If any term is referred to herein as "as described herein," it means that it can be referred to anywhere in the document.
[0108] The terms used in this document have the following meanings:
[0109] The term "halogen atom" refers to a fluorine, chlorine, bromine or iodine atom, specifically a fluorine, chlorine or bromine atom.
[0110] The term "C1-C8-alkyl" denotes a linear or branched, saturated, monovalent hydrocarbon radical having 1, 2, 3, 4, 5 or 6 carbon atoms, for example a methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl, tert-butyl, pentyl, isopentyl, 2-methylbutyl, 1-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, neopentyl, 1,1-dimethylpropyl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 2,3-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, heptyl or octyl radical, or an isomer thereof. In particular, the radicals have 1, 2, 3, 4, 5 or 6 carbon atoms (“C1-C6-alkyl”), for example methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl, tert-butyl, pentyl, isopentyl, 2-methylbutyl, 1-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, neopentyl, 1,1-dimethylpropyl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 2,3-dimethylbutyl, 1,2-dimethylbutyl or 1,3-dimethylbutyl radical. In particular, the radical has 1, 2, 3 or 4 carbon atoms ("C1-C4-alkyl"), for example a methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl or tert-butyl radical, more particularly 1, 2 or 3 carbon atoms ("C1-C3-alkyl"), for example a methyl, ethyl, n-propyl or isopropyl radical.
[0111] The term "C1-C6-hydroxyalkyl" denotes a linear or branched saturated monovalent hydrocarbon radical, wherein the term "C1-C6-alkyl" is as defined above, and wherein one or two hydrogen atoms are replaced by hydroxy groups, for example hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1,2-dihydroxyethyl, 3-hydroxypropyl, 2-hydroxypropyl, 1-hydroxypropyl, 1-hydroxyprop-2-yl, 2-hydroxyprop-2-yl, 2,3-dihydroxypropyl, 1,3-dihydroxyprop-2-yl, 3-hydroxy-2-methylpropyl, 2-hydroxy-2-methyl-propyl, 1-hydroxy-2-methyl-propyl radical. In particular, the radical has 1, 2 or 3 carbon atoms (“C1-C3-hydroxyalkyl”), for example a hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1,2-dihydroxyethyl, 3-hydroxypropyl, 2-hydroxypropyl, 1-hydroxypropyl, 1-hydroxyprop-2-yl, 2-hydroxyprop-2-yl, 2,3-dihydroxypropyl or 1,3-dihydroxyprop-2-yl radical.
[0112] The term "C1-C6-cyanoalkyl" refers to a linear or branched saturated monovalent hydrocarbon radical, wherein the term "C1-C6-alkyl" is as defined above and wherein one or two hydrogen atoms are replaced by a cyano group, for example, cyanomethyl, 1-cyanoethyl, 2-cyanoethyl, 1,2-dicyanoethyl, 3-cyanopropyl, 2-cyanopropyl, 1-cyanopropyl, 1-hydroxypropan-2-yl, 2-cyanopropan-2-yl, 2,3-dicyanopropyl, 1,3-dicyanopropan-2-yl, 3-cyano-2-methylpropyl, 2-cyano-2-methylpropyl, 1-cyano-2-methylpropyl. In particular, the radical has 1, 2 or 3 carbon atoms (“C1-C3-cyanoalkyl”), for example cyanomethyl, 1-cyanoethyl, 2-cyanoethyl, 1,2-dicyanoethyl, 3-cyanopropyl, 2-cyanopropyl, 1-cyanopropyl, 1-cyanoprop-2-yl, 2-cyanoprop-2-yl, 2,3-dicyanopropyl or 1,3-dicyanoprop-2-yl, more specifically the radical has 1, 2 or 3 carbon atoms (“C1-C3-cyanoalkyl”), for example cyanomethyl, 1-cyanoethyl, 2-cyanoethyl, 3-cyanopropyl, 2-cyanopropyl, 1-cyanopropyl, 1-cyanoprop-2-yl or 2-cyanoprop-2-yl.
[0113] The term "C1-C6-alkylthio" denotes a linear or branched saturated monovalent radical of the formula (C1-C6-alkyl)-S-, wherein the term "C1-C6-alkyl" is as defined above, for example methylthio, ethylthio, propylthio, isopropylthio, butylthio, sec-butylthio, isobutylthio, tert-butylthio, pentylthio, isopentylthio, hexylthio radicals.
[0114] The term "C2-C8-haloalkyl" refers to a saturated monovalent hydrocarbon radical that is straight or branched, wherein the term "C2-C8-alkyl" is as defined above, and wherein one or more hydrogen atoms are replaced by identical or different halogen atoms. Specifically, the halogen atom is a fluorine atom. The C2-C8-haloalkyl group is, for example, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 3,3,3-trifluoropropyl or 1,3-difluoroprop-2-yl. Specifically, the group has 2, 3, 4, 5 or 6 carbon atoms ("C2-C6-haloalkyl").
[0115] The term "C1-C6-haloalkyl" refers to a linear or branched saturated monovalent hydrocarbon radical, wherein the term "C1-C6-alkyl" is as defined above and wherein one or more hydrogen atoms are replaced by identical or different halogen atoms. Specifically, the halogen atom is a fluorine atom. The C1-C6-haloalkyl group is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 3,3,3-trifluoropropyl or 1,3-difluoropropyl-2-yl. Specifically, the radical has 1, 2, 3 or 4 carbon atoms (“C1-C4-haloalkyl”), more specifically 1, 2 or 3 carbon atoms (“C1-C3-haloalkyl”), for example fluoromethyl, difluoromethyl, trifluoromethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 3,3,3-trifluoropropyl or 1,3-difluoroprop-2-yl.
[0116] For any substituted alkyl group, the position of the substituent may independently be at any position of the alkyl group, regardless of whether the alkyl group is defined as an "alkyl substituted with [substituent X]" or a "[substituent X]-C1-C6-alkyl" group.
[0117] The term "C1-C6-alkoxy" denotes a linear or branched, saturated, monovalent radical of the formula (C1-C6-alkyl)-O-, wherein the term "C1-C6-alkyl" is as defined above, for example methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy, tert-butoxy, pentyloxy, isopentyloxy or n-hexyloxy, or an isomer thereof. In particular, the radical has 1, 2 or 3 carbon atoms ("C1-C3-alkoxy"), for example methoxy, ethoxy, n-propoxy or isopropoxy.
[0118] The term "C1-C6-haloalkoxy" refers to a straight or branched saturated monovalent C1-C6-alkoxy group as defined above, in which one or more hydrogen atoms are replaced by identical or different halogen atoms. Specifically, the halogen atom is a fluorine atom. The C1-C6-haloalkoxy group is, for example, a fluoromethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy or pentafluoroethoxy group. Specifically, the group has 1, 2 or 3 carbon atoms ("C1-C3-haloalkoxy"), for example a fluoromethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy or pentafluoroethoxy group.
[0119] The term "C2-C6-alkenyl" means a straight-chain or branched monovalent hydrocarbon radical containing one double bond and having 2, 3, 4, 5 or 6 carbon atoms, specifically 2 or 3 carbon atoms ("C2-C3-alkenyl"), it being understood that where the alkenyl group contains more than one double bond, the double bonds may be isolated or conjugated to each other. The alkenyl group is, for example, vinyl, prop-2-en-1-yl (or "allyl"), prop-1-en-1-yl, but-3-enyl, but-2-enyl, but-1-enyl, pent-4-enyl, pent-3-enyl, pent-2-enyl, pent-1-enyl, hex-5-enyl, hex-4-enyl, hex-3-enyl, hex-2-enyl, hex-1-enyl, prop-1-en-2-yl (or "isopropenyl"), 2-methylprop-2-enyl, 1-methylprop-2-enyl, 2-methylprop-1-enyl, 1-methyl Prop-1-enyl, 3-methylbut-3-enyl, 2-methylbut-3-enyl, 1-methylbut-3-enyl, 3-methylbut-2-enyl, 2-methylbut-2-enyl, 1-methylbut-2-enyl, 3-methylbut-1-enyl, 2-methylbut-1-enyl, 1-methylbut-1-enyl, 1,1-dimethylprop-2-enyl, 1-ethylprop-1-enyl, 1-propylvinyl, 1-isopropylvinyl, 4-methylpent-4-enyl, 3-methylpent-4-enyl, 2-methylpent-4-enyl, 1- Methylpent-4-enyl, 4-methylpent-3-enyl, 3-methylpent-3-enyl, 2-methylpent-3-enyl, 1-methylpent-3-enyl, 4-methylpent-2-enyl, 3-methylpent-2-enyl, 2-methylpent-2-enyl, 1-methylpent-2-enyl, 4-methylpent-1-enyl, 3-methylpent-1-enyl, 2-methylpent-1-enyl, 1-methylpent-1-enyl, 3-ethylbut-3-enyl, 2-ethylbut-3-enyl, 1-ethylbut-3-enyl, 3-ethylbut-2-enyl In some embodiments, the group is an allyl group, an 1-propyl group, an 1-propyl group, an 1-propyl group, an 1-iso ...
[0120] The term "C2-C6-alkynyl" denotes a straight-chain or branched monovalent hydrocarbon radical containing one triple bond and having 2, 3, 4, 5 or 6 carbon atoms, specifically 2 or 3 carbon atoms ("C2-C3-alkynyl"). The C2-C6-alkynyl radical is, for example, ethynyl, prop-1-ynyl, prop-2-ynyl (or "propargyl"), but-1-ynyl, but-2-ynyl, but-3-ynyl, pent-1-ynyl, pent-2-ynyl, pent-3-ynyl, pent-4-ynyl, hex-1-ynyl, hex-2-ynyl, hex-3-ynyl, hex-4-ynyl, hex-5-ynyl, 1-methylprop-2-ynyl, 2-methylbut-3-ynyl, 1-methylbut-3-ynyl, 1-methylbut-2-ynyl, 3-methylbut-1-ynyl, 1-ethylprop-2-ynyl, 3-methylpent-4-ynyl. ynyl, 2-methylpent-4-ynyl, 1-methylpent-4-ynyl, 2-methylpent-3-ynyl, 1-methylpent-3-ynyl, 4-methylpent-2-ynyl, 1-methylpent-2-ynyl, 4-methylpent-1-ynyl, 3-methylpent-1-ynyl, 2-ethylbut-3-ynyl, 1-ethylbut-3-ynyl, 1-ethylbut-2-ynyl, 1-propylprop-2-ynyl, 1-isopropylprop-2-ynyl, 2,2-dimethylbut-3-ynyl, 1,1-dimethylbut-3-ynyl, 1,1-dimethylbut-2-ynyl or 3,3-dimethylbut-1-ynyl group.
[0121] The term "bicyclic aryl" refers to an aromatic ring system selected from naphthyl and indenyl.
[0122] The term "partially saturated monocyclic or bicyclic aryl or heteroaryl" includes dihydrophenyl, tetrahydrophenyl, 5- to 7-membered heterocycloalkenyl (as further defined below), indanyl, tetrahydronaphthyl, tetralonyl, dihydroquinolinyl, tetrahydroquinolinyl, dihydroquinazolinyl, tetrahydroquinazolinyl, dihydroisoquinolinyl, tetrahydroisoquinolinyl, dihydrocinnolinyl, tetrahydroquinolinyl, tetrahydroquinazolinyl, dihydro ... quinoxalinyl, tetrahydroquinoxalinyl, dihydropteridinyl or tetrahydropteridinyl, dihydroindolinyl, dihydrobenzofuranyl, dihydrobenzothiophenyl, dihydrobenzimidazolyl, dihydrobenzoxazolyl, dihydrobenzisoxazolyl, dihydrobenzimidazolyl, dihydrobenzothiazolyl, dihydrobenzotriazolyl, dihydroindazolyl, dihydroisoindolyl, dihydroindolizinyl or dihydropurinyl.
[0123] The term "C3-C8-cycloalkyl" refers to a saturated, monovalent, mono- or bicyclic hydrocarbon ring containing 3, 4, 5, 6, 7 or 8 carbon atoms ("C3-C8-cycloalkyl"). The C3-C8-cycloalkyl group is, for example, a monocyclic hydrocarbon ring such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl, or a bicyclic hydrocarbon ring such as bicyclo[4.2.0]octyl or octahydropentenyl. Specifically, the group contains 3, 4, 5 or 6 carbon atoms ("C3-C6-cycloalkyl"), for example, a cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl group. Specifically, the group contains 4, 5, 6, 7 or 8 carbon atoms ("C4-C8-cycloalkyl"). For example, a cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl group.
[0124] The term "C4-C8-cycloalkenyl" denotes a monovalent mono- or bicyclic hydrocarbon ring" which contains 3, 4, 5, 6, 7 or 8 carbon atoms and one double bond. In particular, the ring contains 4, 5 or 6 carbon atoms ("C4-C6-cycloalkenyl"). The C4-C8-cycloalkenyl group is, for example, a monocyclic hydrocarbon ring, such as cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl or cyclooctenyl, or a bicyclic hydrocarbon ring, such as bicyclo[2.2.1]hept-2-enyl or bicyclo[2.2.2]oct-2-enyl.
[0125] The term "C3-C8-cycloalkyloxy" denotes a saturated monovalent mono- or bicyclic radical of the formula (C3-C8-cycloalkyl)-O-, containing 3, 4, 5, 6, 7 or 8 carbon atoms, wherein the term "C3-C8-cycloalkyl" is as defined above, for example cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, cyclohexyloxy, cycloheptyloxy or cyclooctyloxy. In particular, the radical has 3, 4, 5 or 6 carbon atoms ("C3-C6-cycloalkyloxy"), for example cyclopropyloxy, cyclobutyloxy, cyclopentyloxy or cyclohexyloxy.
[0126] The terms "4- to 7-membered heterocycloalkyl" and "4- to 6-membered heterocycloalkyl" refer to monocyclic saturated heterocycles having a total of 4, 5, 6 or 7 or 4, 5 or 6 ring atoms containing one or two identical or different ring heteroatoms of the series N, O and S, said heterocycloalkyl being attached to the remainder of the molecule via any one carbon atom (or, if present, not excluding a nitrogen atom).
[0127] The heterocycloalkyl group may be, but is not limited to, a 4-membered ring such as azetidinyl, oxetanyl, or thietanyl; or, for example, tetrahydrofuranyl, 1,3-dioxolanyl, thiolanyl, pyrrolidinyl, imidazolidinyl, pyrazolidinyl, 1,1-dioxothiolanyl, 1,2-oxazolidinyl, 1,3-oxazolidinyl, or 1,3-thiazolidinyl; or a 6-membered ring such as tetrahydropyranyl, tetrahydrothiopyranyl, piperidinyl, morpholinyl, dithianyl, thiomorpholinyl, piperazinyl, 1,3-dioxanyl, 1,4-dioxanyl, or 1,2-oxazinyl, or a 7-membered ring such as azepanyl, 1,4-diazepanyl, or 1,4-oxazepanyl.
[0128] The terms "4-7-membered nitrogen-containing heterocycloalkyl" and "4-6-membered nitrogen-containing heterocycloalkyl" refer to monocyclic saturated heterocycles having a total of 4, 5, 6 or 7 or 4, 5 or 6 ring atoms, respectively, containing one ring nitrogen atom and optionally another ring heteroatom selected from the series of N, O and S atoms.
[0129] The nitrogen-containing heterocycloalkyl group may be, but is not limited to, a 4-membered ring, such as an azetidinyl group; or a 5-membered ring, such as a pyrrolidinyl group, an imidazolidinyl group, a pyrazolidinyl group, a 1,2-oxazolidinyl group, a 1,3-oxazolidinyl group or a 1,3-thiazolidinyl group; or a 6-membered ring, such as a piperidinyl group, a morpholinyl group, a thiomorpholinyl group, a piperazinyl group or a 1,2-oxazinyl group, or a 7-membered ring, such as an azepanyl group, a 1,4-diazepanyl group or a 1,4-oxepanyl group.
[0130] The term "5- to 7-membered heterocycloalkenyl" refers to a monocyclic, unsaturated, non-aromatic heterocycle having a total of 5, 6 or 7 ring atoms containing one or two double bonds and one or two ring heteroatoms independently selected from the group consisting of N, O, and S.
[0131] The heterocycloalkenyl group is, for example, 4H-pyranyl, 2H-pyranyl, 2,5-dihydro-1H-pyrrolyl, [1,3]dioxolyl, 4H-[1,3,4]thiadiazinyl, 2,5-dihydrofuranyl, 2,3-dihydrofuranyl, 2,5-dihydrothienyl, 2,3-dihydrothienyl, 4,5-dihydrooxazolyl or 4H-[1,4]thiazinyl.
[0132] The term "4- to 7-membered optionally unsaturated heterocyclyl" encompasses the terms "4- to 7-membered heterocycloalkyl" and "5- to 7-membered heterocycloalkenyl."
[0133] The term "aryl" refers to phenyl and naphthyl.
[0134] The term "phenyl wherein two ortho substituents may together form a 5- or 6-membered, optionally aromatic or non-aromatic ring, and optionally containing a C(=O) group" includes naphthyl, indanyl and tetrahydronaphthyl.
[0135] The term "heteroaryl" denotes monovalent monocyclic and bicyclic aromatic rings having 5, 6, 8, 9 or 10 ring atoms (a "5-10-membered heteroaryl" group), specifically 5, 6, 9 or 10 ring atoms, which contain at least one ring heteroatom and optionally one, two or three further ring heteroatoms from the series N, O and / or S, and are bonded via a ring carbon atom or optionally via a ring nitrogen atom (if permitted by valence).
[0136] The heteroaryl group can be a 5-membered heteroaryl group, for example, thienyl, furanyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, triazolyl, thiadiazolyl or tetrazolyl; or a 6-membered heteroaryl group, for example, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl or triazinyl; or a 9-membered heteroaryl group, for example, benzofuranyl, benzothienyl, benzoxazolyl, benzisoxazolyl, benzimidazolyl, benzothiazolyl, benzotriazolyl, indazolyl, indolyl, isoindolyl, indolizinyl or purinyl; or a 10-membered heteroaryl group, for example, quinolinyl, quinazolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinoxalinyl or pteridinyl.
[0137] In general and unless otherwise specified, a heteroaryl or heteroarylene group includes all possible isomeric forms thereof, such as tautomers and positional isomers relative to the point of attachment to the rest of the molecule. Thus, for some illustrative, non-limiting examples, the term pyridyl includes pyridin-2-yl, pyridin-2-ene, pyridin-3-yl, and pyridin-4-yl; or the term thienyl includes thien-2-yl and thien-3-yl.
[0138] The term "C1-C6" as used in the present context, for example in the context of the definition of "C1-C6-alkyl", "C1-C6-haloalkyl", "C1-C6-hydroxyalkyl", "C1-C6-alkoxy", or "C1-C6-haloalkoxy", refers to an alkyl group having a finite number of carbon atoms of 1 to 6, i.e. having 1, 2, 3, 4, 5, or 6 carbon atoms.
[0139] Furthermore, as used herein, the term "C3-C8" as used herein in the context, for example in the context of the definition of "C3-C8-cycloalkyl", refers to a cycloalkyl group having a finite number of carbon atoms of 3 to 8, i.e. having 3, 4, 5, 6, 7 or 8 carbon atoms.
[0140] When a range of values is given, that range includes every value and sub-range within that range.
[0141] For example,
[0142] "C1-C8" includes C1, C2, C3, C4, C5, C6, C7, C8, C1-C8, C1-C7, C1-C6, C1-C5, C1-C4, C1-C3, C1-C2, C2-C8, C2-C7, C2-C6, C2-C5, C2-C4, C2-C3, C3-C8, C3-C7, C3-C6, C3-C5, C3-C4, C4-C8, C4-C7, C4-C6, C4-C5, C5-C8, C5-C7, C5-C6, C6-C8, C6-C7, and C7-C8;
[0143] "C1-C6" includes C1, C2, C3, C4, C5, C6, C1-C6, C1-C5, C1-C4, C1-C3, C1-C2, C2-C6, C2-C5, C2-C4, C2-C3, C3-C6, C3-C5, C3-C4, C4-C6, C4-C5, and C5-C6;
[0144] "C1-C4" includes C1, C2, C3, C4, C1-C4, C1-C3, C1-C2, C2-C4, C2-C3, and C3-C4;
[0145] "C1-C3" includes C1, C2, C3, C1-C3, C1-C2, and C2-C3;
[0146] "C2-C6" includes C2, C3, C4, C5, C6, C2-C6, C2-C5, C2-C4, C2-C3, C3-C6, C3-C5, C3-C4, C4-C6, C4-C5, and C5-C6;
[0147] "C3-C8" includes C3, C4, C5, C6, C7, C8, C3-C8, C3-C7, C3-C6, C3-C"C4-C7" includes C4, C5, C6, C7, C4-C7, C4-C6, C4-C5, C5-C7, C5-C6 and C6-C7;
[0151] "C4-C6" includes C4, C5, C6, C4-C6, C4-C5, and C5-C6;
[0152] "C5-C 10 "Including C5, C6, C7, C8, C9, C 10 、C5-C 10 ,C5-C9,C5-C8,C5-C7,C5-C6,C6-C 10 ,C6-C9,C6-C8,C6-C7,C7-C 10 、C7-C9、C7-C8、C8-C 10 , C8-C9 and C9-C 10 ;
[0153] "C6-C 10 "Including C6, C7, C8, C9, C 10 、C6-C 10 ,C6-C9,C6-C8,C6-C7,C7-C 10 、C7-C9、C7-C8、C8-C 10 , C8-C9 and C9-C 10 .
[0154] As used herein, the term "as defined above" means as defined anywhere in the specification and claims.
[0155] As used herein, the term "leaving group" refers to an atom or group of atoms that is displaced in a chemical reaction as a stabilizing species for the electrons bound thereto. Specifically, such leaving groups are selected from the group consisting of halides, specifically fluorides, chlorides, bromides, or iodides, (methylsulfonyl)oxy, [(trifluoromethyl)sulfonyl]oxy, [(nonafluorobutyl)sulfonyl]oxy, (phenylsulfonyl)oxy, [(4-methylphenyl)sulfonyl]oxy, [(4-bromophenyl)sulfonyl]oxy, [(4-nitrophenyl)sulfonyl]oxy, [(2-nitrophenyl)sulfonyl]oxy, [(4-isopropylphenyl)sulfonyl]oxy, [(2,4,6-triisopropylphenyl)sulfonyl]oxy, [(2,4,6-trimethylphenyl)sulfonyl]oxy, [(4-tert-butylphenyl)sulfonyl]oxy, and [(4-methoxyphenyl)sulfonyl]oxy.
[0156] The term "substituent" refers to a "substituted" group that replaces one or more hydrogen atoms on any atom of the group, for example, on an alkyl, haloalkyl, cycloalkyl, heterocyclyl, heterocyclylalkenyl, cycloalkenyl, aryl or heteroaryl group. In one aspect, the substituent on the group is independently any single atom or atomic group, or any combination of two or more permissible atoms or atomic groups depicted for the substituent. On the other hand, the substituent itself can be substituted with any one of the above-mentioned substituents. In addition, as used herein, the phrase "optionally substituted" refers to unsubstituted (e.g., substituted with H) or substituted.
[0157] It should be understood that the description of compounds herein is limited by the principles of chemical bonding known to those skilled in the art. Thus, when a group may be substituted with one or more of a variety of substituents, such substitutions are selected to conform to the principles of chemical bonding with respect to valence, etc., and to yield compounds that are not inherently unstable. For example, any carbon atom will be bonded to two, three, or four other atoms, consistent with the four valence electrons of carbon.
[0158] "Subject" refers to a mammal, including but not limited to a human or a non-human mammal, such as a bovine, equine, canine, ovine, rodent, or feline.
[0159] The compounds of formula (I) may exist as isotopic variations. Accordingly, the present invention includes one or more isotopic variations of the compounds of formula (I), in particular deuterated compounds of formula (I).
[0160] The term "isotopic variation" of a compound or agent is defined as a compound that exhibits unnatural ratios of one or more isotopes that constitute such compound.
[0161] The term "isotopic variation of a compound of formula (I)" is defined as a compound of formula (I) that exhibits an unnatural ratio of one or more isotopes that constitute such compound.
[0162] The expression "unnatural proportions" in relation to an isotope means that the proportion of this isotope is higher than its natural abundance. The natural abundance of isotopes used in this context is described in "Isotopic Compositions of the Elements 1997", Pure Appl. Chem., 70(1), 217-235, 1998.
[0163] Examples of such isotopes include stable and radioactive isotopes of hydrogen, carbon, nitrogen, oxygen, phosphorus, sulfur, fluorine, chlorine, bromine and iodine, for example 2 H (deuterium), 3 H (tritium), 11 C, 13 C, 14C, 15 N, 17 O, 18 O, 32 P, 33 P, 33 S, 34 S, 35 S, 36 S, 18 F, 36 Cl, 82 Br, 123 I, 124 I, 125 I, 129 I and 131 I.
[0164] For the treatment and / or prevention of the conditions described herein, isotopic variations of the compounds of formula (I) preferably contain deuterium ("deuterated compounds of formula (I)"). 3 H or 14 Isotopic variations of compounds of formula (I) having a C-terminal structure are useful, for example, in drug and / or substrate tissue distribution studies. These isotopes are particularly preferred because they are easy to incorporate and detect. Positron emitting isotopes such as 18 F or 11 C can be incorporated into the compounds of formula (I). These isotopic variants of the compounds of formula (I) can be used for in vivo imaging applications. 13 Compounds of formula (I) of C can be used for mass spectrometry analysis in preclinical or clinical research settings.
[0165] Isotopic variants of the compound of general formula (I) can generally be prepared by methods well known to those skilled in the art, such as those described in the scheme and / or embodiments herein, by replacing a reagent with an isotopic variant of the reagent, preferably for deuterated reagents. Depending on the desired deuteration site, in some cases, deuterium from D2O can be directly incorporated into the compound or incorporated into a reagent that can be used to synthesize these compounds. Deuterium gas is also a useful reagent for incorporating deuterium into molecules. The catalytic deuteration of olefinic and acetylenic bonds is a rapid pathway for incorporation of deuterium. Metal catalysts (i.e., Pd, Pt, and Rh) in the presence of deuterium gas can be used to directly exchange deuterium with hydrogen in a functional group containing hydrocarbons. Various deuterated reagents and synthetic building blocks are commercially available from companies such as: C / D / N Isotopes, Quebec, Canada; Cambridge Isotope Laboratories Inc., Andover, MA, USA; and CombiPhos Catalysts, Inc., Princeton, NJ, USA.
[0166] The term "deuterated compound of formula (I)" is defined as a compound of formula (I) wherein one or more hydrogen atoms are replaced by one or more deuterium atoms and wherein the abundance of deuterium at each deuterated position of the compound of formula (I) is greater than the natural abundance of deuterium (approximately 0.015%). Specifically, in the deuterated compound of formula (I), the abundance of deuterium at each deuterated position of the compound of formula (I) is greater than 10%, 20%, 30%, 40%, 50%, 60%, 70% or 80%, preferably greater than 90%, 95%, 96% or 97%, even more preferably greater than 98% or 99% at said position. It will be understood that the deuterium abundance at each deuterated position is independent of the deuterium abundance at other deuterated positions.
[0167] The selective incorporation of one or more deuterium atoms into compounds of general formula (I) can alter the physicochemical properties (e.g. acidity [CL Perrin, et al., J. Am. Chem. Soc., 2007, 129, 4490], basicity [CL Perrin et al., J. Am. Chem. Soc., 2005, 127, 9641], lipophilicity [B. Testa et al., Int. J. Pharm., 1984, 19 (3), 271]) and / or metabolic characteristics of the molecule, and can result in a change in the ratio of parent compound to metabolite or the number of metabolites formed. These changes may result in certain therapeutic advantages and may therefore be preferred in certain circumstances. A reduction in metabolic rate and metabolic turnover rate has been reported, wherein the ratio of metabolites is altered (AEMutlib et al., Toxicol. Appl. Pharmacol., 2000, 169, 102). These changes in exposure to the parent drug and metabolites may have important consequences for the pharmacodynamics, tolerance and efficacy of the deuterated compounds of general formula (I). In some cases, deuterium substitution reduces or eliminates the formation of undesirable or toxic metabolites and enhances the formation of desired metabolites (e.g., nevirapine: AM Sharma et al., Chem. Res. Toxicol., 2013, 26, 410; Efavirenz: AEMutlib et al., Toxicol. Appl. Pharmacol., 2000, 169, 102). In other cases, the main effect of deuteration is to reduce systemic clearance. Therefore, the biological half-life of the compound is increased. Potential clinical benefits include the ability to maintain similar systemic exposure, reduced peak levels and increased trough levels. This may result in lower side effects and enhanced efficacy, depending on the pharmacokinetic / pharmacodynamic relationship of the specific compound. ML-337 (CJ Wenthur et al., J. Med. Chem., 2013, 56, 5208) and Odankapol (K. Kassahun et al., WO 2012 / 112363) are examples of this deuterium effect. Other examples have also been reported, in which the reduced metabolic rate leads to increased drug exposure without changing systemic clearance (e.g., rofecoxib: Schneider et al., Arzneim. Forsch. / Drug. Res., 2006, 56, 295; Telaprevir: F. Maltais et al., J. Med. Chem., 2009, 52, 7993). Deuterated drugs showing this effect can reduce dosing requirements (e.g., reduced dosing frequency or reduced dosage to achieve the desired effect) and / or can produce reduced metabolite load.
[0168] The compound of general formula (I) can have multiple potential metabolic attack sites. In order to optimize the above-mentioned influence on physicochemical properties and metabolic characteristics, the deuterated compound of general formula (I) with a specific pattern of one or more deuterium-hydrogen exchanges can be selected. Specifically, the deuterium atom of the deuterated compound of general formula (I) is connected to a carbon atom and / or is located at those positions of the compound of general formula (I) that are metabolic enzymes such as cytochrome P 450 attack site.
[0169] In another embodiment, the present invention relates to deuterium-containing compounds of the general formula (I) having 1, 2, 3 or 4 deuterium atoms, in particular 1, 2 or 3 deuterium atoms.
[0170] When plural forms of compounds, salts, polymorphs, hydrates, solvates, etc. are used herein, this also means a single compound, salt, polymorph, isomer, hydrate, solvate, etc.
[0171] By "stable compound" or "stable structure" is meant a compound that is sufficiently robust to survive isolation to a useful degree of purity from a reaction mixture, and formulation into an efficacious therapeutic agent.
[0172] Depending on the desired position and properties of the various substituents, the compounds of the present invention may contain one or more asymmetric centers. Asymmetric carbon atoms may exist in the (R) or (S) configuration, forming a racemic mixture in the case of a single asymmetric center and a mixture of diastereomers in the case of multiple asymmetric centers. In some cases, asymmetry may also exist due to the restricted rotation around a given bond, for example, the central bond connecting two substituted aromatic rings of a particular compound.
[0173] Preferred isomers are those that produce more desirable biological activity. Isolation, purification or partially purified isomers or racemic mixtures of the compounds of the invention are also included within the scope of the invention. Purification and separation of such substances can be achieved by standard techniques known in the art.
[0174] Optical isomers can be obtained by resolving the racemic mixture according to conventional methods, for example, using optically active acids or bases to form diastereomeric salts, or forming covalent diastereoisomers. Examples of suitable acids are tartaric acid, diacetyltartaric acid, ditoluoyltartaric acid and camphorsulfonic acid. Using methods well known to those skilled in the art, for example, chromatography or fractional crystallization, mixtures of diastereoisomers can be separated into their single diastereoisomers based on their physical and / or chemical differences. The optically active acid or base is then released from the separated diastereomeric salts. Different methods for separating optical isomers include: using chiral chromatography (for example, using an HPLC column with a chiral phase) with or without conventional derivatization, preferably selecting a method that maximizes the separation of enantiomers. Suitable HPLC columns using chiral phases are commercially available, such as those produced by Daicel, for example, Chiracel OD and Chiracel OJ, and many other chiral HPLC columns are generally available. Enzymatic separation is also used with or without derivatization. Likewise, the optically active compounds of the present invention can be obtained by chiral synthesis using optically active starting materials.
[0175] In order to distinguish isomers of different types from each other, reference is made to IUPAC Rules Section E (Pure Appl Chem 45, 11-30, 1976).
[0176] Separation of single stereoisomers (eg, single enantiomers or single diastereomers) of the compounds of the invention can be achieved by any suitable method known in the art, such as chromatography, especially chiral chromatography.
[0177] In addition, the compounds of the present invention may exist as tautomers. For example, any compound of the present invention containing an imidazopyridine moiety as a heteroaryl group may exist as a 1H tautomer, or a 3H tautomer, or even a mixture of any amount of both tautomers, i.e.:
[0178]
[0179] The present invention includes all possible tautomers of the compounds of the present invention, either as single tautomers or as any mixture of said tautomers in any ratio.
[0180] Additionally, the compounds of the present invention may exist as N-oxides, which are defined as compounds of the present invention in which at least one nitrogen atom is oxidized. The present invention includes all such possible N-oxides.
[0181] The present invention also relates to useful forms of the compounds disclosed herein, such as metabolites, hydrates, solvates, prodrugs, salts, especially pharmaceutically acceptable salts, and / or coprecipitates.
[0182] The compounds of the present invention may exist in the form of hydrates or solvates, wherein the compounds of the present invention contain polar solvents, such as water, methanol or ethanol, as structural elements of the crystal lattice of the compound. The amount of polar solvent, especially water, may be present in a stoichiometric or non-stoichiometric ratio. In the case of stoichiometric solvates, such as hydrates, these may be hemi-, semi-, mono-, sesqui-, di-, tri-, tetra-, penta-solvates or hydrates, etc. The present invention includes all such hydrates or solvates.
[0183] Furthermore, the compounds of the present invention may exist in free form, for example as a free base, a free acid, or a zwitterion, or in the form of a salt. The salt may be any salt commonly used in pharmacy, whether an organic or inorganic addition salt, in particular any pharmaceutically acceptable organic or inorganic addition salt, or a salt useful, for example, for isolating or purifying the compounds of the present invention.
[0184] The term "pharmaceutically acceptable salt" refers to a relatively non-toxic inorganic or organic acid addition salt of a compound of the present invention. For example, see SM Berge, et al. "Pharmaceutical Salts," J. Pharm. Sci. 1977, 66, 1-19.
[0185] Suitable pharmaceutically acceptable salts of the compounds of the invention may be, for example, acid addition salts of the compounds of the invention carrying nitrogen atoms in the chain or ring (for example, when they are sufficiently basic), such as acid addition salts formed with inorganic acids or "mineral acids", such as hydrochlorides, hydrobromides, hydroiodides, sulfates, sulfamates, hydrogensulfates, phosphates or nitrates, or acid addition salts formed with organic acids, such as formate, acetate, acetoacetate, pyruvate, trifluoroacetate, propionate, butyrate, hexanoate, heptanoate, undecanoate, laurate, benzoate, salicylate, 2-(4-hydroxybenzoyl)-benzoate, camphorate, cinnamate, cyclopentanepropionic acid. salt, digluconate, 3-hydroxy-2-naphthoate, nicotinate, pamoate, pectinate, 3-phenylpropionate, picrate, pivalate, 2-hydroxyethanesulfonate, itaconate, trifluoromethanesulfonate, dodecylsulfate, ethanesulfonate, benzenesulfonate, p-toluenesulfonate, methanesulfonate, 2-naphthalenesulfonate, naphthalenedisulfonate, camphorsulfonate, citrate, tartrate, stearate, lactate, oxalate, malonate, succinate, malate, adipate, alginate, maleate, fumarate, D-gluconate, mandelate, ascorbate, glucoheptonate, glycerophosphate, aspartate, sulfosalicylate, or thiocyanate.
[0186] Furthermore, other suitable pharmaceutically acceptable salts of the compounds of the invention which are sufficiently acidic are alkali metal salts, such as sodium or potassium salts, alkaline earth metal salts, such as calcium, magnesium or strontium salts, or ammonium or zinc salts, or ammonium salts derived from ammonia or from organic primary, secondary or tertiary amines having 1 to 20 carbon atoms, for example ammonium salts from ethylamine, diethylamine, triethylamine, ethyldiisopropylamine, monoethanolamine, diethanolamine, triethanolamine, dicyclohexylamine, dimethylaminoethanol, diethylaminoethanol, tris(hydroxymethyl)aminomethane, procaine, dibenzylamine, N-methylmorpholine, arginine, lysine, 1,2- Ethylenediamine, N-methylpiperidine, N-methyl-glucamine, N,N-dimethyl-glucamine, N-ethyl-glucamine, 1,6-hexanediamine, glucosamine, sarcosine, serinol, 2-amino-1,3-propanediol, 3-amino-1,2-propanediol, 4-amino-1,2,3-butanetriol, or salts with quaternary ammonium ions having 1 to 20 carbon atoms, such as salts from tetramethylammonium, tetraethylammonium, tetra(n-propyl)ammonium, tetra(n-butyl)ammonium, N-benzyl-N,N,N-trimethylammonium, choline or benzalkonium.
[0187] Those skilled in the art will further appreciate that the acid addition salts of the claimed compounds can be prepared by any of a number of known methods by reacting the compounds with a suitable inorganic or organic acid. Alternatively, alkali metal or alkaline earth metal salts of the acidic compounds of the present invention can be prepared by reacting the compounds of the present invention with a suitable base by various known methods.
[0188] The present invention includes all possible salts of the compounds of the present invention, either as single salts or as any mixture of all salts in any ratio.
[0189] One aspect of the present invention is the tautomers, N-oxides or salts thereof, and salts of the tautomers or N-oxides.
[0190] The present invention includes diastereomers, racemates, tautomers, N-oxides, hydrates, solvates and salts of the compounds of the present invention, and mixtures thereof.
[0191] In this text, in particular in the experimental part, for synthetic intermediates and examples according to the present invention, when reference is made to compounds in the form of salts with the corresponding bases or acids (obtained by the respective preparation and / or purification methods), the exact stoichiometric composition of said salts is, in most cases, not known.
[0192] Unless otherwise indicated, suffixes to chemical names or structural formulas relating to salts, such as "hydrochloride", "trifluoroacetate", "sodium salt" or "xHCl", "xCF3COOH", "xNa + ″, for example, refers to a salt form without specifying the stoichiometry of the salt form.
[0193] This applies analogously to the case in which the synthesis intermediates or their example compounds or salts thereof are obtained by the preparation and / or purification processes as solvates, for example hydrates, which have (if defined) an unknown stoichiometric composition.
[0194] Furthermore, the present invention includes all possible crystalline forms or polymorphs of the compounds of the present invention, either as a single polymorph or as a mixture of more than one polymorph in any ratio.
[0195] Furthermore, the present invention also includes prodrugs of the compounds according to the invention. The term "prodrug" herein means that these compounds themselves may be biologically active or inactive, but are converted (eg metabolized or hydrolyzed) into the compounds according to the invention during their residence time in the body.
[0196] According to certain embodiments, the present invention provides compounds of formula (I), as above,
[0197] in
[0198] R 1 represents a group selected from the following:
[0199] C4-C8-cycloalkyl,
[0200] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0201] and wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0202] -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[0203] 4- to 7-membered heterocycloalkyl, 5- to 7-membered heterocycloalkenyl,
[0204] wherein the 4- to 7-membered heterocycloalkyl and the 5- to 7-membered heterocycloalkenyl are attached to the rest of the molecule via carbon atoms and are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo(=O),
[0205] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0206] phenyl group,
[0207] which are optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), hydroxyl, cyano, C1-C6-hydroxyalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(=O)OR 6 、-C(=O)N(R7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 ), -OC(=O)-(C1-C6-alkyl)-, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2N(R 7 )(R 8 ), -S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -S(=O)(=NR 11 )(C1-C3-alkyl), -N(O)2, -P(=O)(C1-C3-alkyl)2 and SF5,
[0208] or
[0209] wherein the two ortho substituents may together form a 5- or 6-membered optionally heterocyclic, aromatic or non-aromatic ring, which optionally has 1-3 heteroatoms independently selected from the following: -N=, -NH-, -N(R 7 )-, -O-, -S-, and optionally containing a C(═O) group, and wherein the ring so formed is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[0210] and
[0211] Bicyclic aryl,
[0212] partially saturated monocyclic or bicyclic aryl or heteroaryl,
[0213] a monocyclic or bicyclic heteroaryl group,
[0214] which is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -O(C2-C6-alkenyl), C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, C(=O)OR 6 , hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -N(O)2 and -N(R 7 )(R 8 ),
[0215] R 2 represents a hydrogen atom or a halogen atom,
[0216] R 3 represents a group selected from the following,
[0217] C1-C6-alkyl,
[0218] which are optionally replaced by C3-C8-cycloalkyl or NR 7 R 8 Group substitution,
[0219] C3-C8-cycloalkyl,
[0220] C1-C6-haloalkyl,
[0221] C1-C6-hydroxyalkyl,
[0222] C2-C6-alkenyl,
[0223] C2-C6-alkynyl,
[0224] C4-C8-cycloalkenyl,
[0225] (C1-C6-alkyl)-N(R 7 )R 8 Group
[0226] -(C1-C6-alkyl)-(4- to 7-membered nitrogen-containing heterocycloalkyl) group,
[0227] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0228] and which are optionally substituted by C1-C3-alkyl, and
[0229] Phenyl,
[0230] which is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -N(O)2 and -N(R 7 )(R 8 ),
[0231] R 4 represents a group selected from the following
[0232] C1-C6-alkyl,
[0233] which are optionally substituted by a group selected from the group consisting of C3-C8-cycloalkyl and phenyl,
[0234] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(=O)OR 6 , hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -N(O)2 and -N(R 7 )(R 8 ),
[0235] C2-C6-alkenyl,
[0236] C3-C8-cycloalkyl,
[0237] C2-C6-haloalkyl,
[0238] C2-C6-hydroxyalkyl,
[0239] -(C2-C6-alkyl)-N(R 7)(R 8 ) group,
[0240] R 5 represents a halogen atom or a group selected from the following:
[0241] C1-C6-alkyl,
[0242] C3-C8-cycloalkyl,
[0243] C1-C6-haloalkyl, which is optionally substituted by hydroxy,
[0244] C1-C6-hydroxyalkyl,
[0245] -(C1-C6-alkyl)-N(R 7 )(R 8 ) group,
[0246] -(C1-C6-alkyl)-O-(C1-C6-alkyl) group,
[0247] C2-C6-alkenyl,
[0248] C2-C6-alkynyl,
[0249] C1-C6-alkoxy groups,
[0250] C1-C6-alkylthio and
[0251] -N(R 7 )(R 8 ) group,
[0252] -C(=O)OR 6 Group,
[0253] -C(=O)N(R 7 )(R 8 ) group,
[0254] -S(=O)(=NR 11 )(C1-C3-alkyl) groups, and
[0255] Phenyl,
[0256] which is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(=O)OR 6, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -N(O)2 and -N(R 7 )(R 8 ),
[0257] R 6 represents a hydrogen atom or a group selected from the following:
[0258] C1-C6-alkyl and benzyl,
[0259] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from:
[0260] C1-C6-alkyl, C2-C6-hydroxyalkyl, C3-C6-cycloalkyl and -(C2-C6-alkyl)-N(R 9 )(R 10 ) group,
[0261] or
[0262] R 7 and R 8 Together with the nitrogen to which they are attached, they represent a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0263] which are optionally substituted by a group selected from the group consisting of C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0264] R 9 and R 10 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group,
[0265] or
[0266] R 9 and R 10 Together with the nitrogen to which they are attached, they represent a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0267] R 11 represents a hydrogen atom or a group selected from the following:
[0268] cyano and -C(=O)(C1-C3-haloalkyl) groups,
[0269] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[0270] According to some embodiments, the present invention provides a compound of the above general formula (I),
[0271]
[0272] in:
[0273] R 1 represents a group selected from the following:
[0274] C5-C8-alkyl,
[0275] C2-C8-haloalkyl,
[0276] C4-C8-cycloalkyl,
[0277] C1-C6-alkyl, which is substituted by C3-C8-cycloalkyl,
[0278] C2-C6-alkyl, which is substituted by a cyano or phenyl group,
[0279] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[0280] C2-C6-hydroxyalkyl,
[0281] (C2-C6-hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[0282] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[0283] -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[0284] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[0285] 4-7-membered optionally unsaturated heterocyclic group,
[0286] Phenyl and
[0287] a monocyclic or bicyclic heteroaryl group,
[0288] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0289] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0290] and
[0291] wherein the 4- to 7-membered heterocycloalkyl and 5- to 7-membered heterocycloalkenyl groups are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[0292] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0293] and
[0294] wherein the 4-7-membered optionally unsaturated heterocyclic group is attached to the remainder of the molecule via a carbon atom,
[0295] and
[0296] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C1-C6-hydroxyalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxy, aryl, -O-aryl, cyano, -C(O)OH, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 ), -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -S(=O)2N(R 7 )(R 8)、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -N(O)2, -P(=O)(C1-C3-alkyl)2 and SF5,
[0297] or wherein the two ortho substituents of the phenyl group may together form a 5- or 6-membered optionally heterocyclic, aromatic or non-aromatic ring, which optionally has 1-3 heteroatoms independently selected from the group consisting of: -N=, -NH-, -N(R 7 )-, -O-, -S-, and optionally containing a C(═O) group, and wherein the ring so formed is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[0298] and
[0299] wherein the monocyclic or bicyclic heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -O(C2-C6-alkenyl), C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[0300] R 2 represents a hydrogen atom or a halogen atom,
[0301] R 3 represents a group selected from the following:
[0302] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C4-C8-cycloalkenyl, (C1-C6-alkyl)-N(R 7 )R 8 group, -(C1-C6-alkyl)-(4- to 7-membered nitrogen-containing heterocycloalkyl) group and phenyl,
[0303] wherein the C1-C6-alkyl group is optionally substituted by a C3-C8-cycloalkyl group,
[0304] and
[0305] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a C1-C3-alkyl group,
[0306] and
[0307] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0308] and
[0309] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxyl, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[0310] R 4 represents a group selected from the following:
[0311] C1-C6-alkyl, C3-C8-cycloalkyl, C2-C6-haloalkyl, C2-C6-hydroxyalkyl and -(C2-
[0312] C6-alkyl)-N(R 7 )(R 8 ) group,
[0313] wherein the C1-C6-alkyl group is optionally substituted by a group selected from the group consisting of C3-C8-cycloalkyl and phenyl,
[0314] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxyl, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[0315] R 5 represents a halogen atom or a group selected from the following:
[0316] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, (C1-C3-alkoxy)-(C1-C6-alkyl)-group, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy group, C1-C6-alkylthio group, -(C1-C6-alkyl)-N(R 7 )(R 8 ) group and -N(R 7 )(R 8 ) group,
[0317] R 6 represents a hydrogen atom or a group selected from the following:
[0318] C1-C6-alkyl and benzyl,
[0319] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from:
[0320] C1-C6-alkyl, C2-C6-hydroxyalkyl and -(C2-C6-alkyl)-N(R 9 )(R 10 ) group,
[0321] or
[0322] R 7 and R 8 Together with the nitrogen to which they are attached
[0323] a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0324] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a group selected from the following:
[0325] C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0326] R 9 and R 10 Each occurrence independently represents a hydrogen atom or a C1-C3-alkyl group,
[0327] or
[0328] R 9 and R 10 Together with the nitrogen to which they are attached, they represent a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0329] R 11 represents a hydrogen atom or a group selected from the following:
[0330] cyano and -C(=O)(C1-C3-haloalkyl) groups,
[0331] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[0332] According to some embodiments, the present invention provides a compound of the above general formula (I), wherein:
[0333] R 1 represents a group selected from the following:
[0334] C5-C8-alkyl,
[0335] C2-C8-haloalkyl,
[0336] C4-C8-cycloalkyl,
[0337] C1-C6-alkyl, which is substituted by C3-C8-cycloalkyl,
[0338] C2-C6-alkyl, which is substituted by a cyano or phenyl group,
[0339] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[0340] C2-C6-hydroxyalkyl,
[0341] (C2-C6-hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[0342] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[0343] -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[0344] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[0345] 4-7-membered heterocycloalkyl,
[0346] 5- to 7-membered heterocycloalkenyl,
[0347] Phenyl and
[0348] a monocyclic or bicyclic heteroaryl group,
[0349] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0350] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0351] and
[0352] wherein the 4- to 7-membered heterocycloalkyl and 5- to 7-membered heterocycloalkenyl groups are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[0353] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0354] and
[0355] wherein the 4-7-membered optionally unsaturated heterocyclic group is attached to the remainder of the molecule via a carbon atom,
[0356] and
[0357] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C1-C6-hydroxyalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxy, aryl, -O-aryl, cyano, -C(O)OH, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 ), -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2, -S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -N(O)2, -P(=O)(C1-C3-alkyl)2 and SF5,
[0358] or wherein the two ortho substituents of the phenyl group may together form a 5- or 6-membered optionally heterocyclic, aromatic or non-aromatic ring, which optionally has 1-3 heteroatoms independently selected from the group consisting of: -N=, -NH-, -N(R 7 )-, -O-, -S-, and optionally containing a C(═O) group, and wherein the ring so formed is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2(C1-C6-alkyl), -N(O)2 and -N(R7 )(R 8 ),
[0359] and
[0360] wherein the monocyclic or bicyclic heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -O(C2-C6-alkenyl), C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[0361] R 2 represents a hydrogen atom or a halogen atom,
[0362] R 3 represents a group selected from the following:
[0363] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C4-C8-cycloalkenyl, (C1-C6-alkyl)-N(R 7 )R 8 Group, -(C1-
[0364] C6-alkyl)-(4- to 7-membered nitrogen-containing heterocycloalkyl) group and phenyl,
[0365] wherein the C1-C6-alkyl group is optionally substituted by a C3-C8-cycloalkyl group,
[0366] and
[0367] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a C1-C3-alkyl group,
[0368] and
[0369] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0370] and
[0371] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxyl, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[0372] R 4 represents a group selected from the following:
[0373] C1-C6-alkyl, C3-C8-cycloalkyl, C2-C6-haloalkyl, C2-C6-hydroxyalkyl and -(C2-C6-alkyl)-N(R 7 )(R 8 ) group,
[0374] wherein the C1-C6-alkyl group is optionally substituted by a group selected from the group consisting of C3-C8-cycloalkyl and phenyl,
[0375] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxyl, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[0376] R 5 represents a halogen atom or a group selected from the following:
[0377] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, (C1-C3-alkoxy)-(C1-C6-alkyl)-group, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy group, C1-C6-alkylthio group, -(C1-C6-alkyl)-N(R 7 )(R 8 ) group and -N(R 7 )(R 8 ) group,
[0378] R 6 represents a hydrogen atom or a group selected from the following:
[0379] C1-C6-alkyl and benzyl,
[0380] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from:
[0381] C1-C6-alkyl, C2-C6-hydroxyalkyl and -(C2-C6-alkyl)-N(R 9 )(R 10 ) group,
[0382] or
[0383] R 7 and R 8 Together with the nitrogen to which they are attached, they represent a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0384] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a group selected from the following:
[0385] C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0386] R 9 and R 10 Each occurrence independently represents a hydrogen atom or a C1-C3-alkyl group,
[0387] or
[0388] R 9 and R 10 Together with the nitrogen to which they are attached, they represent a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0389] R 11 represents a hydrogen atom or a group selected from the following:
[0390] cyano and -C(=O)(C1-C3-haloalkyl) groups,
[0391] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[0392] According to some embodiments, the present invention provides a compound of the above general formula (I), wherein:
[0393] R 1 represents a group selected from the following:
[0394] C5-C8-alkyl,
[0395] C2-C8-haloalkyl,
[0396] C4-C8-cycloalkyl,
[0397] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0398] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0399] C1-C6-alkyl, which is substituted by C3-C8-cycloalkyl,
[0400] C2-C6-alkyl, which is substituted by cyano, hydroxy or phenyl groups,
[0401] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[0402] (C2-C6-hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[0403] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[0404] -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[0405] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[0406] 4- to 7-membered heterocycloalkyl,
[0407] which is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[0408] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0409] and wherein the 4- to 7-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of the heterocycloalkyl group or heterocycloalkenyl group,
[0410] 5- to 7-membered heterocycloalkenyl,
[0411] It is optionally substituted once or twice, each substituent being independently selected from the following groups:
[0412] C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -
[0413] C(═O)(C1-C6-alkyl), —C(═O)(C3-C6-cycloalkyl), —S(═O)2(C1-C6-alkyl) and oxo(═O),
[0414] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0415] and wherein the 5- to 7-membered heterocycloalkenyl group is linked to the remainder of the molecule via a carbon atom of the heterocycloalkyl or heterocycloalkenyl group,
[0416] phenyl group,
[0417] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[0418] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from:
[0419] -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-,
[0420] Indanyl group, tetrahydronaphthyl,
[0421] wherein the indanyl or tetrahydronaphthyl is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0422] and
[0423] a monocyclic or bicyclic heteroaryl group,
[0424] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0425] R 2 represents a hydrogen atom or a halogen atom,
[0426] R 3 represents a group selected from the following:
[0427] C1-C6-alkyl,
[0428] which are optionally replaced by C3-C8-cycloalkyl or NR 7 R 8 C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C4-C8-cycloalkenyl, (C1-C6-alkyl)-N(R 7 )R 8 group, -(C1-C6-alkyl)-(4- to 7-membered nitrogen-containing heterocycloalkyl) group, and
[0429] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a C1-C3-alkyl group,
[0430] and
[0431] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0432] Phenyl,
[0433] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0434] R 4 represents a group selected from the following:
[0435] C2-C6-alkylene groups, C3-C8-cycloalkyl groups, C2-C6-haloalkyl groups, C2-C6-hydroxyalkyl groups and -(C2-C6-alkyl)-N(R 7 )(R 8 ) group,
[0436] C1-C6-alkyl,
[0437] which are optionally substituted by a group selected from the group consisting of C3-C8-cycloalkyl and phenyl,
[0438] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0439] R 5 represents a halogen atom or a group selected from the following:
[0440] C1-C6-alkyl,
[0441] C3-C8-cycloalkyl,
[0442] C1-C6-haloalkyl,
[0443] C1-C6-hydroxyalkyl, which is optionally substituted by hydroxy,
[0444] (C1-C3-alkoxy)-(C1-C6-alkyl)-group,
[0445] C2-C6-alkenyl, C2-C6-alkynyl,
[0446] C1-C6-alkoxy groups,
[0447] C1-C6-alkylthio group,
[0448] -(C1-C6-alkyl)-N(R 7 )(R 8 ) group,
[0449] -N(R 7 )(R 8 ) group,
[0450] -C(=O)OR 6 Group,
[0451] -C(=O)N(R 7 )(R 8 ) group and -S(=O)(=NR 11 )(C1-C3-alkyl) group,
[0452] R 6 represents a hydrogen atom or a group selected from the following:
[0453] C1-C6-alkyl and benzyl,
[0454] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from:
[0455] C1-C6-alkyl, C2-C6-hydroxyalkyl, -(C2-C6-alkyl)-N(R 9 )(R 10 ) groups and C3-C6-cycloalkyl groups,
[0456] or
[0457] R 7 and R 8 Together with the nitrogen to which they are attached, they represent a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0458] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a group selected from the following:
[0459] C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0460] R 9 and R 10 Each occurrence independently represents a hydrogen atom or
[0461] C1-C3-alkyl,
[0462] or
[0463] R 9 and R 10 Together with the nitrogen to which they are attached
[0464] a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0465] R 11 represents a hydrogen atom or a group selected from the following:
[0466] cyano and -C(=O)(C1-C3-haloalkyl) groups,
[0467] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[0468] According to some embodiments, the present invention provides a compound of the above general formula (I),
[0469] in
[0470] R 1 represents a group selected from the following:
[0471] C4-C8-cycloalkyl,
[0472] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0473] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0474] -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[0475] 4- to 7-membered heterocycloalkyl,
[0476] which is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[0477] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0478] and wherein the 4- to 7-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of the heterocycloalkyl group or heterocycloalkenyl group,
[0479] 5- to 7-membered heterocycloalkenyl,
[0480] which is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[0481] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0482] and wherein the 5- to 7-membered heterocycloalkenyl group is linked to the remainder of the molecule via a carbon atom of the heterocycloalkyl or heterocycloalkenyl group,
[0483] phenyl group,
[0484] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[0485] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from: -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-,
[0486] Indanyl group, tetrahydronaphthyl,
[0487] wherein the indanyl or tetrahydronaphthyl is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0488] and
[0489] a monocyclic or bicyclic heteroaryl group,
[0490] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0491] R 2 represents a hydrogen atom or a halogen atom,
[0492] R 3 represents a group selected from the following:
[0493] C1-C6-alkyl,
[0494] which are optionally replaced by C3-C8-cycloalkyl or NR 7R 8 C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C4-C8-cycloalkenyl, (C1-C6-alkyl)-N(R 7 )R 8 group, -(C1-C6-alkyl)-(4- to 7-membered nitrogen-containing heterocycloalkyl) group, and
[0495] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a C1-C3-alkyl group,
[0496] and
[0497] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0498] Phenyl,
[0499] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0500] R 4 represents a group selected from the following:
[0501] C2-C6-alkylene groups, C3-C8-cycloalkyl groups, C2-C6-haloalkyl groups, C2-C6-hydroxyalkyl groups and -(C2-C6-alkyl)-N(R 7 )(R 8 ) group,
[0502] C1-C6-alkyl,
[0503] which are optionally substituted by a group selected from the group consisting of C3-C8-cycloalkyl and phenyl,
[0504] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0505] R 5 represents a halogen atom or a group selected from the following:
[0506] C1-C6-alkyl,
[0507] C3-C8-cycloalkyl,
[0508] C1-C6-haloalkyl,
[0509] C1-C6-hydroxyalkyl, which is optionally substituted by hydroxy,
[0510] (C1-C3-alkoxy)-(C1-C6-alkyl)-group,
[0511] C2-C6-alkenyl, C2-C6-alkynyl,
[0512] C1-C6-alkoxy groups,
[0513] C1-C6-alkylthio group,
[0514] -(C1-C6-alkyl)-N(R 7 )(R 8 ) group,
[0515] -N(R 7 )(R 8 ) group,
[0516] -C(=O)OR 6 Group,
[0517] -C(=O)N(R 7 )(R 8 ) group and -S(=O)(=NR 11 )(C1-C3-alkyl) group,
[0518] R 6 represents a hydrogen atom or a group selected from the following:
[0519] C1-C6-alkyl and benzyl,
[0520] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from:
[0521] C1-C6-alkyl, C2-C6-hydroxyalkyl, -(C2-C6-alkyl)-N(R 9 )(R 10 ) groups and C3-C6-cycloalkyl groups,
[0522] or
[0523] R 7 and R 8 Together with the nitrogen to which they are attached
[0524] a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0525] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a group selected from the following:
[0526] C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0527] R 9 and R 10 Each occurrence independently represents a hydrogen atom or a C1-C3-alkyl group,
[0528] or
[0529] R 9 and R 10 Together with the nitrogen to which they are attached
[0530] a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0531] R 11 represents a hydrogen atom or a group selected from the following:
[0532] cyano and -C(=O)(C1-C3-haloalkyl) groups,
[0533] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[0534] According to some embodiments, the present invention provides a compound of the above general formula (I), wherein:
[0535] R 1 represents a group selected from the following:
[0536] C5-C8-alkyl,
[0537] C2-C8-haloalkyl,
[0538] C4-C8-cycloalkyl,
[0539] C1-C6-alkyl, which is substituted by C3-C8-cycloalkyl,
[0540] C2-C6-alkyl, which is substituted by a cyano or phenyl group,
[0541] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[0542] C2-C6-hydroxyalkyl,
[0543] (C2-C6-hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[0544] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[0545] -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[0546] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[0547] 4- to 7-membered heterocycloalkyl,
[0548] 5- to 7-membered heterocycloalkenyl, phenyl group, indanyl group, tetrahydronaphthyl and monocyclic or bicyclic heteroaryl,
[0549] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following:
[0550] Hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0551] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0552] and
[0553] wherein the 4- to 7-membered heterocycloalkyl and 5- to 7-membered heterocycloalkenyl groups are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[0554] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[0555] C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0556] and
[0557] wherein the 4- to 7-membered heterocycloalkyl and 5- to 7-membered heterocycloalkenyl groups are attached to the remainder of the molecule via a carbon atom of the heterocycloalkyl or heterocycloalkenyl group,
[0558] and
[0559] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[0560] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from: -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-,
[0561] and
[0562] wherein the indanyl or tetrahydronaphthyl is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following:
[0563] C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkoxy, cyano, hydroxy and -N(R 7 )(R 8 ),and
[0564] wherein the monocyclic or bicyclic heteroaryl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[0565] C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkoxy, cyano, hydroxy and -N(R 7 )(R 8 ),
[0566] R 2 represents a hydrogen atom or a fluorine atom,
[0567] R 3 represents a group selected from the following:
[0568] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C4-C8-cycloalkenyl, (C1-C6-alkyl)-N(R 7 )R 8 group, -(C1-C6-alkyl)-(4- to 7-membered nitrogen-containing heterocycloalkyl) group and phenyl,
[0569] wherein the C1-C6-alkyl group is optionally substituted by a C3-C8-cycloalkyl group,
[0570] and
[0571] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a C1-C3-alkyl group,
[0572] and
[0573] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0574] and
[0575] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0576] R 4 represents a group selected from the following:
[0577] C1-C6-alkyl, C3-C8-cycloalkyl, C2-C6-haloalkyl,
[0578] C2-C6-hydroxyalkyl and -(C2-C6-alkyl)-N(R 7 )(R 8 ) group,
[0579] wherein the C1-C6-alkyl group is optionally substituted by a group selected from the group consisting of C3-C8-cycloalkyl and phenyl,
[0580] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[0581] C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0582] R 5 represents a halogen atom or a group selected from the following:
[0583] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, (C1-C3-alkoxy)-(C1-C6-alkyl)-group, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy group, C1-C6-alkylthio group, -(C1-C6-alkyl)-N(R 7 )(R 8 ) group and -N(R 7 )(R 8 ) group,
[0584] R 6 represents a hydrogen atom or a group selected from the following:
[0585] C1-C6-alkyl and benzyl,
[0586] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from:
[0587] C1-C6-alkyl, C2-C6-hydroxyalkyl and -(C2-C6-alkyl)-N(R 9 )(R 10 ) group,
[0588] or
[0589] R 7 and R 8 Together with the nitrogen to which they are attached
[0590] a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0591] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a group selected from the following:
[0592] C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0593] R 9 and R 10 Each occurrence independently represents a hydrogen atom or a C1-C3-alkyl group,
[0594] or
[0595] R 9 and R 10 Together with the nitrogen to which they are attached
[0596] a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0597] R 11 represents a hydrogen atom or a group selected from the following
[0598] cyano and -C(=O)(C1-C3-haloalkyl) groups,
[0599] or a tautomer, N-oxide or a salt thereof, and a salt of a tautomer or N-oxide.
[0600] According to some embodiments, the present invention provides a compound of the above general formula (I), wherein:
[0601] R 1 represents a group selected from the following:
[0602] C4-C8-cycloalkyl,
[0603] -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[0604] 4- to 7-membered heterocycloalkyl,
[0605] 5- to 7-membered heterocycloalkenyl, phenyl group, indanyl group, tetrahydronaphthyl and monocyclic or bicyclic heteroaryl,
[0606] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0607] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0608] and
[0609] wherein the 4- to 7-membered heterocycloalkyl and 5- to 7-membered heterocycloalkenyl groups are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[0610] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0611] and
[0612] wherein the 4- to 7-membered heterocycloalkyl and 5- to 7-membered heterocycloalkenyl groups are attached to the remainder of the molecule via a carbon atom of the heterocycloalkyl or heterocycloalkenyl group,
[0613] and
[0614] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[0615] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from: -CH2-N(R 7)-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-,
[0616] and
[0617] wherein the indanyl or tetrahydronaphthyl is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0618] and
[0619] wherein the monocyclic or bicyclic heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0620] R 2 represents a hydrogen atom or a fluorine atom,
[0621] R 3 represents a group selected from the following:
[0622] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C4-C8-cycloalkenyl, (C1-C6-alkyl)-N(R 7 )R 8 group, -(C1-C6-alkyl)-(4- to 7-membered nitrogen-containing heterocycloalkyl) group and phenyl,
[0623] wherein the C1-C6-alkyl group is optionally substituted by a C3-C8-cycloalkyl group,
[0624] and
[0625] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a C1-C3-alkyl group,
[0626] and
[0627] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0628] and
[0629] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0630] R 4 represents a group selected from the following:
[0631] C1-C6-alkyl, C3-C8-cycloalkyl, C2-C6-haloalkyl, C2-C6-hydroxyalkyl and -(C2-C6-alkyl)-N(R 7 )(R 8 ) group,
[0632] wherein the C1-C6-alkyl group is optionally substituted by a group selected from the group consisting of C3-C8-cycloalkyl and phenyl,
[0633] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[0634] R 5 represents a halogen atom or a group selected from the following:
[0635] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, (C1-C3-alkoxy)-(C1-C6-alkyl)-group, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy group, C1-C6-alkylthio group, -(C1-C6-alkyl)-N(R 7 )(R 8 ) group and -N(R 7 )(R 8 ) group,
[0636] R 6 represents a hydrogen atom or a group selected from the following:
[0637] C1-C6-alkyl and benzyl,
[0638] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from:
[0639] C1-C6-alkyl, C2-C6-hydroxyalkyl and -(C2-C6-alkyl)-N(R 9 )(R 10 ) group,
[0640] or
[0641] R 7 and R 8 Together with the nitrogen to which they are attached
[0642] a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0643] wherein the 4- to 7-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a group selected from the following:
[0644] C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0645] R 9 and R 10 Each occurrence independently represents a hydrogen atom or a C1-C3-alkyl group,
[0646] or
[0647] R 9 and R 10 Together with the nitrogen to which they are attached
[0648] a nitrogen-containing 4- to 7-membered heterocycloalkyl group,
[0649] R 11 represents a hydrogen atom or a group selected from the following:
[0650] cyano and -C(=O)(C1-C3-haloalkyl) groups,
[0651] or a tautomer, N-oxide or a salt thereof, and a salt of a tautomer or N-oxide.
[0652] According to some embodiments, the present invention provides a compound of the above general formula (I), wherein:
[0653] R 1 represents a group selected from the following:
[0654] C5-C8-alkyl,
[0655] C2-C8-haloalkyl,
[0656] C4-C8-cycloalkyl,
[0657] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0658] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0659] C1-C3-alkyl, which is substituted by C3-C6-cycloalkyl,
[0660] C2-C6-alkyl, which is substituted by cyano, hydroxy or phenyl groups,
[0661] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[0662] (C2-C3-Hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[0663] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[0664] -(C3-C6-cycloalkyl)-N(R 7 )(R 8 ) group,
[0665] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[0666] 4- to 6-membered heterocycloalkyl,
[0667] which is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C3-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C3-alkyl) and oxo (=O),
[0668] wherein the 5- to 6-membered heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0669] wherein the 4- to 6-membered heterocycloalkyl group is attached to the remainder of the molecule via a carbon atom or a nitrogen atom of the heterocycloalkyl or heterocycloalkenyl group,
[0670] 5- to 6-membered heterocycloalkenyl,
[0671] which is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C3-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C3-alkyl) and oxo (=O),
[0672] wherein the 5- to 6-membered heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0673] wherein the 5- to 6-membered heterocycloalkenyl group is attached to the remainder of the molecule via a carbon atom or a nitrogen atom of the heterocycloalkyl or heterocycloalkenyl group,
[0674] phenyl group,
[0675] which are optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C4-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -(C1-C3-alkyl)-C(=O)OR 6 、-(C1-C3-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[0676] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from: -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-,
[0677] Indanyl group,
[0678] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0679] Tetrahydronaphthyl and
[0680] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0681] a monocyclic or bicyclic heteroaryl group,
[0682] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0683] R 2 represents a hydrogen atom or a halogen atom,
[0684] R 3 represents a group selected from the following:
[0685] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C4-C6-cycloalkenyl, (C1-C6-alkyl)-N(R 7 )R 8 group, -(C1-C6-alkyl)-(4- to 6-membered nitrogen-containing heterocycloalkyl) group and phenyl,
[0686] wherein the C1-C6-alkyl group is optionally replaced by a C3-C6-cycloalkyl group or a NR 7 R 8 Group substitution,
[0687] and
[0688] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a C1-C3-alkyl group,
[0689] and
[0690] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0691] and
[0692] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0693] R 4 represents a group selected from the following:
[0694] C2-C6-alkylene groups, C3-C6-cycloalkyl groups, C2-C6-haloalkyl groups, C2-C6-hydroxyalkyl groups and -(C2-C6-alkyl)-N(R 7 )(R 8 ) group,
[0695] C1-C6-alkyl,
[0696] It is optionally substituted with a group selected from:
[0697] C3-C6-cycloalkyl and phenyl,
[0698] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0699] R 5 represents a halogen atom or a group selected from the following:
[0700] C1-C6-alkyl,
[0701] C3-C6-cycloalkyl,
[0702] C1-C6-haloalkyl, which is optionally substituted by hydroxy,
[0703] C1-C6-hydroxyalkyl,
[0704] (C1-C3-alkoxy)-(C1-C6-alkyl)-group,
[0705] C2-C6-alkenyl, C2-C6-alkynyl,
[0706] C1-C6-alkoxy groups,
[0707] C1-C6-alkylthio group,
[0708] -(C1-C6-alkyl)-N(R 7 )(R 8 ) group,
[0709] -N(R 7 )(R 8 ) group,
[0710] -C(=O)OR 6 Group,
[0711] -C(=O)N(R 7 )(R 8 ) group and -S(=O)(=NR 11 )(C1-C3-alkyl) group,
[0712] R 6 represents a hydrogen atom or a group selected from the following:
[0713] C1-C4-alkyl and benzyl,
[0714] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from:
[0715] C1-C3-alkyl, C2-C3-hydroxyalkyl, -(C2-C3-alkyl)-N(R 9 )(R 10 ) groups and C3-C6-cycloalkyl groups,
[0716] or
[0717] R 7 and R 8 Together with the nitrogen to which they are attached
[0718] a nitrogen-containing 4- to 6-membered heterocycloalkyl group,
[0719] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a group selected from the following:
[0720] C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0721] R 9 and R 10 identically or differently represent a hydrogen atom or a C1-C3-alkyl group,
[0722] or
[0723] R 9 and R 10Together with the nitrogen to which they are attached
[0724] a nitrogen-containing 4- to 6-membered heterocycloalkyl group,
[0725] R 11 represents a hydrogen atom or a group selected from the following:
[0726] cyano and -C(=O)(C1-C3-haloalkyl) groups,
[0727] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[0728] According to some embodiments, the present invention provides a compound of the above general formula (I), wherein:
[0729] R 1 represents a group selected from the following:
[0730] C4-C8-cycloalkyl,
[0731] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0732] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0733] -(C3-C6-cycloalkyl)-N(R 7 )(R 8 ) group,
[0734] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[0735] 4- to 6-membered heterocycloalkyl,
[0736] which is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C3-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C3-alkyl) and oxo (=O),
[0737] wherein the 5- to 6-membered heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0738] wherein the 4- to 6-membered heterocycloalkyl group is attached to the remainder of the molecule via a carbon atom or a nitrogen atom of the heterocycloalkyl or heterocycloalkenyl group,
[0739] 5- to 6-membered heterocycloalkenyl,
[0740] which is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C3-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C3-alkyl) and oxo (=O),
[0741] wherein the 5- to 6-membered heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0742] wherein the 5- to 6-membered heterocycloalkenyl group is attached to the remainder of the molecule via a carbon atom or a nitrogen atom of the heterocycloalkyl or heterocycloalkenyl group,
[0743] phenyl group,
[0744] which are optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C4-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -(C1-C3-alkyl)-C(=O)OR 6 、-(C1-C3-alkyl)-C(=O)N(R 7 )(R 8 )、S(=O)2N(R 7 )(R 8)、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[0745] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from: -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-,
[0746] Indanyl group,
[0747] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0748] Tetrahydronaphthyl and
[0749] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0750] a monocyclic or bicyclic heteroaryl group,
[0751] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0752] R 2 represents a hydrogen atom or a halogen atom,
[0753] R 3 represents a group selected from the following:
[0754] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C4-C6-cycloalkenyl, (C1-C6-alkyl)-N(R 7 )R 8 group, -(C1-C6-alkyl)-(4- to 6-membered nitrogen-containing heterocycloalkyl) group and phenyl,
[0755] wherein the C1-C6-alkyl group is optionally replaced by a C3-C6-cycloalkyl group or a NR 7 R 8 Group substitution,
[0756] and
[0757] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a C1-C3-alkyl group,
[0758] and
[0759] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0760] and
[0761] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0762] R 4 represents a group selected from the following:
[0763] C2-C6-alkylene groups, C3-C6-cycloalkyl groups, C2-C6-haloalkyl groups, C2-C6-hydroxyalkyl groups and -(C2-C6-alkyl)-N(R 7 )(R 8 ) group,
[0764] C1-C6-alkyl,
[0765] It is optionally substituted by a group selected from
[0766] C3-C6-cycloalkyl and phenyl,
[0767] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0768] R 5 represents a halogen atom or a group selected from the following:
[0769] C1-C6-alkyl,
[0770] C3-C6-cycloalkyl,
[0771] C1-C6-haloalkyl, which is optionally substituted by hydroxy,
[0772] C1-C6-hydroxyalkyl,
[0773] (C1-C3-alkoxy)-(C1-C6-alkyl)-group,
[0774] C2-C6-alkenyl, C2-C6-alkynyl,
[0775] C1-C6-alkoxy groups,
[0776] C1-C6-alkylthio group,
[0777] -(C1-C6-alkyl)-N(R 7 )(R 8 ) group,
[0778] -N(R 7 )(R 8 ) group,
[0779] -C(=O)OR 6 Group,
[0780] -C(=O)N(R 7 )(R 8 ) group and -S(=O)(=NR 11 )(C1-C3-alkyl) group,
[0781] R 6 represents a hydrogen atom or a group selected from the following:
[0782] C1-C4-alkyl and benzyl,
[0783] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from:
[0784] C1-C3-alkyl, C2-C3-hydroxyalkyl, -(C2-C3-alkyl)-N(R 9 )(R 10 ) groups and C3-C6-cycloalkyl groups,
[0785] or
[0786] R 7 and R 8 Together with the nitrogen to which they are attached
[0787] a nitrogen-containing 4- to 6-membered heterocycloalkyl group,
[0788] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a group selected from the following:
[0789] C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0790] R 9 and R 10 identically or differently represent a hydrogen atom or a C1-C3-alkyl group,
[0791] or
[0792] R 9 and R 10 Together with the nitrogen to which they are attached
[0793] a nitrogen-containing 4- to 6-membered heterocycloalkyl group,
[0794] R 11 represents a hydrogen atom or a group selected from the following:
[0795] cyano and -C(=O)(C1-C3-haloalkyl) groups,
[0796] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[0797] According to some embodiments, the present invention provides a compound of the above general formula (I), wherein:
[0798] R 1 represents a group selected from the following:
[0799] C5-C8-alkyl, C2-C8-haloalkyl, C4-C8-cycloalkyl,
[0800] C1-C3-alkyl, which is substituted by C3-C6-cycloalkyl,
[0801] C2-C6-alkyl, which is substituted by a cyano or phenyl group,
[0802] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[0803] C2-C6-hydroxyalkyl, (C2-C3-hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[0804] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group, -(C3-C6-cycloalkyl)-N(R 7 )(R 8 ) group,
[0805] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group, a 4- to 6-membered heterocycloalkyl group, a 5- to 6-membered heterocycloalkenyl group, a phenyl group, an indanyl group, a tetrahydronaphthyl group and a monocyclic or bicyclic heteroaryl group,
[0806] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0807] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0808] and
[0809] wherein the 4- to 6-membered heterocycloalkyl and the 5- to 6-membered heterocycloalkenyl are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C3-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C3-alkyl) and oxo (=O),
[0810] wherein the 5- to 6-membered heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0811] and
[0812] wherein the 4- to 6-membered heterocycloalkyl group and the 5- to 6-membered heterocycloalkenyl group are attached to the remainder of the molecule via a carbon atom of the heterocycloalkyl group or heterocycloalkenyl group,
[0813] and
[0814] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C4-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -(C1-C3-alkyl)-C(=O)OR 6 、-(C1-C3-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[0815] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from:
[0816] -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-,
[0817] and
[0818] wherein the indanyl- or tetrahydronaphthyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following:
[0819] C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkoxy, cyano, hydroxy and -N(R 7 )(R 8 ),
[0820] and
[0821] wherein the monocyclic or bicyclic heteroaryl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[0822] C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkoxy, cyano, hydroxy and -N(R 7 )(R 8 ),
[0823] R 2 represents a hydrogen atom or a fluorine atom,
[0824] R3 represents a group selected from the following:
[0825] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C4-C6-cycloalkenyl, (C1-C6-alkyl)-N(R 7 )R 8 group, -(C1-C6-alkyl)-(4- to 6-membered nitrogen-containing heterocycloalkyl) group and phenyl,
[0826] wherein the C1-C6-alkyl group is optionally substituted by a C3-C6-cycloalkyl group,
[0827] and
[0828] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a C1-C3-alkyl group,
[0829] and
[0830] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0831] and
[0832] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0833] R 4 represents a group selected from the following:
[0834] C1-C6-alkyl, C3-C6-cycloalkyl, C2-C6-haloalkyl, C2-C6-hydroxyalkyl and -(C2-C6-alkyl)-N(R 7 )(R 8 ) group,
[0835] wherein the C1-C6-alkyl group is optionally substituted by a group selected from the group consisting of C3-C6-cycloalkyl and phenyl,
[0836] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0837] R 5 represents a halogen atom or a group selected from the following:
[0838] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, (C1-C3-alkoxy)-(C1-C6-alkyl)-group, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy group, C1-C6-alkylthio group, -(C1-C6-alkyl)-N(R 7 )(R 8 ) group and -N(R 7 )(R 8 ) group,
[0839] R 6 represents a hydrogen atom or a group selected from the following:
[0840] C1-C4-alkyl and benzyl,
[0841] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from:
[0842] C1-C3-alkyl, C2-C3-hydroxyalkyl and -(C2-C3-alkyl)-N(R 9 )(R 10 ) group,
[0843] or
[0844] R 7 and R 8 Together with the nitrogen to which they are attached
[0845] a nitrogen-containing 4- to 6-membered heterocycloalkyl group,
[0846] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a group selected from the following:
[0847] C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0848] R 9 and R 10 identically or differently represent a hydrogen atom or a C1-C3-alkyl group,
[0849] or
[0850] R 9 and R 10 Together with the nitrogen to which they are attached
[0851] a nitrogen-containing 4- to 6-membered heterocycloalkyl group,
[0852] R 11 represents a hydrogen atom or a group selected from the following:
[0853] cyano and -C(=O)(C1-C3-haloalkyl) groups,
[0854] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[0855] According to some embodiments, the present invention provides a compound of the above general formula (I), wherein:
[0856] R 1 represents a group selected from the following:
[0857] C4-C8-cycloalkyl,
[0858] -(C3-C6-cycloalkyl)-N(R 7 )(R 8 ) group,
[0859] 4- to 6-membered heterocycloalkyl, 5- to 6-membered heterocycloalkenyl, phenyl group, indanyl group, tetrahydronaphthyl group and monocyclic or bicyclic heteroaryl group,
[0860] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R 8 ),
[0861] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0862] and
[0863] wherein the 4- to 6-membered heterocycloalkyl and the 5- to 6-membered heterocycloalkenyl are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C3-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C3-alkyl) and oxo (=O),
[0864] wherein the 5- to 6-membered heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0865] and
[0866] wherein the 4- to 6-membered heterocycloalkyl group and the 5- to 6-membered heterocycloalkenyl group are attached to the remainder of the molecule via a carbon atom of the heterocycloalkyl group or heterocycloalkenyl group,
[0867] and
[0868] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C4-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -(C1-C3-alkyl)-C(=O)OR 6 、-(C1-C3-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[0869] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from: -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-,
[0870] and
[0871] wherein the indanyl- or tetrahydronaphthyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0872] and
[0873] wherein the monocyclic or bicyclic heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[0874] R 2 represents a hydrogen atom or a fluorine atom,
[0875] R 3 represents a group selected from the following:
[0876] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C2-C6-alkenyl, C2-C6-alkynyl, C4-C6-cycloalkenyl, (C1-C6-alkyl)-N(R 7 )R 8 group, -(C1-C6-alkyl)-(4- to 6-membered nitrogen-containing heterocycloalkyl) group and phenyl,
[0877] wherein the C1-C6-alkyl group is optionally substituted by a C3-C6-cycloalkyl group,
[0878] and
[0879] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a C1-C3-alkyl group,
[0880] and
[0881] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is connected to the alkyl group via a carbon atom of the heterocycloalkyl group,
[0882] and
[0883] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0884] R 4 represents a group selected from the following:
[0885] C1-C6-alkyl, C3-C6-cycloalkyl, C2-C6-haloalkyl, C2-C6-hydroxyalkyl and -(C2-C6-alkyl)-N(R 7 )(R 8 ) group,
[0886] wherein the C1-C6-alkyl group is optionally substituted by a group selected from the group consisting of C3-C6-cycloalkyl and phenyl,
[0887] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[0888] R 5 represents a halogen atom or a group selected from the following:
[0889] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, (C1-C3-alkoxy)-(C1-C6-alkyl)-group, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy group, C1-C6-alkylthio group, -(C1-C6-alkyl)-N(R 7 )(R 8 ) group and -N(R 7 )(R 8 ) group,
[0890] R 6 represents a hydrogen atom or a group selected from the following:
[0891] C1-C4-alkyl and benzyl,
[0892] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a group selected from the group consisting of C1-C3-alkyl, C2-C3-hydroxyalkyl and -(C2-C3-alkyl)-N(R 9 )(R 10 ) group,
[0893] or
[0894] R 7 and R 8 Together with the nitrogen to which they are attached
[0895] a nitrogen-containing 4- to 6-membered heterocycloalkyl group,
[0896] wherein the 4- to 6-membered nitrogen-containing heterocycloalkyl group is optionally substituted by a group selected from the following:
[0897] C1-C3-alkyl, -S(=O)2(C1-C3-alkyl) and -C(=O)O(C1-C4-alkyl),
[0898] R 9 and R 10 identically or differently represent a hydrogen atom or a C1-C3-alkyl group,
[0899] or
[0900] R 9 and R 10 Together with the nitrogen to which they are attached
[0901] a nitrogen-containing 4- to 6-membered heterocycloalkyl group,
[0902] R 11 represents a hydrogen atom or a group selected from the following:
[0903] cyano and -C(=O)(C1-C3-haloalkyl) groups,
[0904] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[0905] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[0906] R 1 represents a group selected from the following:
[0907] C5-C8-alkyl,
[0908] C4-C8-cycloalkyl,
[0909] which are optionally substituted once or twice with phenyl groups,
[0910] wherein the phenyl substituent is optionally substituted once, twice or three times, each of which
[0911] The groups are independently selected from halogen atoms,
[0912] C1-C3-alkyl, which is substituted by C3-C6-cycloalkyl,
[0913] C2-C6-alkyl, which is substituted by a hydroxyl or phenyl group,
[0914] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[0915] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[0916] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[0917] 4- to 6-membered heterocycloalkyl,
[0918] which is optionally substituted once or twice, each substituent being independently selected from C1-C3-alkyl,
[0919] and
[0920] which is linked to the rest of the molecule via a carbon atom of said heterocycloalkyl group,
[0921] phenyl group,
[0922] It is optionally substituted once, twice, three times or four times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -OC(=O)-(C1-C4-alkyl), -S-C1-C3-alkyl, -S(=O)2(C1-C3-alkyl), -S(=O)(=NR 11 )(C1-C3-alkyl) and -P(=O)(C1-C3-alkyl)2, indanyl and
[0923] a monocyclic or bicyclic heteroaryl group,
[0924] which are optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[0925] R 2 represents a hydrogen atom or a halogen atom,
[0926] R 3 represents a group selected from the following:
[0927] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and phenyl,
[0928] wherein the C1-C6-alkyl group is optionally replaced by a C3-C6-cycloalkyl group or a NR 7 R 8 Group substitution,
[0929] R 4 represents a group selected from the following:
[0930] C2-C6-alkenyl, C3-C6-cycloalkyl and C2-C6-hydroxyalkyl,
[0931] C1-C6-alkyl,
[0932] which are optionally substituted by a group selected from the group consisting of C3-C6-cycloalkyl and phenyl,
[0933] R 5 represents a halogen atom or a group selected from the following:
[0934] C1-C6-alkyl,
[0935] C3-C6-cycloalkyl,
[0936] C1-C6-haloalkyl, which is optionally substituted by hydroxy,
[0937] C1-C6-hydroxyalkyl,
[0938] (C1-C3-alkoxy)-(C1-C6-alkyl)-group,
[0939] C1-C6-alkoxy groups,
[0940] C1-C6-alkylthio group,
[0941] -(C1-C6-alkyl)-N(R 7 )(R 8 ) group,
[0942] -N(R 7 )(R 8 ) group,
[0943] -C(=O)OR 6 Group,
[0944] -C(=O)N(R 7 )(R 8 ) group and -S(=O)(=NR 11 )(C1-C3-alkyl) group,
[0945] R 6 represents a hydrogen atom or a C1-C4-alkyl group,
[0946] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group or a cyclopropyl group,
[0947] R 11 represents a hydrogen atom,
[0948] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[0949] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[0950] R 1represents a group selected from the following:
[0951] C4-C8-cycloalkyl,
[0952] which are optionally substituted once or twice with phenyl groups,
[0953] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom,
[0954] 4- to 6-membered heterocycloalkyl,
[0955] which is optionally substituted once or twice, each substituent being independently selected from C1-C3-alkyl,
[0956] and
[0957] which is linked to the rest of the molecule via a carbon atom of said heterocycloalkyl group,
[0958] phenyl group,
[0959] It is optionally substituted once, twice, three times or four times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、--C(=O)N(R 7 )(R 8 )、N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -OC(=O)-(C1-C4-alkyl), -S-C1-C3-alkyl, -S(=O)2(C1-C3-alkyl), -S(=O)(=NR 11 )(C1-C3-alkyl) and -P(=O)(C1-C3-alkyl)2,
[0960] Indole
[0961] a monocyclic or bicyclic heteroaryl group,
[0962] which are optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[0963] R 2 represents a hydrogen atom or a halogen atom,
[0964] R 3 represents a group selected from the following:
[0965] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and phenyl,
[0966] wherein the C1-C6-alkyl group is optionally replaced by a C3-C6-cycloalkyl group or a NR 7 R 8 Group substitution
[0967] R 4 represents a group selected from the following:
[0968] C2-C6-alkenyl, C3-C6-cycloalkyl and C2-C6-hydroxyalkyl, C1-C6-alkyl,
[0969] which are optionally substituted by a group selected from the group consisting of C3-C6-cycloalkyl and phenyl,
[0970] R 5 represents a halogen atom or a group selected from the following:
[0971] C1-C6-alkyl,
[0972] C3-C6-cycloalkyl,
[0973] C1-C6-haloalkyl, which is optionally substituted by hydroxy,
[0974] C1-C6-hydroxyalkyl,
[0975] (C1-C3-alkoxy)-(C1-C6-alkyl)-group,
[0976] C1-C6-alkoxy groups,
[0977] C1-C6-alkylthio group,
[0978] -(C1-C6-alkyl)-N(R 7 )(R 8 ) group,
[0979] -N(R 7 )(R 8 ) group,
[0980] -C(=O)OR 6 Group,
[0981] -C(=O)N(R 7 )(R 8 ) group and -S(=O)(=NR 11 )(C1-C3-alkyl) group,
[0982] R 6 represents a hydrogen atom or a C1-C4-alkyl group,
[0983] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group or a cyclopropyl group,
[0984] R 11 represents a hydrogen atom,
[0985] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[0986] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[0987] R 1 represents a group selected from the following:
[0988] C5-C8-alkyl, C4-C8-cycloalkyl,
[0989] C1-C3-alkyl, which is substituted by C3-C6-cycloalkyl,
[0990] C2-C6-alkyl, which is substituted by a phenyl group,
[0991] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[0992] C2-C6-hydroxyalkyl, -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[0993] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group, 4- to 6-membered heterocycloalkyl group,
[0994] phenyl groups, indanyl groups and monocyclic or bicyclic heteroaryl groups,
[0995] wherein the cycloalkyl group is optionally substituted once or twice with a phenyl group,
[0996] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom,
[0997] and
[0998] wherein the 4- to 6-membered heterocycloalkyl is optionally substituted once or twice, each substituent being independently selected from C1-C3-alkyl,
[0999] and
[1000] wherein said 4- to 6-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of said heterocycloalkyl group,
[1001] and
[1002] wherein the phenyl group is optionally substituted once, twice, three times or four times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、-N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl) and -P(=O)(C1-C3-alkyl)2,
[1003] and
[1004] wherein the monocyclic or bicyclic heteroaryl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[1005] R 2 represents a hydrogen atom or a fluorine atom,
[1006] R 3 represents a group selected from the following:
[1007] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and phenyl,
[1008] wherein the C1-C6-alkyl group is optionally substituted by a C3-C6-cycloalkyl group,
[1009] R 4 represents a group selected from the following:
[1010] C1-C6-alkyl, C3-C6-cycloalkyl and C2-C6-hydroxyalkyl,
[1011] wherein the C1-C6-alkyl group is optionally substituted by a group selected from the group consisting of C3-C6-cycloalkyl and phenyl,
[1012] R 5 represents a halogen atom or a group selected from the following:
[1013] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, (C1-C3-alkoxy)-(C1-C6-alkyl)-group, C1-C6-alkoxy group, C1-C6-alkylthio group, -(C1-C6-alkyl)-N(R 7 )(R 8 ) group and -N(R 7 )(R 8 ) group,
[1014] R 6 represents a hydrogen atom or a C1-C4-alkyl group,
[1015] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group,
[1016] R 11 represents a hydrogen atom,
[1017] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1018] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1019] R 1 represents a group selected from the following:
[1020] C4-C8-cycloalkyl,
[1021] 4- to 6-membered heterocycloalkyl,
[1022] phenyl groups, indanyl groups and monocyclic or bicyclic heteroaryl groups,
[1023] wherein the cycloalkyl group is optionally substituted once or twice with a phenyl group,
[1024] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom,
[1025] and
[1026] wherein the 4- to 6-membered heterocycloalkyl is optionally substituted once or twice, each substituent being independently selected from C1-C3-alkyl,
[1027] and
[1028] wherein said 4- to 6-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of said heterocycloalkyl group,
[1029] and
[1030] wherein the phenyl group is optionally substituted once, twice, three times or four times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、-N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl) and -P(=O)(C1-C3-alkyl)2,
[1031] and
[1032] wherein the monocyclic or bicyclic heteroaryl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[1033] R 2 represents a hydrogen atom or a fluorine atom,
[1034] R 3 represents a group selected from the following:
[1035] C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and phenyl,
[1036] wherein the C1-C6-alkyl group is optionally substituted by a C3-C6-cycloalkyl group,
[1037] R 4 represents a group selected from the following:
[1038] C1-C6-alkyl, C3-C6-cycloalkyl and C2-C6-hydroxyalkyl,
[1039] wherein the C1-C6-alkyl group is optionally substituted by a group selected from the group consisting of C3-C6-cycloalkyl and phenyl,
[1040] R 5 represents a halogen atom or a group selected from the following:
[1041] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, (C1-C3-alkoxy)-(C1-C6-alkyl)-group, C1-C6-alkoxy group, C1-C6-alkylthio group, -(C1-C6-alkyl)-N(R 7 )(R 8 ) group and -N(R7 )(R 8 ) group,
[1042] R 6 represents a hydrogen atom or a C1-C4-alkyl group,
[1043] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group,
[1044] R 11 represents a hydrogen atom,
[1045] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1046] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1047] R 1 represents a group selected from the following:
[1048] C5-C7-alkyl,
[1049] C5-C7-cycloalkyl,
[1050] C1-C2-alkyl, which is substituted by C5-C7-cycloalkyl,
[1051] C2-C6-alkyl, which is substituted by a phenyl group,
[1052] C2-C5-hydroxyalkyl,
[1053] -(C3-C5-alkyl)-N(R 7 )(R 8 ) group,
[1054] -(C3-C5-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[1055] 5- to 6-membered heterocycloalkyl,
[1056] which are optionally substituted once or twice by C1-C3-alkyl,
[1057] and
[1058] It is connected to the rest of the molecule through a carbon atom,
[1059] phenyl group,
[1060] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -OC(=O)-(C1-C4-alkyl), -S-C1-C3-alkyl, -S(=O)2-C1-C3-alkyl, -S(=O)(=NH)(C1-C3-alkyl), and
[1061] Indole
[1062] Monocyclic heteroaryl,
[1063] It is optionally substituted once or twice, each substituent being independently selected from the following groups:
[1064] C1-C3-alkyl and C1-C3-alkoxy,
[1065] R 2 represents a hydrogen atom or a halogen atom,
[1066] R 3 represents a group selected from the following:
[1067] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and phenyl,
[1068] wherein the C1-C6-alkyl group is optionally replaced by a cyclopropyl or NR 7 R 8 Group substitution,
[1069] R 4 represents a group selected from the following:
[1070] C2-C4-alkenyl, C3-C6-cycloalkyl and C2-C3-hydroxyalkyl,
[1071] C1-C5-alkyl,
[1072] which is optionally substituted by a group selected from the group consisting of cyclopropyl and phenyl,
[1073] R 5 represents a halogen atom or a group selected from the following:
[1074] C1-C4-alkyl,
[1075] C3-C6-cycloalkyl,
[1076] C1-C3-haloalkyl, which is optionally substituted by hydroxy,
[1077] C1-C3-hydroxyalkyl,
[1078] (C1-C3-alkyl)-O-(C1-C3-alkyl)-group,
[1079] C1-C4-alkoxy groups,
[1080] C1-C3-alkylthio group,
[1081] -(C1-C3-alkyl)-N(R 7 )(R 8 ) group,
[1082] -N(R 7 )(R 8 ) group,
[1083] -C(=O)OR 6 Group,
[1084] -C(=O)N(R 7 )(R 8 ) group and -S(=O)(=NR 11 )(C1-C3-alkyl) group,
[1085] R 6 represents a hydrogen atom or a C1-C3-alkyl group,
[1086] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group or a cyclopropyl group,
[1087] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[1088] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1089] R 1 represents a group selected from the following:
[1090] C5-C7-cycloalkyl,
[1091] 5- to 6-membered heterocycloalkyl,
[1092] which are optionally substituted once or twice by C1-C3-alkyl,
[1093] and
[1094] It is connected to the rest of the molecule through a carbon atom,
[1095] phenyl group,
[1096] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -OC(=O)-(C1-C4-alkyl), -S-C1-C3-alkyl, -S(=O)2-C1-C3-alkyl, -S(=O)(=NH)(C1-C3-alkyl), and
[1097] Indole
[1098] Monocyclic heteroaryl,
[1099] It is optionally substituted once or twice, each substituent being independently selected from the following groups:
[1100] C1-C3-alkyl and C1-C3-alkoxy,
[1101] R 2 represents a hydrogen atom or a halogen atom,
[1102] R 3 represents a group selected from the following:
[1103] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and phenyl,
[1104] wherein the C1-C6-alkyl group is optionally replaced by a cyclopropyl or NR 7 R 8 Group substitution,
[1105] R 4 represents a group selected from the following:
[1106] C2-C4-alkenyl, C3-C6-cycloalkyl and C1-C3-hydroxyalkyl,
[1107] C1-C5-alkyl,
[1108] which is optionally substituted by a group selected from the group consisting of cyclopropyl and phenyl,
[1109] R 5represents a halogen atom or a group selected from the following:
[1110] C1-C4-alkyl,
[1111] C3-C5-cycloalkyl,
[1112] C1-C3-haloalkyl, which is optionally substituted by hydroxy,
[1113] C1-C3-hydroxyalkyl,
[1114] (C1-C3-alkyl)-O-(C1-C3-alkyl)-group,
[1115] C1-C4-alkoxy groups,
[1116] C1-C3-alkylthio group,
[1117] -(C1-C3-alkyl)-N(R 7 )(R 8 ) group,
[1118] R 6 represents a hydrogen atom or a C1-C3-alkyl group,
[1119] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group or a cyclopropyl group,
[1120] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[1121] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1122] R 1 represents a group selected from the following:
[1123] C5-C7-alkyl, C5-C7-cycloalkyl,
[1124] C1-C2-alkyl, which is substituted by C5-C7-cycloalkyl,
[1125] C2-C5-hydroxyalkyl, -(C3-C5-alkyl)-N(R 7 )(R 8 ) group, -(C3-C5-alkyl)-C(=O)N(R 7 )(R 8 ) group, a 5- to 6-membered heterocycloalkyl group, a phenyl group, an indanyl group, and a monocyclic heteroaryl group,
[1126] The 5- to 6-membered heterocycloalkyl group is optionally substituted once or twice by C1-C3-alkyl,
[1127] and
[1128] wherein said 5- to 6-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of said heterocycloalkyl group,
[1129] and
[1130] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxyl, -C(=O)OR 6 、-N(R 7 )(R 8 ) and -(C1-C3-alkyl)-N(R 7 )(R 8 ),
[1131] and
[1132] The monocyclic heteroaryl is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[1133] R 2 represents a hydrogen atom or a fluorine atom,
[1134] R 3 represents a group selected from the following:
[1135] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and phenyl,
[1136] wherein the C1-C6-alkyl group is optionally substituted by a cyclopropyl group,
[1137] R 4 represents a group selected from the following:
[1138] C1-C5-alkyl, C3-C6-cycloalkyl and C2-C3-hydroxyalkyl,
[1139] wherein the C1-C4-alkyl group is optionally substituted by a group selected from the group consisting of cyclopropyl and phenyl,
[1140] R 5 represents a halogen atom or a group selected from the following:
[1141] C1-C4-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, (C1-C3-alkyl)-O-(C1-C3-alkyl)-group, C1-C4-alkoxy group, C1-C3-alkylthio group, -(C1-C3-alkyl)-N(R 7 )(R8 ) group and -N(R 7 )(R 8 ) group,
[1142] R 6 represents a hydrogen atom or a C1-C3-alkyl group,
[1143] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group,
[1144] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1145] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1146] R 1 represents a group selected from the following:
[1147] C5-C7-cycloalkyl,
[1148] 5- to 6-membered heterocycloalkyl,
[1149] phenyl groups, indanyl groups and monocyclic heteroaryl groups,
[1150] The 5- to 6-membered heterocycloalkyl group is optionally substituted once or twice by C1-C3-alkyl,
[1151] and
[1152] wherein said 5- to 6-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of said heterocycloalkyl group,
[1153] and
[1154] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxyl, -C(=O)OR 6 、-N(R 7 )(R 8 ) and -(C1-C3-alkyl)-N(R 7 )(R 8 ),
[1155] and
[1156] The monocyclic heteroaryl is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[1157] R 2 represents a hydrogen atom or a fluorine atom,
[1158] R 3 represents a group selected from the following:
[1159] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and phenyl,
[1160] wherein the C1-C6-alkyl group is optionally substituted by a cyclopropyl group,
[1161] R 4 represents a group selected from the following:
[1162] C1-C5-alkyl, C3-C6-cycloalkyl and C2-C3-hydroxyalkyl,
[1163] wherein the C1-C4-alkyl group is optionally substituted by a group selected from the group consisting of cyclopropyl and phenyl,
[1164] R 5 represents a halogen atom or a group selected from the following:
[1165] C1-C4-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl,
[1166] C1-C3-hydroxyalkyl, (C1-C3-alkyl)-O-(C1-C3-alkyl)-group, C1-C4-alkoxy group, C1-C3-alkylthio group, -(C1-C3-alkyl)-N(R 7 )(R 8 ) group and -N(R 7 )(R 8 ) group,
[1167] R 6 represents a hydrogen atom or a C1-C3-alkyl group,
[1168] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group,
[1169] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1170] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1171] R 1 represents a group selected from the following:
[1172] C5-C7-alkyl,
[1173] C5-C7-cycloalkyl,
[1174] C1-C2-alkyl, which is substituted by C5-C6-cycloalkyl,
[1175] C2-C6-alkyl, which is substituted by a phenyl group,
[1176] C2-C4-hydroxyalkyl,
[1177] -(C3-C4-alkyl)-N(R 7 )(R 8 ) group,
[1178] CH3CH2CH-C(=O)NH2 group,
[1179] 5- to 6-membered heterocycloalkyl,
[1180] which are optionally substituted once or twice by C1-C3-alkyl,
[1181] and
[1182] It is connected to the rest of the molecule through a carbon atom,
[1183] phenyl group,
[1184] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -OC(=O)-(C1-C4-alkyl), -S-C1-C3-alkyl, -S(=O)2-C1-C3-alkyl, -S(=O)(=NH)(C1-C3-alkyl) and -(C1-C3-alkyl)-N(R 7 )(R 8 ),
[1185] Indole
[1186] Monocyclic heteroaryl,
[1187] It is optionally substituted once or twice, each substituent being independently selected from the following groups:
[1188] C1-C3-alkyl and C1-C3-alkoxy,
[1189] R 2 represents a hydrogen atom or a halogen atom,
[1190] R 3 represents a group selected from the following:
[1191] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl, C2-C6-alkenyl and phenyl,
[1192] wherein the C1-C6-alkyl group is optionally replaced by a cyclopropyl or N(R 7 )(R 8 ) group substituted,
[1193] R 4 represents a group selected from the following:
[1194] C2-C4-alkenyl,
[1195] C3-C5-cycloalkyl,
[1196] C1-C3-hydroxyalkyl,
[1197] C1-C4-alkyl,
[1198] which is optionally substituted by a group selected from the group consisting of cyclopropyl and phenyl,
[1199] R 5 represents a halogen atom or a group selected from the following:
[1200] C1-C4-alkyl,
[1201] C3-C5-cycloalkyl,
[1202] C1-C3-haloalkyl, which is optionally substituted by hydroxy,
[1203] C1-C3-hydroxyalkyl,
[1204] CH3O-(C1-C2-alkyl)-group,
[1205] C1-C3-alkoxy groups,
[1206] methylthio group,
[1207] -(C1-C2-alkyl)-N(R 7 )(R 8 ) group,
[1208] -N(R 7 )(R 8 ) group,
[1209] -C(=O)OR 6 Group,
[1210] -C(=O)N(R 7 )(R 8 ) groups and
[1211] -S(=O)(=NR 11 )(C1-C3-alkyl) group,
[1212] R 6 represents a hydrogen atom or a methyl group,
[1213] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group or a cyclopropyl group,
[1214] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[1215] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1216] R 1 represents a group selected from the following:
[1217] C5-C7-cycloalkyl,
[1218] 5- to 6-membered heterocycloalkyl,
[1219] which are optionally substituted once or twice by C1-C3-alkyl,
[1220] and
[1221] It is connected to the rest of the molecule through a carbon atom,
[1222] phenyl group,
[1223] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -OC(=O)-(C1-C4-alkyl), -S-C1-C3-alkyl, -S(=O)2-C1-C3-alkyl, -S(=O)(=NH)(C1-C3-alkyl) and -(C1-C3-alkyl)-N(R 7 )(R 8 ),
[1224] Indole
[1225] Monocyclic heteroaryl,
[1226] It is optionally substituted once or twice, each substituent being independently selected from the following groups:
[1227] C1-C3-alkyl and C1-C3-alkoxy,
[1228] R 2 represents a hydrogen atom or a halogen atom,
[1229] R 3 represents a group selected from the following:
[1230] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl, C2-C6-alkenyl and phenyl,
[1231] wherein the C1-C6-alkyl group is optionally replaced by a cyclopropyl or N(R 7 )(R 8 ) group substituted,
[1232] R 4 represents a group selected from the following:
[1233] C2-C4-alkenyl,
[1234] C3-C5-cycloalkyl,
[1235] C1-C3-hydroxyalkyl,
[1236] C1-C4-alkyl,
[1237] which is optionally substituted by a group selected from the group consisting of cyclopropyl and phenyl,
[1238] R 5 represents a halogen atom or a group selected from the following:
[1239] C1-C4-alkyl,
[1240] C3-C5-cycloalkyl,
[1241] C1-C3-haloalkyl, which is optionally substituted by hydroxy,
[1242] C1-C3-hydroxyalkyl,
[1243] CH3O-(C1-C2-alkyl)-group,
[1244] C1-C3-alkoxy groups,
[1245] methylthio group,
[1246] -(C1-C2-alkyl)-N(R 7 )(R 8 ) group,
[1247] -N(R 7 )(R 8 ) group,
[1248] -C(=O)OR 6 Group,
[1249] -C(=O)N(R 7 )(R 8 ) groups and
[1250] -S(=O)(=NR 11 )(C1-C3-alkyl) group,
[1251] R 6 represents a hydrogen atom or a methyl group,
[1252] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group or a cyclopropyl group,
[1253] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[1254] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1255] R 1 represents a group selected from the following:
[1256] C5-C7-alkyl, C5-C7-cycloalkyl,
[1257] C1-C2-alkyl, which is substituted by C5-C6-cycloalkyl,
[1258] C3-C4-hydroxyalkyl, -(C3-C4-alkyl)-N(R 7 )(R 8 ) group, CH3CH2CH-C(=O)NH2 group, 5- to 6-membered heterocycloalkyl group, phenyl group, indanyl group and monocyclic heteroaryl group,
[1259] wherein the 5- to 6-membered heterocycloalkyl group is optionally substituted once or twice by C1-C3-alkyl,
[1260] and
[1261] wherein said 5- to 6-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of said heterocycloalkyl group,
[1262] and
[1263] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxyl, -C(=O)OR 6 、-N(R7 )(R 8 ) and -(C1-C3-alkyl)-N(R 7 )(R 8 ),
[1264] and
[1265] wherein the monocyclic heteroaryl is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[1266] R 2 represents a hydrogen atom or a fluorine atom,
[1267] R 3 represents a group selected from the following:
[1268] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and phenyl,
[1269] wherein the C1-C6-alkyl group is optionally substituted by a cyclopropyl group,
[1270] R 4 represents a group selected from the following:
[1271] C1-C4-alkyl, C3-C5-cycloalkyl and C2-C3-hydroxyalkyl,
[1272] wherein the C1-C4-alkyl group is optionally substituted by a group selected from the group consisting of:
[1273] Cyclopropyl and phenyl,
[1274] R 5 represents a halogen atom or a group selected from the following:
[1275] C1-C4-alkyl, C3-C6-cycloalkyl, C1-haloalkyl,
[1276] C1-C3-hydroxyalkyl, methoxy-(C1-C2-alkyl)-group, C1-C3-alkoxy group, methylthio group, -(C1-C2-alkyl)-N(R 7 )(R 8 ) group and -N(R 7 )(R 8 ) group,
[1277] R 6 represents a hydrogen atom or a methyl group,
[1278] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group,
[1279] or a tautomer, N-oxide or a salt thereof, and a salt of a tautomer or N-oxide.
[1280] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1281] R 1 represents a group selected from the following:
[1282] C5-C7-cycloalkyl,
[1283] 5- to 6-membered heterocycloalkyl, phenyl group, indanyl and monocyclic heteroaryl,
[1284] wherein the 5- to 6-membered heterocycloalkyl group is optionally substituted once or twice by C1-C3-alkyl,
[1285] and
[1286] wherein said 5- to 6-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of said heterocycloalkyl group,
[1287] and
[1288] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxyl, -C(=O)OR 6 、-N(R 7 )(R 8 ) and -(C1-C3-alkyl)-N(R 7 )(R 8 ),
[1289] and
[1290] wherein the monocyclic heteroaryl is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[1291] R 2 represents a hydrogen atom or a fluorine atom,
[1292] R 3 represents a group selected from the following:
[1293] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and phenyl,
[1294] wherein the C1-C6-alkyl group is optionally substituted by a cyclopropyl group,
[1295] R 4 represents a group selected from the following:
[1296] C1-C4-alkyl, C3-C5-cycloalkyl and C2-C3-hydroxyalkyl,
[1297] wherein the C1-C4-alkyl group is optionally substituted by a group selected from the group consisting of:
[1298] Cyclopropyl and phenyl,
[1299] R 5 represents a halogen atom or a group selected from the following:
[1300] C1-C4-alkyl, C3-C6-cycloalkyl, C1-haloalkyl, C1-C3-hydroxyalkyl, methoxy-(C1-C2-alkyl)-group, C1-C3-alkoxy group, methylthio group, -(C1-C2-alkyl)-N(R 7 )(R 8 ) group and -N(R 7 )(R 8 ) group,
[1301] R 6 represents a hydrogen atom or a methyl group,
[1302] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group,
[1303] and tautomers, N-oxides or salts thereof, and salts of tautomers or N-oxides.
[1304] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1305] R 1 represents a group selected from the following:
[1306] C5-C7-alkyl, C5-C7-cycloalkyl,
[1307] C1-C2-alkyl, which is substituted by C5-C6-cycloalkyl,
[1308] C3-C4-hydroxyalkyl, -(C3-C4-alkyl)-N(R 7 )(R 8 ) group, CH3CH2CH-C(=O)NH2 group, 5- to 6-membered heterocycloalkyl group, phenyl group, indanyl group and monocyclic heteroaryl group,
[1309] wherein the 5- to 6-membered heterocycloalkyl group is selected from:
[1310] tetrahydrofuranyl, tetrahydro-2H-pyranyl and piperidinyl,
[1311] wherein the 5- to 6-membered heterocycloalkyl group is optionally substituted once or twice by C1-C3-alkyl,
[1312] and
[1313] wherein said 5- to 6-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of said heterocycloalkyl group,
[1314] and
[1315] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxyl, -C(=O)OR 6 、-N(R 7 )(R 8 ) and -(C1-C3-alkyl)-N(R 7 )(R 8 ),
[1316] and
[1317] wherein the monocyclic heteroaryl group is selected from the group consisting of oxazolyl, pyrazolyl, pyridinyl and pyrimidinyl,
[1318] wherein the monocyclic heteroaryl is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[1319] R 2 represents a hydrogen atom or a fluorine atom,
[1320] R 3 represents a group selected from the following:
[1321] C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and phenyl,
[1322] wherein the C1-C6-alkyl group is optionally substituted by a cyclopropyl group,
[1323] R 4 represents a group selected from the following:
[1324] C1-C4-alkyl, C3-C5-cycloalkyl and C2-C3-hydroxyalkyl,
[1325] wherein the C1-C4-alkyl group is optionally substituted by a group selected from the group consisting of:
[1326] Cyclopropyl and phenyl,
[1327] R 5 represents a halogen atom or a group selected from the following:
[1328] C1-C4-alkyl, C3-C6-cycloalkyl, C1-haloalkyl, C1-C3-hydroxyalkyl, methoxy-(C1-C2-alkyl)-group, C1-C3-alkoxy group, methylthio group, -(C1-C2-alkyl)-N(R 7 )(R 8 ) group and -N(R 7 )(R 8 ) group,
[1329] R 6 represents a hydrogen atom or a methyl group,
[1330] R 7 and R 8 represents independently at each occurrence a hydrogen atom or a C1-C3-alkyl group,
[1331] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1332] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1333] R 1 represents a group selected from the following:
[1334] 3-pentyl, 2,2-dimethylpropyl, 4-heptyl, 4-fluorophenylcyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclohexylethyl, 1-hydroxypropan-2-yl, 2-hydroxypropyl, 1-hydroxybutan-2-yl, 1-cyanobutan-2-yl, 1-phenylbutan-2-yl, 1-amino-2-propyl, 1-amino-2-butyl, 1-amino-1-oxobutan-2-yl, indan-2-yl, 5- to 6-membered heterocycloalkyl selected from the group consisting of tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl and piperidin-4-yl, and which is optionally substituted once or twice with methyl,
[1335] A phenyl group, which is optionally substituted once, twice or three times, each substituent being independently selected from:
[1336] a fluorine atom or a chlorine atom or a group selected from the group consisting of methyl, ethyl, propyl, isopropyl, difluoromethyl, trifluoromethyl, methoxy, -OC(=O)-1,1-dimethylethyl, hydroxy, -C(=O)OCH3, -C(=O)NH-cyclopropyl, amino, methylamino, aminomethyl, -S-CH3, -S(=O)2CH3 and -S(=O)(NH)CH3, and
[1337] Monocyclic heteroaryl selected from
[1338] oxazol-2-yl, pyrazol-3-yl, pyrazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, quinolin-5-yl, indazol-5-yl, and which are optionally substituted once or twice, each substituent being independently selected from methyl and methoxy,
[1339] R 2 represents a hydrogen atom or a fluorine or chlorine atom,
[1340] R 3 represents a group selected from the following:
[1341] propyl, 2-methylpropyl, 3-pentyl, cyclopropylmethyl, cyclopropyl, cyclopropylmethyl, cyclobutyl, cyclopentyl, cyclohexyl, difluoromethyl, trifluoromethyl, 1,1-difluoroethyl, prop-2-en-1-yl, 2-methyl-prop-1-en-1-yl, N,N-dimethylaminoethyl and phenyl,
[1342] R 4 represents a group selected from the following:
[1343] methyl, ethyl, propyl, isopropyl, 2-butyl, prop-2-en-1-yl, cyclopropylmethyl, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, 2-hydroxyethyl,
[1344] R 5 represents a chlorine atom or a group selected from the following:
[1345] methyl, ethyl, propyl, isopropyl, 2-butyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, trifluoromethyl, hydroxymethyl, 1-hydroxyethyl, 2-hydroxyprop-2-yl, 1-chloroethyl, 1-hydroxy-2,2,2-trifluoroethyl, 1-methoxyethyl, methoxy, isopropyloxy, methylthio, aminomethyl, (methylamino)methyl, (dimethylamino)methyl, 1-aminoethyl, 2-aminoethyl, methylamino and ethyl(methyl)amino, -C(=O)OH, -C(=O)OCH3, -C(=O)NH2, -C(=O)NHCH3, -C(=O)NHcyclopropyl, -C(=O)N(CH3)2 and -S(=O)(=NH)CH3,
[1346] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[1347] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1348] R 1 represents a group selected from the following:
[1349] 4-fluorophenylcyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclohexylmethyl, 1-indan-2-yl,
[1350] 5- to 6-membered heterocycloalkyl selected from
[1351] tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl and piperidin-4-yl,
[1352] and which is optionally substituted once or twice with methyl,
[1353] A phenyl group, which is optionally substituted once, twice or three times, each substituent being independently selected from:
[1354] a fluorine atom or a chlorine atom or a group selected from the group consisting of methyl, ethyl, propyl, isopropyl, difluoromethyl, trifluoromethyl, methoxy, -OC(=O)-1,1-dimethylethyl, hydroxy, -C(=O)OCH3, -C(=O)NH-cyclopropyl, amino, methylamino, aminomethyl, -S-CH3, -S(=O)2CH3 and -S(=O)(NH)CH3, and
[1355] Monocyclic heteroaryl selected from
[1356] oxazol-2-yl, pyrazol-3-yl, pyrazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, quinolin-5-yl, indazol-5-yl,
[1357] and which is optionally substituted once or twice, each substituent being independently selected from: methyl and methoxy,
[1358] R 2 represents a hydrogen atom or a fluorine or chlorine atom,
[1359] R 3 represents a group selected from the following:
[1360] propyl, 2-methylpropyl, 3-pentyl, cyclopropylmethyl, cyclopropyl, cyclopropylmethyl, cyclobutyl, cyclopentyl, cyclohexyl, difluoromethyl, trifluoromethyl, 1,1-difluoroethyl, prop-2-en-1-yl, 2-methyl-prop-1-en-1-yl, N,N-dimethylaminoethyl and phenyl,
[1361] R 4 represents a group selected from the following:
[1362] methyl, ethyl, propyl, isopropyl, 2-butyl, prop-2-en-1-yl, cyclopropylmethyl, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, 2-hydroxyethyl,
[1363] R 5 represents a chlorine atom or a group selected from the following:
[1364] methyl, ethyl, propyl, isopropyl, 2-butyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, trifluoromethyl, hydroxymethyl, hydroxy(trifluoromethyl)methyl, 1-hydroxyethyl, 2-hydroxyprop-2-yl, 1-chloroethyl, 1-hydroxy-2,2,2-trifluoroethyl, 1-methoxyethyl, methoxy, isopropoxy, methylthio, aminomethyl, (methylamino)methyl, (dimethylamino)methyl, 1-aminoethyl, 2-aminoethyl, methylamino and ethyl(methyl)amino, -C(=O)OH, -C(=O)OCH3, -C(=O)NH2, -C(=O)NHCH3, -C(=O)NHcyclopropyl, -C(=O)N(CH3)2 and -S(=O)(=NH)CH3,
[1365] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[1366] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1367] R 1 represents a group selected from the following:
[1368] 3-pentyl, 2,2-dimethylpropyl, 4-heptyl, 4-fluorophenylcyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclohexylethyl, 1-hydroxypropyl-2-yl, 2-hydroxypropyl, 1-hydroxybutyl-2-yl, 1-cyanobutyl-2-yl, 1-phenylbutyl-2-yl, 1-amino-2-propyl, 1-amino-2-butyl, 1-amino-1-oxobutyl-2-yl, indan-2-yl,
[1369] 5- to 6-membered heterocycloalkyl selected from
[1370] tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl and piperidin-4-yl,
[1371] and which is optionally substituted once or twice with methyl,
[1372] A phenyl group, which is optionally substituted once, twice or three times, each substituent being independently selected from:
[1373] a fluorine atom or a chlorine atom or a group selected from the group consisting of methyl, ethyl, propyl, isopropyl, difluoromethyl, trifluoromethyl, methoxy, -OC(=O)-1,1-dimethylethyl, hydroxy, -C(=O)OCH3, -C(=O)NH-cyclopropyl, amino, methylamino, aminomethyl, -S-CH3, -S(=O)2CH3 and -S(=O)(NH)CH3, and
[1374] Monocyclic heteroaryl selected from
[1375] oxazol-2-yl, pyrazol-3-yl, pyrazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, quinolin-5-yl, indazol-5-yl,
[1376] and which is optionally substituted once or twice, each substituent being independently selected from: methyl and methoxy,
[1377] R 2 represents a hydrogen atom or a fluorine atom,
[1378] R 3 represents a group selected from the following:
[1379] propyl, 2-methylpropyl, 3-pentyl, cyclopropylmethyl, cyclopropyl, cyclopropylmethyl, cyclobutyl, cyclopentyl, cyclohexyl, difluoromethyl, trifluoromethyl, 1,1-difluoroethyl, prop-2-en-1-yl, 2-methyl-prop-1-en-1-yl, N,N-dimethylaminoethyl and phenyl,
[1380] R 4 represents a group selected from the following:
[1381] methyl, ethyl, propyl, isopropyl, 2-butyl, prop-2-en-1-yl, cyclopropylmethyl, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, 2-hydroxyethyl, -C(=O)OH, -C(=O)OCH3, -C(=O)NH2, -C(=O)NHCH3, -C(=O)NHcyclopropyl, -C(=O)N(CH3)2 and -S(=O)(=NH)CH3,
[1382] R 5 represents a chlorine atom or a group selected from the following:
[1383] methyl, ethyl, propyl, isopropyl, 2-butyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, trifluoromethyl, hydroxymethyl, hydroxy(trifluoromethyl)methyl, 1-hydroxyethyl, 2-hydroxyprop-2-yl, 1-chloroethyl, 1-hydroxy-2,2,2-trifluoroethyl, 1-methoxyethyl, methoxy, isopropoxy, methylthio, aminomethyl, (methylamino)methyl, (dimethylamino)methyl, 1-aminoethyl, 2-aminoethyl, methylamino and ethyl(methyl)amino,
[1384] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[1385] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1386] R1 represents a group selected from the following:
[1387] 4-fluorophenylcyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl, indan-2-yl, 5- to 6-membered heterocycloalkyl selected from
[1388] tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl and piperidin-4-yl,
[1389] and which is optionally substituted once or twice with methyl,
[1390] A phenyl group, which is optionally substituted once, twice or three times, each substituent being independently selected from:
[1391] a fluorine atom or a chlorine atom or a group selected from the group consisting of methyl, ethyl, propyl, isopropyl, difluoromethyl, trifluoromethyl, methoxy, -OC(=O)-1,1-dimethylethyl, hydroxy, -C(=O)OCH3, -C(=O)NH-cyclopropyl, amino, methylamino, aminomethyl, -S-CH3, -S(=O)2CH3 and -S(=O)(NH)CH3, and
[1392] Monocyclic heteroaryl selected from
[1393] oxazol-2-yl, pyrazol-3-yl, pyrazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, quinolin-5-yl, indazol-5-yl,
[1394] and which is optionally substituted once or twice, each substituent being independently selected from methyl and methoxy,
[1395] R 2 represents a hydrogen atom or a fluorine atom,
[1396] R 3 represents a group selected from the following:
[1397] propyl, 2-methylpropyl, 3-pentyl, cyclopropylmethyl, cyclopropyl, cyclopropylmethyl, cyclobutyl, cyclopentyl, cyclohexyl, difluoromethyl, trifluoromethyl, 1,1-difluoroethyl, prop-2-en-1-yl, 2-methyl-prop-1-en-1-yl, N,N-dimethylaminoethyl and phenyl,
[1398] R 4 represents a group selected from the following:
[1399] methyl, ethyl, propyl, isopropyl, 2-butyl, prop-2-en-1-yl, cyclopropylmethyl, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, 2-hydroxyethyl,
[1400] R 5represents a chlorine atom or a group selected from the following:
[1401] methyl, ethyl, propyl, isopropyl, 2-butyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, trifluoromethyl, hydroxymethyl, hydroxy(trifluoromethyl)methyl, 1-hydroxyethyl, 2-hydroxyprop-2-yl, 1-chloroethyl, 1-hydroxy-2,2,2-trifluoroethyl, 1-methoxyethyl, methoxy, isopropoxy, methylthio, aminomethyl, (methylamino)methyl, (dimethylamino)methyl, 1-aminoethyl, 2-aminoethyl, methylamino and ethyl(methyl)amino, -C(=O)OH, -C(=O)OCH3, -C(=O)NH2, -C(=O)NHCH3, -C(=O)NHcyclopropyl, -C(=O)N(CH3)2 and -S(=O)(=NH)CH3,
[1402] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[1403] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1404] R 1 represents a group selected from the following:
[1405] 3-pentyl, 2,2-dimethylpropyl, 4-heptyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclohexylethyl, 1-hydroxypropan-2-yl, 2-hydroxypropyl, 1-hydroxybutan-2-yl, 1-amino-2-propyl, 1-amino-2-butyl, CH3CH2CH-C(=O)NH2, 5- to 6-membered heterocycloalkyl, phenyl, indan-2-yl and monocyclic heteroaryl,
[1406] wherein the 5- to 6-membered heterocycloalkyl group is selected from:
[1407] tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl and piperidin-4-yl,
[1408] wherein the 5- to 6-membered heterocycloalkyl group is optionally substituted once or twice with a methyl group,
[1409] and
[1410] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a fluorine atom or a chlorine atom or a group selected from the following: methyl, ethyl, propyl, isopropyl, trifluoromethyl, methoxy, hydroxy, C(=O)OCH3, amino, methylamino and aminomethyl,
[1411] and
[1412] wherein the monocyclic heteroaryl group is selected from
[1413] oxazol-2-yl, pyrazol-3-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidin-2-yl and pyrimidin-4-yl,
[1414] wherein the monocyclic heteroaryl group is optionally substituted once or twice, each substituent being independently selected from the group consisting of methyl and methoxy,
[1415] R 2 represents a hydrogen atom or a fluorine atom,
[1416] R 3 represents a group selected from the following:
[1417] propyl, 2-methylpropyl, 3-pentyl, cyclopropylmethyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, trifluoromethyl, allyl, 2-methyl-prop-enyl and phenyl,
[1418] R 4 represents a group selected from the following:
[1419] methyl, ethyl, propyl, isopropyl, 2-butyl, cyclopropylmethyl, benzyl, cyclopropyl, cyclopentyl and 2-hydroxyethyl,
[1420] R 5 represents a chlorine atom or a group selected from the following:
[1421] methyl, ethyl, propyl, isopropyl, 2-butyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, trifluoromethyl, hydroxymethyl, 1-hydroxyethyl, 2-hydroxyprop-2-yl, 1-methoxyethyl, methoxy, isopropoxy, methylthio, aminomethyl, (methylamino)methyl, (dimethylamino)methyl, 1-aminoethyl, 2-aminoethyl, methylamino and ethyl(methyl)amino,
[1422] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1423] According to other embodiments, the present invention provides compounds of the above general formula (I), wherein:
[1424] R 1 represents a group selected from the following:
[1425] Cyclopentyl, cyclohexyl, cycloheptyl,
[1426] CH3CH2CH-C(=O)NH2,
[1427] 5- to 6-membered heterocycloalkyl, phenyl, indan-2-yl and monocyclic heteroaryl,
[1428] wherein the 5- to 6-membered heterocycloalkyl group is selected from:
[1429] tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl and piperidin-4-yl,
[1430] wherein the 5- to 6-membered heterocycloalkyl group is optionally substituted once or twice with a methyl group,
[1431] and
[1432] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a fluorine atom or a chlorine atom or a group selected from the following: methyl, ethyl, propyl, isopropyl, trifluoromethyl, methoxy, hydroxy, C(=O)OCH3, amino, methylamino and aminomethyl,
[1433] and
[1434] wherein the monocyclic heteroaryl group is selected from:
[1435] oxazol-2-yl, pyrazol-3-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidin-2-yl and pyrimidin-4-yl,
[1436] wherein the monocyclic heteroaryl group is optionally substituted once or twice, each substituent being independently selected from the group consisting of methyl and methoxy,
[1437] R 2 represents a hydrogen atom or a fluorine atom,
[1438] R 3 represents a group selected from the following:
[1439] propyl, 2-methylpropyl, 3-pentyl, cyclopropylmethyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, trifluoromethyl, allyl, 2-methyl-prop-enyl and phenyl,
[1440] R 4 represents a group selected from the following:
[1441] methyl, ethyl, propyl, isopropyl, 2-butyl, cyclopropylmethyl, benzyl, cyclopropyl, cyclopentyl and 2-hydroxyethyl,
[1442] R 5 represents a chlorine atom or a group selected from the following:
[1443] methyl, ethyl, propyl, isopropyl, 2-butyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, trifluoromethyl, hydroxymethyl, 1-hydroxyethyl, 2-hydroxyprop-2-yl, 1-methoxyethyl, methoxy, isopropoxy, methylthio, aminomethyl, (methylamino)methyl, (dimethylamino)methyl, 1-aminoethyl, 2-aminoethyl, methylamino and ethyl(methyl)amino,
[1444] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1445] According to other embodiments, the present invention provides a compound of the above general formula (I), which is selected from
[1446] 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1447] N-(2,6-difluorophenyl)-5-fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1448] 5-Fluoro-N-(2-fluorophenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1449] 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-[3-(trifluoromethyl)phenyl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1450] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1451] 5-Fluoro-N-(2-fluorophenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(1S)-1-phenylethoxy]benzamide,
[1452] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(1S)-1-phenylethoxy]benzamide,
[1453] N-(2,6-difluorophenyl)-5-fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(1S)-1-phenylethoxy]benzamide,
[1454] 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(1S)-1-phenylethoxy]-N-[3-(trifluoromethyl)phenyl]benzamide,
[1455] 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methylphenyl)-2-[(1S)-1-phenylethoxy]benzamide,
[1456] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1457] N-(2,6-difluorophenyl)-5-fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1458] 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1459] 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]-N-[3-(trifluoromethyl)phenyl]benzamide,
[1460] 5-Fluoro-N-(2-fluorophenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1461] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1462] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1463] N-(2,6-difluorophenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1464] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1465] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-[3-(trifluoromethyl)phenyl]benzamide,
[1466] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(4-methoxyphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1467] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-[4-(trifluoromethyl)phenyl]benzamide,
[1468] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-[2-(trifluoromethyl)phenyl]benzamide,
[1469] N-(3-amino-2-methylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1470] N-(2-cyano-6-methylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1471] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(3-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1472] N-(2,2-dimethylpropyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1473] N-cycloheptyl-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1474] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-hydroxyphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1475] N-(cyclohexylmethyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1476] N-(1-cyclohexylethyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, a mixture of stereoisomers,
[1477] N-(2,4-dimethylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1478] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-[2-(methylamino)phenyl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1479] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-methoxyphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1480] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(3-methoxyphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1481] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2-ethylphenyl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1482] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-[2-(propan-2-yl)phenyl]benzamide,
[1483] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-(2-propylphenyl)benzamide,
[1484] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(4-ethylphenyl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1485] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-[4-(propan-2-yl)phenyl]benzamide,
[1486] N-(2,3-dihydro-1H-inden-2-yl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1487] N-(cyclopentylmethyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1488] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(4-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1489] N-(4-amino-2,6-dimethylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1490] N-(2-amino-4,6-dimethylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1491] N-[4-(aminomethyl)-3-methylphenyl]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-(pentan-2-yloxy)benzamide,
[1492] 4-(3-cyclopropyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1493] 4-(3-cyclopropyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1494] 4-(3-cyclopropyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1495] 4-(3-cyclobutyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1496] 4-(3-cyclobutyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1497] 4-(3-cyclobutyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1498] 4-(3-cyclopropyl-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1499] 4-(3-cyclopropyl-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1500] 4-(3-cyclopropyl-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1501] 4-(4-cyclopropyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1502] 4-(4-cyclopropyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1503] 4-(4-cyclopropyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1504] N-(2,6-difluorophenyl)-5-fluoro-4-[4-methyl-5-oxo-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1505] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[4-methyl-5-oxo-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1506] 5-Fluoro-N-(2-fluorophenyl)-4-[4-methyl-5-oxo-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1507] 4-(4-cyclopropyl-3-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1508] 4-(4-cyclopropyl-3-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1509] 4-(4-cyclopropyl-3-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1510] N-(2,6-difluorophenyl)-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1511] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1512] 5-Fluoro-N-(2-fluorophenyl)-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1513] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-[(1S)-1-phenylethoxy]benzamide,
[1514] N-(2,6-difluorophenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(1S)-1-phenylethoxy]benzamide,
[1515] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1516] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1517] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(4-fluoro-2-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1518] 5-Fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(2-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1519] 5-Fluoro-N-[(2R)-1-hydroxypropan-2-yl]-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1520] 5-Fluoro-N-[(2R)-1-hydroxybutan-2-yl]-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1521] N-[(2R)-1-amino-1-oxobutan-2-yl]-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1522] 5-fluoro-N-(hept-4-yl)-4-[4-methyl-5-oxo-3-(prop-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1523] 2-(1-cyclohexylethoxy)-N-(2,4-dimethylphenyl)-5-fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide, a mixture of stereoisomers,
[1524] N-(2-amino-6-methylphenyl)-2-(1-cyclohexylethoxy)-5-fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide, a mixture of stereoisomers,
[1525] N-(4-amino-2-methylphenyl)-2-(1-cyclohexylethoxy)-5-fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide, a mixture of stereoisomers,
[1526] 2-(1-cyclohexylethoxy)-N-(2,6-dimethylphenyl)-5-fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide, a mixture of stereoisomers,
[1527] 5-Fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(2-methylphenyl)-2-(pentan-2-yloxy)benzamide, a mixture of stereoisomers,
[1528] N-(2-amino-6-methylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-(pent-4-en-2-yloxy)benzamide, a mixture of stereoisomers,
[1529] N-(2,6-dimethylphenyl)-5-fluoro-4-{3-[(1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-[(2R)-pentan-2-yloxy]benzamide, a mixture of stereoisomers,
[1530] N-(4-amino-2-methylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[pent-4-en-2-yloxy]benzamide, a mixture of stereoisomers,
[1531] 5-Fluoro-4-{4-methyl-3-[(methylamino)methyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(pentan-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1532] 2-(1-cyclohexylethoxy)-N-(2,6-dimethylphenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide, a mixture of stereoisomers,
[1533] 4-[3-(Aminomethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-N-(2-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1534] N-[4-amino-2-(trifluoromethyl)phenyl]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1535] N-[2-(Aminomethyl)-6-methylphenyl]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide,
[1536] 4-{3-[(1R)-1-aminoethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(4-amino-2-methylphenyl)-2-(1-cyclohexylethoxy)-5-fluorobenzamide, a mixture of stereoisomers,
[1537] 4-(4-cyclopentyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1538] N-(2,6-difluorophenyl)-4-{3-[ethyl(methyl)amino]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1539] N-(2,6-difluorophenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1540] N-(2,6-Difluorophenyl)-5-fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, a single stereoisomer,
[1541] N-(2,6-difluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1542] N-(2,6-difluorophenyl)-4-{3-[(dimethylamino)methyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1543] N-(2,6-difluorophenyl)-5-fluoro-4-(4-methyl-5-oxo-3-propyl-4,5-dihydro-1H-1,2,4-triazol-1-yl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1544] N-(2,6-difluorophenyl)-5-fluoro-4-[4-methyl-3-(methylthio)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1545] 4-[3-(2-aminoethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1546] N-(2,6-difluorophenyl)-5-fluoro-4-[4-methyl-3-(methylamino)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1547] 4-(3-tert-butyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1548] 4-(3-chloro-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1549] 4-[4-(cyclopropylmethyl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1550] N-(2,6-difluorophenyl)-5-fluoro-4-(3-methyl-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazol-1-yl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1551] N-(2,6-difluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1552] N-(2,6-difluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1553] N-(2,6-difluorophenyl)-4-[3-ethyl-4-(2-hydroxyethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1554] 4-(3,4-diethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1555] 4-(4-cyclopropyl-3-methoxy-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1556] 4-(3-chloro-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1557] 4-(3-cyclopentyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1558] 4-[4-(But-2-yl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, a mixture of stereoisomers,
[1559] 4-[3-(But-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, a mixture of stereoisomers,
[1560] N-(2,6-difluorophenyl)-4-[4-ethyl-3-(methylthio)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1561] N-(2,6-Difluorophenyl)-5-fluoro-4-[3-(1-methoxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, a mixture of stereoisomers,
[1562] N-(2,6-difluorophenyl)-4-[4-ethyl-5-oxo-3-(propan-2-yloxy)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1563] 4-(4-benzyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1564] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1565] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1566] N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1567] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1568] 5-Fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1569] 4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1570] 5-Fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1571] 5-Fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1572] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1573] 4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1574] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1575] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1576] N-(2,6-dichlorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1577] N-(2,6-dichlorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1578] N-(2,6-dichlorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1579] N-(2,6-dichlorophenyl)-5-fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1580] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1581] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-[(2S)-pentan-2-yloxy]benzamide,
[1582] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1583] 5-Fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methoxy-4-methylpyridin-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1584] 5-fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(2-methoxy-4-methylpyridin-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1585] 5-Fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methoxy-4-methylpyridin-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1586] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1587] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-[(2S)-pentan-2-yloxy]benzamide,
[1588] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1589] 5-Fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(pentan-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1590] 5-Fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(pentan-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1591] N-(2,6-difluorophenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1592] 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(tetrahydrofuran-3-yl)benzamide, a mixture of stereoisomers,
[1593] 5-Fluoro-N-[(2R)-1-hydroxypropan-2-yl]-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide,
[1594] 5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(1H-pyrazol-3-yl)benzamide,
[1595] 5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(pyridin-2-yl)benzamide,
[1596] 5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(pyridin-4-yl)benzamide,
[1597] 5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(1-methylpiperidin-4-yl)benzamide,
[1598] 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(tetrahydro-2H-pyran-4-yl)benzamide,
[1599] 5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(pyrimidin-4-yl)benzamide,
[1600] 5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(1,3-oxazol-2-yl)benzamide,
[1601] 5-Fluoro-N-[(2R)-1-hydroxybutan-2-yl]-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide,
[1602] N-cyclopentyl-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide,
[1603] N-cyclohexyl-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide,
[1604] 5-Fluoro-N-(2-hydroxypropyl)-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide, a mixture of stereoisomers,
[1605] 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-phenylbenzamide,
[1606] 5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(pyrimidin-2-yl)benzamide,
[1607] N-[(2R)-1-aminopropan-2-yl]-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide,
[1608] N-[(2R)-1-aminobutan-2-yl]-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide,
[1609] 5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(piperidin-4-yl)benzamide,
[1610] 2-(1-cyclohexylethoxy)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers,
[1611] 2-[(1-Cyclopropylpropan-2-yl)oxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers,
[1612] 2-(1-cyclopentylethoxy)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers,
[1613] 2-(1-cyclopropylethoxy)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers,
[1614] 4-(3-Ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)-2-(1-phenylethoxy)benzamide, a mixture of stereoisomers,
[1615] 4-(3-Ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-2-[(3-ethylpentan-2-yl)oxy]-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers,
[1616] 4-(3-Ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(4-methylpent-3-en-2-yl)oxy]-N-(pent-3-yl)benzamide, a mixture of stereoisomers,
[1617] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pent-3-yl)-2-(pent-4-en-2-yloxy)benzamide, a mixture of stereoisomers,
[1618] 2-(1-cyclobutylethoxy)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers,
[1619] 5-Fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(pentan-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide, a mixture of stereoisomers, and
[1620] 5-Fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methylphenyl)-2-(pentan-2-yloxy)benzamide, a mixture of stereoisomers,
[1621] or a tautomer, an N-oxide, a salt of a tautomer, or a salt of an N-oxide thereof.
[1622] According to other embodiments, the present invention provides a compound of the above general formula (I) selected from:
[1623] N-(2-chloro-6-fluorophenyl)-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1624] N-(2,6-difluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1625] N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1626] N-(2-Chloro-6-fluorophenyl)-2-{[1,1-difluoroprop-2-yl]oxy}-4-[3-(2-hydroxyprop-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide (racemic)
[1627] N-(2-Chloro-6-fluorophenyl)-2-{[1,1-difluoroprop-2-yl]oxy}-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide (racemic)
[1628] N-(2-Chloro-6-fluorophenyl)-4-[4-cyclopropyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide
[1629] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1630] N-(2-chloro-6-fluorophenyl)-4-[4-cyclobutyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1631] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-5-oxo-4-(prop-2-en-1-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1632] N-(2-chloro-6-fluorophenyl)-2-{[3,3-difluorobut-2-yl]oxy}-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluorobenzamide (racemate),
[1633] 5-Fluoro-4-[3-(hydroxymethyl)-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1634] N-(2-Chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-3-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide
[1635] N-(2-Chloro-6-fluorophenyl)-3-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide
[1636] N-(6-chloro-2-fluoro-3-methoxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1637] N-(6-Chloro-2-fluoro-3-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide
[1638] N-(6-chloro-2-fluoro-3-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1639] 2,2-Dimethylpropanoic acid 3-chloro-4-(4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamido)-5-fluorophenyl ester,
[1640] N-(2-chloro-6-fluoro-4-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1641] N-(2-chloro-6-fluoro-3-methoxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1642] N-(2-chloro-6-fluoro-3-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1643] 2-[(1S)-1-cyclohexylethoxy]-N-(1,4-dimethyl-1H-pyrazol-3-yl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluorobenzamide,
[1644] 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-[1-(4-fluorophenyl)cyclopropyl]benzamide
[1645] 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(oxan-4-yl)benzamide
[1646] 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(1-phenylbutan-2-yl)benzamide
[1647] 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-[3-(methylsulfonyl)phenyl]benzamide,
[1648] 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(1-methyl-1H-pyrazol-5-yl)benzamide,
[1649] N-(2-chloro-6-fluorophenyl)-4-[3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1650] 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-[4-(methylthio)phenyl]benzamide,
[1651] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(4-methylpyridin-3-yl)-2-[(1S)-1-phenylethoxy]benzamide,
[1652] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-methylquinolin-5-yl)-2-[(1S)-1-phenylethoxy]benzamide,
[1653] N-[3-(cyclopropylcarbamoyl)phenyl]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(1S)-1-phenylethoxy]benzamide,
[1654] N-[2-(difluoromethyl)phenyl]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(1S)-1-phenylethoxy]benzamide,
[1655] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(6-methyl-1H-indazol-5-yl)-2-[(1S)-1-phenylethoxy]benzamide,
[1656] N-(1-cyanobutan-2-yl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(1S)-1-phenylethoxy]benzamide,
[1657] 2-{[(2S)-1-(dimethylamino)propan-2-yl]oxy}-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)benzamide,
[1658] 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-[4-(S-methylsulfimidoyl)phenyl]benzamide (mixture of stereoisomers),
[1659] N-(2,6-difluorophenyl)-4-[4-ethyl-3-(S-methylsulfimidoyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide (mixture of stereoisomers),
[1660] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-3-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1661] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1662] 1-(4-[(2,6-difluorophenyl)carbamoyl]-3-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1663] 4-ethyl-1-(2-fluoro-4-[(2-fluoro-6-methylphenyl)carbamoyl]-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1664] 1-(4-[(2,6-dichlorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1665] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-3-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1666] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-3-{[1,1-difluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid (racemate),
[1667] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1668] 1-(2-fluoro-4-[(2-fluoro-6-methylphenyl)carbamoyl]-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1669] 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1670] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1671] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-5-{[3,3-difluorobut-2-yl]oxy}-2-fluorophenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid (racemate),
[1672] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-cyclopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1673] 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid
[1674] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-5-oxo-4-(prop-2-en-1-yl)-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1675] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-cyclobutyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1676] 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide,
[1677] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide,
[1678] N-cyclopropyl-1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide,
[1679] 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-N,4-dimethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide
[1680] 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide
[1681] 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-N,N-dimethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide
[1682] 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid methyl ester,
[1683] 5-Fluoro-4-{3-[1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(2-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide (mixture of stereoisomers) and
[1684] 4-{4-ethyl-5-oxo-3-[(1S)-2,2,2-trifluoro-1-hydroxyethyl]-4,5-dihydro-1H-1,2,4-triazol-1-yl}-5-fluoro-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide (mixture of stereoisomers)
[1685] or a tautomer, an N-oxide, a salt of a tautomer, or a salt of an N-oxide thereof.
[1686] According to other embodiments, the present invention provides compounds of the above general formula (I), which are exemplified in the experimental part.
[1687] In other embodiments, the present invention provides a compound of formula (I) above, any compound selected from:
[1688] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1689] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide,
[1690] 4-(3-cyclopropyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1691] 4-(3-cyclopropyl-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1692] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1693] 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1694] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1695] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1696] N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1697] 4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1698] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1699] N-(2,6-dichlorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1700] N-(2,6-dichlorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1701] N-(2,6-dichlorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1702] N-(2,6-dichlorophenyl)-5-fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1703] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1704] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-[(2S)-pentan-2-yloxy]benzamide,
[1705] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1706] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1707] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-[(2S)-pentan-2-yloxy]benzamide,
[1708] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide,
[1709] N-(2-chloro-6-fluorophenyl)-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1710] N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1711] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1712] N-(2-chloro-6-fluorophenyl)-4-[4-cyclobutyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1713] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-5-oxo-4-(prop-2-en-1-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1714] N-(6-chloro-2-fluoro-3-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1715] N-(2-chloro-6-fluoro-4-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1716] N-(2-chloro-6-fluoro-3-methoxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1717] N-(2-chloro-6-fluoro-3-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1718] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-3-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1719] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1720] 1-(4-[(2,6-difluorophenyl)carbamoyl]-3-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1721] 4-ethyl-1-(2-fluoro-4-[(2-fluoro-6-methylphenyl)carbamoyl]-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1722] 1-(4-[(2,6-dichlorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1723] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1724] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid,
[1725] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-5-{[3,3-difluorobut-2-yl]oxy}-2-fluorophenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid (racemate),
[1726] 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid
[1727] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-5-oxo-4-(prop-2-en-1-yl)-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, and
[1728] 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide, or a tautomer, N-oxide, a salt of a tautomer, or a salt of an N-oxide thereof.
[1729] In other embodiments, the present invention provides a compound of formula (I) above, any compound selected from:
[1730] 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide
[1731] N-(2,6-Difluorophenyl)-5-fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide
[1732] 5-Fluoro-N-(2-fluorophenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide
[1733] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide
[1734] 5-Fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(2-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide
[1735] N-(2,6-Difluorophenyl)-5-fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, single stereoisomer N-(2,6-difluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide
[1736] N-(2,6-Difluorophenyl)-5-fluoro-4-(3-methyl-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazol-1-yl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide
[1737] N-(2,6-Difluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide
[1738] N-(2,6-Difluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide
[1739] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1740] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1741] N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1742] N-(2-Chloro-6-fluorophenyl)-5-fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide
[1743] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide
[1744] 4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1745] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1746] 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide
[1747] N-(2,6-dichlorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1748] N-(2,6-dichlorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1749] N-(2,6-dichlorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide,
[1750] N-(2,6-dichlorophenyl)-5-fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1751] N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1752] N-(6-chloro-2-fluoro-3-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide,
[1753] N-(2-chloro-6-fluoro-4-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, and
[1754] N-(2-chloro-6-fluoro-3-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, or a tautomer, N-oxide, a salt of a tautomer, or a salt of an N-oxide thereof.
[1755] In other embodiments, the present invention provides a compound of formula (I) above, any compound selected from:
[1756] 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide
[1757] N-(2,6-difluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, and
[1758] N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, or a tautomer, N-oxide, a salt of a tautomer, or a salt of an N-oxide thereof.
[1759] In another embodiment, the present invention provides a compound of formula (I) as above, which is
[1760] 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide or a tautomer, N-oxide, a salt of a tautomer, or a salt of an N-oxide.
[1761] In another embodiment, the present invention provides a compound of formula (I) as above, which is
[1762] N-(2,6-difluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, and or a tautomer, N-oxide, a salt of a tautomer, or a salt of an N-oxide thereof.
[1763] In another embodiment, the present invention provides a compound of formula (I) as above, which is
[1764] N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, or a tautomer, N-oxide, a salt of a tautomer, or a salt of an N-oxide thereof.
[1765] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[1766] R 1 represents a group selected from the following:
[1767] C5-C8-alkyl,
[1768] C2-C8-haloalkyl,
[1769] C4-C8-cycloalkyl,
[1770] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of hydroxyl, phenyl and -N(R 7 )(R 8 ),
[1771] and wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[1772] C1-C6-alkyl, which is substituted by C3-C8-cycloalkyl,
[1773] C2-C6-alkyl, which is substituted by cyano, hydroxy, C3-C8-heterocycloalkyl or phenyl groups,
[1774] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[1775] (C2-C6-hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[1776] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[1777] -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[1778] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[1779] 4- to 7-membered heterocycloalkyl, 5- to 7-membered heterocycloalkenyl,
[1780] wherein the 4- to 7-membered heterocycloalkyl and the 5- to 7-membered heterocycloalkenyl are attached to the rest of the molecule via carbon atoms and are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo(=O),
[1781] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[1782] phenyl group,
[1783] which are optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), hydroxyl, cyano, C1-C6-hydroxyalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 ), -OC(=O)-(C1-C6-alkyl)-, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2N(R 7 )(R 8 ), -S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -S(=O)(=NR 11 )(C1-C3-alkyl), -N(O)2, -P(=O)(C1-C3-alkyl)2 and SF5,
[1784] or
[1785] wherein the two ortho substituents may together form a 5- or 6-membered optionally heterocyclic, aromatic or non-aromatic ring, which optionally has 1-3 heteroatoms independently selected from the following: -N=, -NH-, -N(R 7)-, -O-, -S-, and optionally containing a C(═O) group, and wherein the ring so formed is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[1786] and
[1787] Bicyclic aryl,
[1788] partially saturated monocyclic or bicyclic aryl or heteroaryl,
[1789] a monocyclic or bicyclic heteroaryl group,
[1790] which is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -O(C2-C6-alkenyl), C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, C(=O)OR 6 , hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -N(O)2 and -N(R 7 )(R 8 ),
[1791] or a tautomer, an N-oxide, a salt of a tautomer, or a salt of an N-oxide thereof.
[1792] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[1793] R 1 represents a group selected from the following:
[1794] C5-C8-alkyl, C2-C8-haloalkyl, C4-C8-cycloalkyl,
[1795] C1-C6-alkyl, which is substituted by C3-C8-cycloalkyl,
[1796] C2-C6-alkyl, which is substituted by a cyano or phenyl group,
[1797] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[1798] C2-C6-hydroxyalkyl, (C2-C6-hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[1799] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group, -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[1800] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group, a 4-7-membered optionally unsaturated heterocyclic group, a phenyl group and a monocyclic or bicyclic heteroaryl group,
[1801] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R 8 ),
[1802] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[1803] C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[1804] and
[1805] wherein the 4- to 7-membered heterocycloalkyl and 5- to 7-membered heterocycloalkenyl groups are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[1806] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[1807] and
[1808] wherein the 4-7-membered optionally unsaturated heterocyclic group is attached to the remainder of the molecule via a carbon atom,
[1809] and
[1810] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C1-C6-hydroxyalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxy, aryl, -O-aryl, cyano, -C(O)OH, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 ), -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -N(O)2, -P(=O)(C1-C3-alkyl)2 and SF5,
[1811] or wherein the two ortho substituents of the phenyl group may together form a 5- or 6-membered optionally heterocyclic, aromatic or non-aromatic ring, which optionally has 1-3 heteroatoms independently selected from the group consisting of: -N=, -NH-, -N(R 7)-, -O-, -S-, and optionally containing a C(=O) group, and wherein the ring so formed is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[1812] and
[1813] wherein the monocyclic or bicyclic heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -O(C2-C6-alkenyl), C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[1814] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1815] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[1816] R 1 represents a group selected from the following:
[1817] C5-C8-alkyl,
[1818] C2-C8-haloalkyl,
[1819] C4-C8-cycloalkyl,
[1820] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R8 ),
[1821] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[1822] C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[1823] C1-C6-alkyl, which is substituted by C3-C8-cycloalkyl,
[1824] C2-C6-alkyl, which is substituted by cyano, hydroxy or phenyl groups,
[1825] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[1826] C2-C6-cyanoalkyl-group,
[1827] -(C2-C6-alkyl)phenyl,
[1828] (C2-C6-hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[1829] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[1830] -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[1831] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[1832] 4- to 7-membered heterocycloalkyl,
[1833] which is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[1834] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[1835] and wherein the 4- to 7-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of the heterocycloalkyl group or heterocycloalkenyl group,
[1836] 5- to 7-membered heterocycloalkenyl,
[1837] It is optionally substituted once or twice, each substituent being independently selected from the following groups:
[1838] C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[1839] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[1840] and wherein the 5- to 7-membered heterocycloalkenyl group is linked to the remainder of the molecule via a carbon atom of the heterocycloalkyl or heterocycloalkenyl group,
[1841] A phenyl group, wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[1842] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from: -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-,
[1843] Indanyl group, tetrahydronaphthyl group, wherein the indanyl or tetrahydronaphthyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),and
[1844] a monocyclic or bicyclic heteroaryl group,
[1845] wherein the monocyclic or bicyclic heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[1846] or a tautomer, an N-oxide, a salt of a tautomer, or a salt of an N-oxide thereof.
[1847] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[1848] R 1 represents a group selected from the following:
[1849] C5-C8-alkyl, C2-C8-haloalkyl, C4-C8-cycloalkyl,
[1850] C1-C6-alkyl, which is substituted by C3-C8-cycloalkyl,
[1851] C2-C6-alkyl, which is substituted by a cyano or phenyl group,
[1852] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[1853] C2-C6-hydroxyalkyl, (C2-C6-hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[1854] -(C3-C6-alkyl)-N(R7 )(R 8 ) group, -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[1855] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group, a 4- to 7-membered heterocycloalkyl group, a 5- to 7-membered heterocycloalkenyl group, a phenyl group, an indanyl group, a tetrahydronaphthyl group, and a monocyclic or bicyclic heteroaryl group,
[1856] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R 8 ),
[1857] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[1858] and
[1859] wherein the 4- to 7-membered heterocycloalkyl and 5- to 7-membered heterocycloalkenyl groups are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[1860] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[1861] C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[1862] and
[1863] wherein the 4- to 7-membered heterocycloalkyl group and the 5- to 7-membered heterocycloalkenyl group are attached to the remainder of the molecule via a carbon atom of the heterocycloalkyl group or heterocycloalkenyl group,
[1864] and
[1865] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[1866] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from: -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-,
[1867] and
[1868] wherein the indanyl or tetrahydronaphthyl is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[1869] and
[1870] wherein the monocyclic or bicyclic heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[1871] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1872] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[1873] R 1 represents a group selected from the following:
[1874] C5-C8-alkyl,
[1875] C2-C8-haloalkyl,
[1876] C4-C8-cycloalkyl,
[1877] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of hydroxyl, phenyl and -N(R 7 )(R 8 ),
[1878] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[1879] C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[1880] C1-C3-alkyl, which is substituted by C3-C6-cycloalkyl,
[1881] C2-C6-alkyl, which is substituted by cyano, hydroxy or phenyl groups,
[1882] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[1883] C2-C6-cyanoalkyl-group,
[1884] -(C2-C6-alkyl)phenyl group,
[1885] (C2-C3-Hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[1886] -(C3-C6-alkyl)-N(R 7 )(R8 ) group,
[1887] -(C3-C6-cycloalkyl)-N(R 7 )(R 8 ) group,
[1888] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[1889] 4- to 6-membered heterocycloalkyl,
[1890] which is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C3-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C3-alkyl) and oxo (=O),
[1891] wherein the 5- to 6-membered heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[1892] wherein the 4- to 6-membered heterocycloalkyl group is attached to the remainder of the molecule via a carbon atom or a nitrogen atom of the heterocycloalkyl or heterocycloalkenyl group,
[1893] 5- to 6-membered heterocycloalkenyl,
[1894] which is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C3-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C3-alkyl) and oxo (=O),
[1895] wherein the 5- to 6-membered heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[1896] wherein the 5- to 6-membered heterocycloalkenyl group is attached to the remainder of the molecule via a carbon atom or a nitrogen atom of the heterocycloalkyl or heterocycloalkenyl group,
[1897] phenyl group,
[1898] which are optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C4-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -(C1-C3-alkyl)-C(=O)OR 6 、-(C1-C3-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[1899] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from: -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-,
[1900] Indanyl group,
[1901] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[1902] Tetrahydronaphthyl
[1903] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R8 ),
[1904] a monocyclic or bicyclic heteroaryl group,
[1905] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[1906] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[1907] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[1908] R 1 represents a group selected from the following:
[1909] C5-C8-alkyl, C2-C8-haloalkyl, C4-C8-cycloalkyl,
[1910] C1-C3-alkyl, which is substituted by C3-C6-cycloalkyl,
[1911] C2-C6-alkyl, which is substituted by a cyano or phenyl group,
[1912] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[1913] C2-C6-hydroxyalkyl, (C2-C3-hydroxyalkyl)-O-(C2-C6-alkyl)-group,
[1914] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group, -(C3-C6-cycloalkyl)-N(R 7 )(R 8 ) group,
[1915] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group, a 4- to 6-membered heterocycloalkyl group, a 5- to 6-membered heterocycloalkenyl group, a phenyl group, an indanyl group, a tetrahydronaphthyl group, and a monocyclic or bicyclic heteroaryl group,
[1916] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R 8),
[1917] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[1918] and
[1919] wherein the 4- to 6-membered heterocycloalkyl and 5- to 6-membered heterocycloalkenyl groups are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C3-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C3-alkyl) and oxo (=O),
[1920] wherein the 5- to 6-membered heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy and hydroxy,
[1921] and
[1922] wherein the 4- to 6-membered heterocycloalkyl and 5- to 6-membered heterocycloalkenyl groups are attached to the remainder of the molecule via a carbon atom of the heterocycloalkyl or heterocycloalkenyl group,
[1923] and
[1924] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C4-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -(C1-C3-alkyl)-C(=O)OR 6 、-(C1-C3-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8)、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[1925] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from: -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-, and
[1926] wherein the indanyl- or tetrahydronaphthyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[1927] and
[1928] wherein the monocyclic or bicyclic heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C3-alkyl, C1-C3-haloalkyl, C3-C6-cycloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C3-C6-cycloalkyloxy, cyano, hydroxyl and -N(R 7 )(R 8 ),
[1929] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1930] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[1931] R 1 represents a group selected from the following:
[1932] C5-C8-alkyl,
[1933] C4-C8-cycloalkyl,
[1934] which is optionally substituted once or twice with a phenyl group, wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom,
[1935] C1-C3-alkyl, which is substituted by C3-C6-cycloalkyl,
[1936] C2-C6-alkyl, which is substituted by a hydroxyl or phenyl group,
[1937] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[1938] C2-C6-cyanoalkyl-group,
[1939] -(C2-C6-alkyl)phenyl group,
[1940] -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[1941] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[1942] 4- to 6-membered heterocycloalkyl,
[1943] which is optionally substituted once or twice, each substituent being independently selected from C1-C3-alkyl,
[1944] and
[1945] which is linked to the rest of the molecule via a carbon atom of said heterocycloalkyl group,
[1946] phenyl group,
[1947] It is optionally substituted once, twice, three times or four times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、--C(=O)N(R 7 )(R 8 )、N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -OC(=O)-(C1-C4-alkyl), -S-C1-C3-alkyl, -S(=O)2(C1-C3-alkyl), -S(=O)(=NR 11 )(C1-C3-alkyl) and -P(=O)(C1-C3-alkyl)2,
[1948] Indole
[1949] a monocyclic or bicyclic heteroaryl group,
[1950] which are optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[1951] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1952] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[1953] R 1 represents a group selected from the following:
[1954] C5-C8-alkyl, C4-C8-cycloalkyl,
[1955] C1-C3-alkyl, which is substituted by C3-C6-cycloalkyl,
[1956] C2-C6-alkyl, which is substituted by a phenyl group,
[1957] C3-C6-alkyl, which is substituted by monocyclic or bicyclic heteroaryl,
[1958] C2-C6-hydroxyalkyl, -(C3-C6-alkyl)-N(R 7 )(R 8 ) group,
[1959] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group, a 4- to 6-membered heterocycloalkyl group, a phenyl group, an indanyl group, and a monocyclic or bicyclic heteroaryl group,
[1960] wherein the cycloalkyl group is optionally substituted once or twice with a phenyl group, wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom,
[1961] and
[1962] wherein the 4- to 6-membered heterocycloalkyl is optionally substituted once or twice, each substituent being independently selected from C1-C3-alkyl,
[1963] and
[1964] wherein said 4- to 6-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of said heterocycloalkyl group,
[1965] and
[1966] wherein the phenyl group is optionally substituted once, twice, three times or four times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、-N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl) and -P(=O)(C1-C3-alkyl)2,
[1967] and
[1968] wherein the monocyclic or bicyclic heteroaryl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[1969] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[1970] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[1971] R 1 represents a group selected from the following:
[1972] C5-C7-alkyl,
[1973] C5-C7-cycloalkyl,
[1974] C1-C2-alkyl, which is substituted by C5-C7-cycloalkyl,
[1975] C2-C5-alkyl, which is substituted by cyano, hydroxy or phenyl groups,
[1976] -(C3-C5-alkyl)-N(R 7 )(R 8 ) group,
[1977] -(C3-C5-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[1978] 5- to 6-membered heterocycloalkyl,
[1979] which are optionally substituted once or twice by C1-C3-alkyl,
[1980] and
[1981] It is connected to the rest of the molecule through a carbon atom,
[1982] phenyl group,
[1983] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C3-alkyl)-N(R 7 )(R 8 ), -OC(=O)-(C1-C4-alkyl), -S-C1-C3-alkyl, -S(=O)2-C1-C3-alkyl, -S(=O)(=NH)(C1-C3-alkyl), and
[1984] Indole
[1985] Monocyclic heteroaryl,
[1986] which are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[1987] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[1988] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[1989] R 1 represents a group selected from the following:
[1990] C5-C7-alkyl, C5-C7-cycloalkyl,
[1991] C1-C2-alkyl, which is substituted by C5-C7-cycloalkyl,
[1992] C2-C5-hydroxyalkyl, -(C3-C5-alkyl)-N(R 7 )(R 8 ) group,
[1993] -(C3-C5-alkyl)-C(=O)N(R 7 )(R 8 ) group, a 5- to 6-membered heterocycloalkyl group, a phenyl group, an indanyl group, and a monocyclic heteroaryl group,
[1994] wherein the 5- to 6-membered heterocycloalkyl group is optionally substituted once or twice by C1-C3-alkyl,
[1995] and
[1996] wherein said 5- to 6-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of said heterocycloalkyl group,
[1997] and
[1998] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxyl, -C(=O)OR 6 、-N(R 7 )(R 8 ) and -(C1-C3-alkyl)-N(R 7 )(R 8 ),
[1999] and
[2000] wherein the monocyclic heteroaryl is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[2001] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[2002] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[2003] R 1 represents a group selected from the following:
[2004] C5-C7-alkyl,
[2005] C5-C7-cycloalkyl,
[2006] C1-C2-alkyl, which is substituted by C5-C6-cycloalkyl,
[2007] C3-C4-hydroxyalkyl,
[2008] C3-C4-phenylalkyl,
[2009] -(C3-C4-alkyl)-N(R 7 )(R 8 ) group,
[2010] CH3CH2CH-C(=O)NH2 group,
[2011] 5- to 6-membered heterocycloalkyl,
[2012] which are optionally substituted once or twice by C1-C3-alkyl,
[2013] and
[2014] It is connected to the rest of the molecule through a carbon atom,
[2015] phenyl group,
[2016] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxy, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -OC(=O)-(C1-C4-alkyl), -S-C1-C3-alkyl, -S(=O)2-C1-C3-alkyl, -S(=O)(=NH)(C1-C3-alkyl) and -(C1-C3-alkyl)-N(R 7 )(R 8 ),
[2017] Indole
[2018] Monocyclic heteroaryl,
[2019] It is optionally substituted once or twice, each substituent being independently selected from the following groups:
[2020] C1-C3-alkyl and C1-C3-alkoxy,
[2021] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[2022] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[2023] R 1 represents a group selected from the following:
[2024] C5-C7-alkyl, C5-C7-cycloalkyl,
[2025] C1-C2-alkyl, which is substituted by C5-C6-cycloalkyl,
[2026] C3-C4-hydroxyalkyl, -(C3-C4-alkyl)-N(R 7 )(R 8 ) group, CH3CH2CH-C(=O)NH2 group, 5- to 6-membered heterocycloalkyl group, phenyl group, indanyl group and monocyclic heteroaryl group,
[2027] wherein the 5- to 6-membered heterocycloalkyl group is selected from tetrahydrofuranyl, tetrahydro-2H-pyranyl
[2028] and piperidinyl,
[2029] wherein the 5- to 6-membered heterocycloalkyl group is optionally substituted once or twice by C1-C3-alkyl,
[2030] and
[2031] wherein said 5- to 6-membered heterocycloalkyl group is linked to the remainder of the molecule via a carbon atom of said heterocycloalkyl group,
[2032] and
[2033] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C4-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxyl, -C(=O)OR 6 、-N(R 7 )(R 8 ) and -(C1-C3-alkyl)-N(R 7 )(R 8 ),
[2034] and
[2035] wherein the monocyclic heteroaryl is selected from oxazolyl, pyrazolyl, pyridinyl and pyrimidinyl, wherein the monocyclic heteroaryl is optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl and C1-C3-alkoxy,
[2036] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[2037] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[2038] R 1 represents a group selected from the following:
[2039] 3-pentyl, 2,2-dimethylpropyl, 4-heptyl, 4-fluorophenylcyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclohexylethyl, 1-hydroxypropan-2-yl, 2-hydroxypropyl, 1-hydroxybutan-2-yl, 1-cyanobutan-2-yl, 1-phenylbutan-2-yl, 1-amino-2-propyl, 1-amino-2-butyl, 1-amino-1-oxobutan-2-yl, indan-2-yl, 5- to 6-membered heterocycloalkyl selected from
[2040] tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl and piperidin-4-yl,
[2041] and which is optionally substituted once or twice with methyl,
[2042] A phenyl group, which is optionally substituted once, twice or three times, each substituent being independently selected from:
[2043] a fluorine atom or a chlorine atom or a group selected from the group consisting of methyl, ethyl, propyl, isopropyl, difluoromethyl, trifluoromethyl, methoxy, -OC(=O)-1,1-dimethylethyl, hydroxy, -C(=O)OCH3, -C(=O)NH-cyclopropyl, amino, methylamino, aminomethyl, -S-CH3, -S(=O)2CH3 and -S(=O)(NH)CH3, and
[2044] Monocyclic heteroaryl selected from
[2045] oxazol-2-yl, pyrazol-3-yl, pyrazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, quinolin-5-yl, indazol-5-yl,
[2046] and which is optionally substituted once or twice, each substituent being independently selected from methyl and methoxy,
[2047] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[2048] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[2049] R 1 represents a group selected from the following:
[2050] 3-pentyl, 2,2-dimethylpropyl, 4-heptyl, 4-fluorophenylcyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclohexylethyl, 1-hydroxypropan-2-yl, 2-hydroxypropyl, 1-hydroxybutan-2-yl, 1-phenylbutan-2-yl, 1-amino-2-propyl, 1-amino-2-butyl, 1-amino-1-oxobutan-2-yl, indan-2-yl, 5- to 6-membered heterocycloalkyl selected from
[2051] tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl and piperidin-4-yl,
[2052] and which is optionally substituted once or twice with methyl,
[2053] A phenyl group, which is optionally substituted once, twice or three times, each substituent being independently selected from a fluorine atom or a chlorine atom or a group selected from:
[2054] methyl, ethyl, propyl, isopropyl, difluoromethyl, trifluoromethyl, methoxy, -OC(=O)-1,1-dimethylethyl, hydroxy, -C(=O)OCH3, -C(=O)NH-cyclopropyl, amino, methylamino, aminomethyl, -S-CH3, -S(=O)2CH3 and -S(=O)(NH)CH3, and
[2055] Monocyclic heteroaryl selected from
[2056] oxazol-2-yl, pyrazol-3-yl, pyrazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, quinolin-5-yl, indazol-5-yl,
[2057] and which is optionally substituted once or twice, each substituent being independently selected from methyl and methoxy,
[2058] or a tautomer, an N-oxide, a salt, a salt of a tautomer, or a salt of an N-oxide thereof.
[2059] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[2060] R 1 represents a group selected from the following:
[2061] 3-pentyl, 2,2-dimethylpropyl, 4-heptyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclohexylethyl, 1-hydroxypropan-2-yl, 2-hydroxypropyl, 1-hydroxybutan-2-yl, 1-amino-2-propyl, 1-amino-2-butyl, CH3CH2CH-C(=O)NH2, 5- to 6-membered heterocycloalkyl, phenyl, indanyl and monocyclic heteroaryl,
[2062] wherein the 5- to 6-membered heterocycloalkyl group is selected from
[2063] tetrahydrofuranyl, tetrahydro-2H-pyranyl and piperidinyl,
[2064] wherein the 5- to 6-membered heterocycloalkyl group is optionally substituted once or twice with a methyl group,
[2065] and
[2066] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a fluorine atom or a chlorine atom or a group selected from the following:
[2067] methyl, ethyl, propyl, isopropyl, trifluoromethyl, methoxy, hydroxy, C(=O)OCH3, amino, methylamino and aminomethyl,
[2068] and
[2069] wherein the monocyclic heteroaryl group is selected from
[2070] oxazolyl, pyrazolyl, pyridinyl and pyrimidinyl,
[2071] wherein the monocyclic heteroaryl group is optionally substituted once or twice, each substituent being independently selected from the group consisting of methyl and methoxy,
[2072] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[2073] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[2074] R 1 represents a group selected from the following:
[2075] 3-pentyl, 2,2-dimethylpropyl, 4-heptyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclohexylethyl, 1-hydroxypropan-2-yl, 2-hydroxypropyl, 1-hydroxybutan-2-yl, 1-amino-2-propyl, 1-amino-2-butyl, CH3CH2CH-C(=O)NH2, 5- to 6-membered heterocycloalkyl, phenyl, indan-2-yl and monocyclic heteroaryl,
[2076] wherein the 5- to 6-membered heterocycloalkyl group is selected from
[2077] tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl and piperidin-4-yl,
[2078] wherein the 5- to 6-membered heterocycloalkyl group is optionally substituted once or twice with a methyl group,
[2079] and
[2080] wherein the phenyl group is optionally substituted once, twice or three times, each substituent being independently selected from a fluorine atom or a chlorine atom or a group selected from the following:
[2081] methyl, ethyl, propyl, isopropyl, trifluoromethyl, methoxy, hydroxy, C(=O)OCH3, amino, methylamino and aminomethyl,
[2082] and
[2083] wherein the monocyclic heteroaryl group is selected from
[2084] oxazol-2-yl, pyrazol-3-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidin-2-yl and pyrimidin-4-yl,
[2085] Wherein the monocyclic heteroaryl group is optionally substituted once or twice, each substituent is independently selected from the following groups:
[2086] methyl and methoxy groups,
[2087] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[2088] According to other embodiments, the present invention provides compounds of general formula (I), wherein
[2089] R 1 represents phenyl, which is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxyl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 )、-S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -P(=O)(C1-C3-alkyl)2 and SF5,
[2090] or wherein when the two substituents of the phenyl group are attached to adjacent ring atoms, they are optionally attached to each other in such a way that they together form a group selected from:
[2091] -CH2-N(R 7 )-CH2-, -CH2-O-CH2-, -O-CH2-C(=O)-NH- and -NH-C(=O)-NH-, and tautomers, N-oxides and salts thereof and salts of tautomers or N-oxides.
[2092] According to other embodiments, the present invention provides compounds of general formula (I), wherein R 1 represents a phenyl group, which is optionally substituted once or twice, each substituent being independently selected from a hydroxyl group, a fluorine atom, a chlorine atom and a methyl group,
[2093] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[2094] According to other embodiments, the present invention provides compounds of general formula (I), wherein
[2095] R 1 represents a phenyl group, which is optionally substituted once or twice, each substituent being independently selected from a fluorine atom, a chlorine atom and a methyl group.
[2096] According to other embodiments, the present invention provides compounds of general formula (I), wherein
[2097] R 1 represents C4-C8-cycloalkyl or -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group, which is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following: hydroxyl, phenyl and -N(R 7 )(R 8 ),
[2098] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy.
[2099] According to other embodiments, the present invention provides compounds of general formula (I), wherein
[2100] R 1 represents a 4- to 7-membered heterocycloalkyl group or a 5- to 7-membered heterocycloalkenyl group, wherein the 4- to 7-membered heterocycloalkyl group and the 5- to 7-membered heterocycloalkenyl group are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[2101] and wherein the 4- to 7-membered heterocycloalkyl and 5- to 7-membered heterocycloalkenyl are attached to the remainder of the molecule through a carbon atom of the heterocycloalkyl or heterocycloalkenyl.
[2102] According to other embodiments, the present invention provides compounds of general formula (I), wherein R 1 represents an indanyl group, a tetrahydronaphthyl group and a monocyclic or bicyclic heteroaryl group,
[2103] wherein the indanyl or tetrahydronaphthyl is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following:
[2104] C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkoxy, cyano, hydroxy and -N(R 7 )(R 8 ),
[2105] wherein the monocyclic or bicyclic heteroaryl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[2106] C1-C6-alkyl, C1-C6-haloalkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C8-cycloalkoxy, cyano, hydroxy and -N(R 7 )(R 8 ),
[2107] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[2108] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[2109] R 1 represents a group selected from the following:
[2110] C5-C8-alkyl,
[2111] C2-C8-haloalkyl,
[2112] C4-C8-cycloalkyl,
[2113] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following:
[2114] Hydroxyl, phenyl and -N(R 7 )(R 8 ),
[2115] and wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[2116] -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[2117] -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group,
[2118] 4- to 7-membered heterocycloalkyl, 5- to 7-membered heterocycloalkenyl,
[2119] wherein the 4- to 7-membered heterocycloalkyl and the 5- to 7-membered heterocycloalkenyl are attached to the rest of the molecule via carbon atoms and are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo(=O),
[2120] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[2121] phenyl group,
[2122] which are optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), hydroxy, C1-C6-hydroxyalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 ), -OC(=O)-(C1-C6-alkyl)-, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2N(R 7 )(R 8), -S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -S(=O)(=NR 11 )(C1-C3-alkyl), -N(O)2, -P(=O)(C1-C3-alkyl)2 and SF5,
[2123] or
[2124] wherein the two ortho substituents may together form a 5- or 6-membered optionally heterocyclic, aromatic or non-aromatic ring, which optionally has 1-3 heteroatoms independently selected from the following: -N=, -NH-, -N(R 7 )-, -O-, -S-, and optionally containing a C(=O) group, and wherein the ring thus formed is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following:
[2125] C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxyl, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[2126] and
[2127] a monocyclic or bicyclic heteroaryl group,
[2128] It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[2129] C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -O(C2-C6-alkenyl), C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, C(=O)OR 6 , hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -S(=O)2-(C2-C6-alkenyl), -N(O)2 and -N(R 7 )(R 8 ),
[2130] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[2131] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[2132] R 1 represents a group selected from the following:
[2133] C5-C8-alkyl, C4-C8-cycloalkyl, -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[2134] 4-7-membered optionally unsaturated heterocyclic groups, phenyl groups and monocyclic or bicyclic heteroaryl groups,
[2135] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following:
[2136] Hydroxyl, phenyl and -N(R 7 )(R 8 ),
[2137] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[2138] and
[2139] wherein the 4- to 7-membered heterocycloalkyl and 5- to 7-membered heterocycloalkenyl groups are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2(C1-C6-alkyl) and oxo (=O),
[2140] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[2141] and
[2142] wherein the 4-7-membered optionally unsaturated heterocyclic group is attached to the remainder of the molecule via a carbon atom,
[2143] and
[2144] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C1-C6-hydroxyalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxy, aryl, -O-aryl, cyano, -C(O)OH, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 ), -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -S(=O)2N(R 7 )(R 8 )、-S(=O)2(C1-C3-alkyl)、-S(=O)(=NR 11 )(C1-C3-alkyl), -N(O)2, -P(=O)(C1-C3-alkyl)2 and SF5,
[2145] or wherein the two ortho substituents of the phenyl group may together form a 5- or 6-membered optionally heterocyclic, aromatic or non-aromatic ring, which optionally has 1-3 heteroatoms independently selected from the group consisting of: -N=, -NH-, -N(R 7)-, -O-, -S-, and optionally containing a C(═O) group, and wherein the ring so formed is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[2146] and
[2147] wherein the monocyclic or bicyclic heteroaryl is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -O(C2-C6-alkenyl), C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2(C1-C6-alkyl), -N(O)2 and -N(R 7 )(R 8 ),
[2148] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[2149] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[2150] R 1 represents a group selected from the following:
[2151] C5-C8-alkyl, C4-C8-cycloalkyl, -(C3-C8-cycloalkyl)-N(R 7 )(R 8 ) group,
[2152] 4-7-membered optionally unsaturated heterocyclic groups, phenyl groups and monocyclic or bicyclic heteroaryl groups,
[2153] wherein the cycloalkyl group is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following:
[2154] Hydroxyl, phenyl and -N(R 7 )(R 8 ),
[2155] wherein the phenyl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[2156] C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[2157] and
[2158] wherein the 4- to 7-membered heterocycloalkyl and 5- to 7-membered heterocycloalkenyl groups are optionally substituted once or twice, each substituent being independently selected from the group consisting of C1-C3-alkyl, 5- to 6-membered heteroaryl, -C(=O)O(C1-C4-alkyl), -C(=O)(C1-C6-alkyl), -C(=O)(C3-C6-cycloalkyl), -S(=O)2, and oxo (=O),
[2159] wherein the 5- to 6-membered heteroaryl substituent is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[2160] C1-C3-alkyl, C1-C4-haloalkyl, C1-C3-alkoxy and hydroxy,
[2161] and
[2162] wherein the 4-7-membered optionally unsaturated heterocyclic group is attached to the remainder of the molecule via a carbon atom,
[2163] and
[2164] wherein the phenyl group is optionally substituted once, twice, three times, four times or five times, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C1-C6-hydroxyalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, hydroxy, aryl, -O-aryl, cyano, -C(O)OH, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7)(R 8 ), -(C1-C6-alkyl)-N(R 7 )(R 8 ), -(C1-C6-alkyl)-C(=O)OR 6 、-(C1-C6-alkyl)-C(=O)N(R 7 )(R 8 ), -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(=O)2(C1-C6-alkyl), -S(=O)2N(R 7 )(R 8 ), -S(=O)2, -S(=O)(=NR 11 )(C1-C3-alkyl), -N(O)2, -P(=O)(C1-C3-alkyl)2 and SF5,
[2165] or wherein the two ortho substituents of the phenyl group may together form a 5- or 6-membered optionally heterocyclic, aromatic or non-aromatic ring, which optionally has 1-3 heteroatoms independently selected from the group consisting of: -N=, -NH-, -N(R 7 )-, -O-, -S-, and optionally containing a C(═O) group, and wherein the ring so formed is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the group consisting of C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, -O(C2-C6-alkenyl), C1-C6-haloalkoxy, C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxy, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2, -N(O)2 and -N(R 7 )(R 8 ),
[2166] and
[2167] wherein the monocyclic or bicyclic heteroaryl group is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following:
[2168] C1-C6-alkyl, C1-C6-haloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, -(C1-C6-alkyl)-aryl, -aryl-(C1-C6-alkyl), C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, -O(C2-C6-alkenyl), C3-C8-cycloalkyloxy, aryl, -O-aryl, cyano, -C(O)OH, hydroxyl, -SH, -S-(C1-C6-alkyl), -S-(C2-C6-alkenyl), -S(═O)2, -N(O)2 and -N(R 7 )(R 8 ),
[2169] and tautomers, N-oxides and salts thereof, and salts of tautomers or N-oxides.
[2170] In other embodiments, the present invention provides compounds of formula (I) above, wherein:
[2171] R 1 represents a group selected from the following:
[2172] C4-C8-cycloalkyl,
[2173] It is optionally substituted once or twice, each substituent being independently selected from a halogen atom or a group selected from the following:
[2174] Hydroxyl, p...
Claims
1. Use of a compound of formula (I) or its tautomer, salt or tautomer salt in the preparation of a medicament for treating brain cancer or respiratory tract cancer: in R 1 represents a group selected from the following: C5-C8-alkyl, C4-C8-cycloalkyl, which is optionally substituted with a phenyl group, wherein the phenyl substituent is optionally substituted by a halogen atom, C1-C3-alkyl, which is substituted by C3-C8-cycloalkyl, C2-C6-alkyl, which is substituted by cyano, hydroxyl or phenyl groups, C3-C6-alkyl, which is substituted by mono- or bicyclic heteroaryl, -(C3-C6-alkyl)-N(R 7 )(R 8 ) group, -(C3-C6-alkyl)-C(=O)N(R 7 )(R 8 ) group, 4- to 6-membered heterocycloalkyl, which is optionally substituted once or twice, each substituent being independently selected from C1-C3-alkyl, and which is linked to the rest of the molecule via a carbon atom of said heterocycloalkyl group, Phenyl group, It is optionally substituted once, twice, three times or four times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C6-alkyl, C1-C3-haloalkyl, C1-C3-hydroxyalkyl, C1-C6-alkoxy, hydroxy, -C(=O)OR 6 、--C(=O)N(R 7 )(R 8 )、N(R 7 )(R 8 )、-(C1-C3-alkyl)-N(R 7 )(R 8 ), -OC(=O)-(C1-C4-alkyl), -S-C1-C3-alkyl, -S(=O)2(C1-C3-alkyl), -S(=O)(=NH)(C1-C3-alkyl) and -P(=O)(C1-C3-alkyl)2, Indanyl, and a monocyclic or bicyclic heteroaryl group, It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C3-alkyl and C1-C3-alkoxy, R 2 represents a hydrogen atom or a halogen atom, R 3 represents a group selected from the following: C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl, and Phenyl, wherein the C1-C6-alkyl group is optionally replaced by a C3-C6-cycloalkyl group or a NR 7 R 8 Group substitution, R 4 represents a group selected from the following: C2-C6-alkenyl, C3-C8-cycloalkyl, C2-C6-hydroxyalkyl, and C1-C6-alkyl, which is optionally substituted by a group selected from the group consisting of C3-C6-cycloalkyl and phenyl, R 5 represents a halogen atom or a group selected from the following: C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-haloalkyl, which is optionally substituted by hydroxy, C1-C6-hydroxyalkyl, (C1-C3-alkyl)-O-(C1-C6-alkyl)-group, C1-C6-alkoxy radical, C1-C6-alkylthio radical, -(C1-C6-alkyl)-N(R 7 )(R 8 ) group, -N(R 7 )(R 8 ) group, -C(=O)OR 6 Group, -C(=O)N(R 7 )(R 8 ) group, -S(═O)(═NH)(C1-C3-alkyl) group, R 6 represents a hydrogen atom or a C1-C4-alkyl group, R 7 and R 8 Each occurrence independently represents a hydrogen atom or C1-C6-alkyl or cyclopropyl group, The monocyclic heteroaryl group is a monovalent monocyclic aromatic ring having 5 or 6 ring atoms, which contains at least one ring heteroatom and optionally one, two or three other ring heteroatoms selected from the series N, O and / or S; The bicyclic heteroaryl group is a 9-membered or 10-membered heteroaryl group.
2. Use of a compound according to claim 1 or its tautomer, salt or tautomer salt in the preparation of a medicament for treating brain cancer or respiratory tract cancer, wherein R 1 represents a group selected from the following: C5-C7-alkyl, C5-C7-cycloalkyl, C1-C2-alkyl, which is substituted by C5-C7-cycloalkyl, C2-C6-alkyl, which is substituted by a phenyl group, C2-C5-hydroxyalkyl, -(C3-C5-alkyl)-N(R 7 )(R 8 ) group, -(C3-C5-alkyl)-C(=O)N(R 7 )(R 8 ) group, 5- to 6-membered heterocycloalkyl, which is optionally substituted once or twice by C1-C3-alkyl, and It is connected to the rest of the molecule via a carbon atom, Phenyl group, It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxyl, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -S-C1-C3-alkyl, -S(=O)2-C1-C3-alkyl, -S(=O)(=NH)(C1-C3-alkyl), and Indanyl, and Monocyclic heteroaryl, It is optionally substituted once or twice, each substituent being independently selected from the following groups: C1-C3-alkyl and C1-C3-alkoxy, the monocyclic heteroaryl being a monovalent monocyclic aromatic ring having 5 or 6 ring atoms, which contains at least one ring heteroatom and optionally one, two or three further ring heteroatoms selected from the series N, O and / or S; R 2 represents a hydrogen atom or a halogen atom, R 3 represents a group selected from the following: C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-haloalkyl, C2-C6-alkenyl and Phenyl, R 4 represents a group selected from the following: C3-C6-cycloalkyl, C2-C3-hydroxyalkyl, and C1-C5-alkyl, which is optionally substituted by a group selected from the group consisting of cyclopropyl and phenyl, R 5 represents a halogen atom or a group selected from the following: C1-C4-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl, which is optionally substituted by hydroxy, C1-C3-hydroxyalkyl, (C1-C3-alkyl)-O-(C1-C3-alkyl)-group, C1-C4-alkoxy radical, C1-C3-alkylthio radical, -(C1-C3-alkyl)-N(R 7 )(R 8 ) group, -N(R 7 )(R 8 ) group, -C(=O)OR 6 Group, -C(=O)N(R 7 )(R 8 ) group, and -S(═O)(═NH)(C1-C3-alkyl) group, R 6 represents a hydrogen atom or a C1-C3-alkyl group, R 7 and R 8 On each occurrence it independently represents a hydrogen atom or a C1-C3-alkyl group or a cyclopropyl group.
3. Use of a compound according to claim 1 or its tautomer, salt or tautomer salt in the preparation of a medicament for treating brain cancer or respiratory tract cancer, wherein R 1 represents a group selected from the following: C5-C7-alkyl, C5-C7-cycloalkyl, C1-C2-alkyl, which is substituted by C5-C6-cycloalkyl, C2-C6-alkyl, which is substituted by a phenyl group, C3-C4-hydroxyalkyl, -(C3-C4-alkyl)-N(R 7 )(R 8 ) group, CH3CH2CH-C(=O)NH2 group, 5- to 6-membered heterocycloalkyl, which is optionally substituted once or twice by C1-C3-alkyl, and It is connected to the rest of the molecule via a carbon atom, Phenyl group, It is optionally substituted once, twice or three times, each substituent being independently selected from a halogen atom or a group selected from the following: C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, hydroxyl, -C(=O)OR 6 、-C(=O)N(R 7 )(R 8 )、-N(R 7 )(R 8 ), -OC(=O)-(C1-C4-alkyl), -S-C1-C3-alkyl, -S(=O)2-C1-C3-alkyl, -S(=O)(=NH)(C1-C3-alkyl), and -(C1-C3-alkyl)-N(R 7 )(R 8 ),and Indanyl, and Monocyclic heteroaryl, It is optionally substituted once or twice, each substituent being independently selected from the following groups: C1-C3-alkyl and C1-C3-alkoxy, the monocyclic heteroaryl being a monovalent monocyclic aromatic ring having 5 or 6 ring atoms, which contains at least one ring heteroatom and optionally one, two or three further ring heteroatoms selected from the series N, O and / or S; R 2 represents a hydrogen atom or a halogen atom, R 3 represents a group selected from the following: C1-C6-alkyl, C3-C6-cycloalkyl, C1-C3-haloalkyl, C2-C6-alkenyl and Phenyl, R 4 represents a group selected from the following: C3-C5-cycloalkyl, C1-C4-alkyl, It is optionally substituted by a group selected from: Cyclopropyl and phenyl, R 5 represents a halogen atom or a group selected from the following: C1-C4-alkyl, C3-C5-cycloalkyl, C1-C3-haloalkyl, which is optionally substituted by hydroxy, C1-C3-hydroxyalkyl, -(C1-C2-alkyl)-OCH3 group, C1-C3-alkoxy groups, Methylthio group, -(C1-C2-alkyl)-N(R 7 )(R 8 ) group, -N(R 7 )(R 8 ) group, -C(=O)OR 6 Group, -C(=O)N(R 7 )(R 8 ) group, and -S(=O)(=NH)(C1-C3-alkyl) group R 6 represents a hydrogen atom or a methyl group, R 7 and R 8 On each occurrence it independently represents a hydrogen atom or a C1-C3-alkyl group or a cyclopropyl group.
4. Use of a compound according to claim 1 or its tautomer, salt or tautomer salt in the preparation of a medicament for treating brain cancer or respiratory tract cancer, wherein R 1 represents a group selected from the following: 3-pentyl, 2,2-dimethylpropyl, 4-heptyl, 4-fluorophenylcyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclohexylethyl, 1-hydroxypropan-2-yl, 2-hydroxypropyl, 1-hydroxybutan-2-yl, 1-cyanobutan-2-yl, 1-phenylbutan-2-yl, 1-amino-2-propyl, 1-amino-2-butyl, 1-amino-1-oxobutan-2-yl, indan-2-yl, 5- to 6-membered heterocycloalkyl selected from tetrahydrofuran-3-yl, tetrahydro-2H-pyran-4-yl and piperidin-4-yl, and which is optionally substituted once or twice with methyl, a phenyl group, which is optionally substituted once, twice or three times, each substituent being independently selected from a fluorine atom or a chlorine atom or a group selected from the group consisting of methyl, ethyl, propyl, isopropyl, difluoromethyl, trifluoromethyl, methoxy, -OC(=O)-1,1-dimethylethyl, hydroxy, -C(=O)OCH3, -C(=O)NH-cyclopropyl, amino, methylamino, aminomethyl, -S-CH3, -S(=O)2CH3 and -S(=O)(NH)CH3, and A monocyclic heteroaryl group selected from oxazol-2-yl, pyrazol-3-yl, pyrazol-5-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, quinolin-5-yl, indazol-5-yl, and which are optionally substituted once or twice, each substituent being independently selected from methyl and methoxy, R 2 represents a hydrogen atom or a fluorine or chlorine atom, R 3 represents a group selected from the following: propyl, 2-methylpropyl, 3-pentyl, cyclopropylmethyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, difluoromethyl, trifluoromethyl, 1,1-difluoroethyl, prop-2-en-1-yl, 2-methyl-prop-1-en-1-yl, N,N-dimethylaminoethyl and phenyl, R 4 represents a group selected from the following: methyl, ethyl, propyl, isopropyl, 2-butyl, prop-2-en-1-yl, cyclopropylmethyl, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, 2-hydroxyethyl, R 5 represents a chlorine atom or a group selected from the following: methyl, ethyl, propyl, isopropyl, 2-butyl, isobutyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, trifluoromethyl, hydroxymethyl, 1-hydroxyethyl, 2-hydroxypropan-2-yl, 1-chloroethyl, 1-hydroxy-2,2,2-trifluoroethyl, 1-methoxyethyl, methoxy, isopropoxy, methylthio, aminomethyl, (methylamino)methyl, (dimethylamino)methyl, 1-aminoethyl, 2-aminoethyl, methylamino and ethyl(methyl)amino, -C(=O)OH, -C(=O)OCH3, -C(=O)NH2, -C(=O)NHCH3, -C(=O)NHcyclopropyl, -C(=O)N(CH3)2 and -S(=O)(=NH)CH3.
5. Use of a compound according to claim 1 or its tautomer, salt or tautomer salt in the preparation of a medicament for treating brain cancer or respiratory cancer, wherein R 1 represents a phenyl group, which is optionally substituted once or twice, each substituent being independently selected from a fluorine atom or a chlorine atom or a group selected from the group consisting of a hydroxyl group and a methyl group, R 2 represents the fluorine atom, R 3 represents a C1-C3-haloalkyl group, R 4 represents a C1-C4-alkyl group, R 5 represents C1-C4-hydroxyalkyl.
6. Use of the compound of claim 1 or its tautomer, salt or tautomer salt in the preparation of a medicament for treating brain cancer or respiratory cancer, wherein the compound is selected from: 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-5-fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-N-(2-fluorophenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-[3-(trifluoromethyl)phenyl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-N-(2-fluorophenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(1S)-1-phenylethoxy]benzamide, 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(1S)-1-phenylethoxy]benzamide, N-(2,6-difluorophenyl)-5-fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(1S)-1-phenylethoxy]benzamide, 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(1S)-1-phenyl-ethoxy]-N-[3-(trifluoromethyl)phenyl]benzamide, 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methylphenyl)-2-[(1S)-1-phenylethoxy]benzamide, 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide, N-(2,6-difluorophenyl)-5-fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide, 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide, 5-Fluoro-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]-N-[3-(trifluoromethyl)phenyl]benzamide, 5-Fluoro-N-(2-fluorophenyl)-4-[3-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide, N-(2,6-difluorophenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-[3-(trifluoromethyl)phenyl]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(4-methoxyphenyl)-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-[4-(trifluoromethyl)phenyl]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-[2-(trifluoromethyl)phenyl]benzamide, N-(3-amino-2-methylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, N-(2-cyano-6-methylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(3-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide, N-(2,2-dimethylpropyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, N-cycloheptyl-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-hydroxyphenyl)-2-[(2S)-pentan-2-yloxy]benzamide, N-(cyclohexylmethyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, N-(1-cyclohexylethyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, a mixture of stereoisomers, N-(2,4-dimethylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-[2-(methylamino)phenyl]-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-methoxyphenyl)-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(3-methoxyphenyl)-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2-ethylphenyl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-[2-(propan-2-yl)phenyl]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-(2-propylphenyl)benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(4-ethylphenyl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]-N-[4-(propan-2-yl)phenyl]benzamide, N-(2,3-dihydro-1H-inden-2-yl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, N-(cyclopentylmethyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(4-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide, N-(4-amino-2,6-dimethylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, N-(2-amino-4,6-dimethylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, N-[4-(Aminomethyl)-3-methylphenyl]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-(pentan-2-yloxy)benzamide, 4-(3-cyclopropyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-cyclopropyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-cyclopropyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-cyclobutyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-cyclobutyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-cyclobutyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-cyclopropyl-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-cyclopropyl-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-cyclopropyl-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(4-cyclopropyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(4-cyclopropyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(4-cyclopropyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-5-fluoro-4-[4-methyl-5-oxo-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[4-methyl-5-oxo-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-N-(2-fluorophenyl)-4-[4-methyl-5-oxo-3-(trifluoromethyl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(4-cyclopropyl-3-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(4-cyclopropyl-3-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(4-cyclopropyl-3-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-N-(2-fluorophenyl)-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-[(1S)-1-phenylethoxy]benzamide, N-(2,6-difluorophenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(1S)-1-phenylethoxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluorophenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(4-fluoro-2-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(2-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-N-[(2R)-1-hydroxypropan-2-yl]-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide, 5-Fluoro-N-[(2R)-1-hydroxybutan-2-yl]-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide, N-[(2R)-1-amino-1-oxobutan-2-yl]-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide, 5-fluoro-N-(hept-4-yl)-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide, 2-(1-cyclohexylethoxy)-N-(2,4-dimethylphenyl)-5-fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide, a mixture of stereoisomers, N-(2-amino-6-methylphenyl)-2-(1-cyclohexylethoxy)-5-fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide, a mixture of stereoisomers, N-(4-amino-2-methylphenyl)-2-(1-cyclohexylethoxy)-5-fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide, a mixture of stereoisomers, 2-(1-cyclohexylethoxy)-N-(2,6-dimethylphenyl)-5-fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide, a mixture of stereoisomers, 5-Fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(2-methylphenyl)-2-(pentan-2-yloxy)benzamide, a mixture of stereoisomers, N-(2-amino-6-methylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-(pent-4-en-2-yloxy)benzamide, a mixture of stereoisomers, N-(2,6-dimethylphenyl)-5-fluoro-4-{3-[(1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-[(2R)-pentan-2-yloxy]benzamide, a mixture of stereoisomers, N-(4-amino-2-methylphenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[pent-4-en-2-yloxy]benzamide, a mixture of stereoisomers, 5-Fluoro-4-{4-methyl-3-[(methylamino)methyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(pentan-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide, 2-(1-cyclohexylethoxy)-N-(2,6-dimethylphenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide, a mixture of stereoisomers, 4-[3-(Aminomethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-N-(2-methylphenyl)-2-[(2S)-pentan-2-yloxy]benzamide, N-[4-amino-2-(trifluoromethyl)phenyl]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, N-[2-(Aminomethyl)-6-methylphenyl]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(2S)-pentan-2-yloxy]benzamide, 4-{3-[(1R)-1-aminoethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(4-amino-2-methylphenyl)-2-(1-cyclohexylethoxy)-5-fluorobenzamide, a mixture of stereoisomers, 4-(4-cyclopentyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-4-{3-[ethyl(methyl)amino]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-Difluorophenyl)-5-fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, single stereoisomer, N-(2,6-difluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-4-{3-[(dimethylamino)methyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-5-fluoro-4-(4-methyl-5-oxo-3-propyl-4,5-dihydro-1H-1,2,4-triazol-1-yl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-5-fluoro-4-[4-methyl-3-(methylthio)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-[3-(2-aminoethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-5-fluoro-4-[4-methyl-3-(methylamino)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-tert-butyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-chloro-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-[4-(Cyclopropylmethyl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-5-fluoro-4-(3-methyl-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazol-1-yl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-4-[3-ethyl-4-(2-hydroxyethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3,4-diethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(4-cyclopropyl-3-methoxy-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-chloro-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(3-cyclopentyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-[4-(But-2-yl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, a mixture of stereoisomers, 4-[3-(But-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, a mixture of stereoisomers, N-(2,6-difluorophenyl)-4-[4-ethyl-3-(methylthio)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-5-fluoro-4-[3-(1-methoxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, a mixture of stereoisomers, N-(2,6-difluorophenyl)-4-[4-ethyl-5-oxo-3-(propan-2-yloxy)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-(4-benzyl-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-N-(2,6-difluorophenyl)-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2-chloro-6-fluorophenyl)-5-fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-N-(2-fluoro-6-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-dichlorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-dichlorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-dichlorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-dichlorophenyl)-5-fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide, N-(2-chloro-6-fluorophenyl)-5-fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-[(2S)-pentan-2-yloxy]benzamide, N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide, 5-Fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methoxy-4-methylpyridin-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide, 5-Fluoro-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(2-methoxy-4-methylpyridin-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide, 5-Fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methoxy-4-methylpyridin-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide, 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide, 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-{3-[(1S)-1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-2-[(2S)-pentan-2-yloxy]benzamide, 5-Fluoro-N-(2-fluoro-6-methylphenyl)-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-[(2S)-pentan-2-yloxy]benzamide, 5-Fluoro-4-[3-(hydroxymethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(pentan-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide, 5-Fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(pentan-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide, N-(2,6-difluorophenyl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(tetrahydrofuran-3-yl)benzamide, a mixture of stereoisomers, 5-Fluoro-N-[(2R)-1-hydroxypropan-2-yl]-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide, 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(1H-pyrazol-3-yl)benzamide, 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(pyridin-2-yl)benzamide, 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(pyridin-4-yl)benzamide, 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(1-methylpiperidin-4-yl)benzamide, 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(tetrahydro-2H-pyran-4-yl)benzamide, 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(pyrimidin-4-yl)benzamide, 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(1,3-oxazol-2-yl)benzamide, 5-Fluoro-N-[(2R)-1-hydroxybutan-2-yl]-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide, N-cyclopentyl-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide, N-cyclohexyl-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide, 5-Fluoro-N-(2-hydroxypropyl)-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide, a mixture of stereoisomers, 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-phenylbenzamide, 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(pyrimidin-2-yl)benzamide, N-[(2R)-1-aminopropan-2-yl]-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide, N-[(2R)-1-aminobutan-2-yl]-5-fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}benzamide, 5-Fluoro-4-[4-methyl-5-oxo-3-(propan-2-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-4-methylpentan-2-yl]oxy}-N-(piperidin-4-yl)benzamide, 2-(1-cyclohexylethoxy)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers, 2-[(1-cyclopropylpropan-2-yl)oxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers, 2-(1-cyclopentylethoxy)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers, 2-(1-Cyclopropylethoxy)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)-2-(1-phenylethoxy)benzamide, a mixture of stereoisomers, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-2-[(3-ethylpentan-2-yl)oxy]-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(4-methylpent-3-en-2-yl)oxy]-N-(pent-3-yl)benzamide, a mixture of stereoisomers, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pent-3-yl)-2-(pent-4-en-2-yloxy)benzamide, a mixture of stereoisomers, 2-(1-cyclobutylethoxy)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(pentan-3-yl)benzamide, a mixture of stereoisomers, 5-Fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(pentan-3-yl)-2-[(2S)-pentan-2-yloxy]benzamide, a mixture of stereoisomers, and 5-Fluoro-4-[3-(1-hydroxyethyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methylphenyl)-2-(pentan-2-yloxy)benzamide, a mixture of stereoisomers, N-(2-chloro-6-fluorophenyl)-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2,6-difluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2-Chloro-6-fluorophenyl)-2-{[1,1-difluoroprop-2-yl]oxy}-4-[3-(2-hydroxyprop-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide (racemate) N-(2-Chloro-6-fluorophenyl)-2-{[1,1-difluoroprop-2-yl]oxy}-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]benzamide (racemate) N-(2-Chloro-6-fluorophenyl)-4-[4-cyclopropyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, N-(2-chloro-6-fluorophenyl)-4-[4-cyclobutyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2-chloro-6-fluorophenyl)-5-fluoro-4-[3-(hydroxymethyl)-5-oxo-4-(prop-2-en-1-yl)-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamide, N-(2-chloro-6-fluorophenyl)-2-{[3,3-difluorobut-2-yl]oxy}-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluorobenzamide (racemate), 5-Fluoro-4-[3-(hydroxymethyl)-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2-Chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-3-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide N-(2-Chloro-6-fluorophenyl)-3-fluoro-4-[3-(2-hydroxypropan-2-yl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide N-(6-chloro-2-fluoro-3-methoxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(6-Chloro-2-fluoro-3-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide N-(6-chloro-2-fluoro-3-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 2,2-Dimethylpropanoic acid 3-chloro-4-(4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}benzamido)-5-fluorophenyl ester, N-(2-chloro-6-fluoro-4-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2-chloro-6-fluoro-3-methoxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, N-(2-chloro-6-fluoro-3-hydroxyphenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide, 2-[(1S)-1-cyclohexylethoxy]-N-(1,4-dimethyl-1H-pyrazol-3-yl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluorobenzamide, 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-[1-(4-fluorophenyl)cyclopropyl]benzamide 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(oxan-4-yl)benzamide 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(1-phenylbutan-2-yl)benzamide 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-[3-(methylsulfonyl)phenyl]benzamide, 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(1-methyl-1H-pyrazol-5-yl)benzamide, 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-[4-(methylthio)phenyl]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(4-methylpyridin-3-yl)-2-[(1S)-1-phenylethoxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-methylquinolin-5-yl)-2-[(1S)-1-phenylethoxy]benzamide, N-[3-(Cyclopropylcarbamoyl)phenyl]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(1S)-1-phenylethoxy]benzamide, N-[2-(difluoromethyl)phenyl]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(1S)-1-phenylethoxy]benzamide, 4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(6-methyl-1H-indazol-5-yl)-2-[(1S)-1-phenylethoxy]benzamide, N-(1-cyanobutyl-2-yl)-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-2-[(1S)-1-phenylethoxy]benzamide, 2-{[(2S)-1-(dimethylamino)propan-2-yl]oxy}-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-(2-fluoro-6-methylphenyl)benzamide, 2-[(1S)-1-cyclohexylethoxy]-4-(3-ethyl-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-5-fluoro-N-[4-(S-methylsulfimidoyl)phenyl]benzamide (mixture of stereoisomers), N-(2,6-difluorophenyl)-4-[4-ethyl-3-(S-methylsulfimidoyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide (mixture of stereoisomers), 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-3-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2,6-difluorophenyl)carbamoyl]-3-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 4-ethyl-1-(2-fluoro-4-[(2-fluoro-6-methylphenyl)carbamoyl]-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2,6-dichlorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-3-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-3-{[1,1-difluoropropan-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid (racemate), 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(2-Fluoro-4-[(2-fluoro-6-methylphenyl)carbamoyl]-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-5-oxo-4-propyl-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-5-{[3,3-difluorobut-2-yl]oxy}-2-fluorophenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid (racemate), 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-cyclopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoroprop-2-yl]oxy}phenyl)-5-oxo-4-(prop-2-en-1-yl)-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-cyclobutyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid, 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide, 1-(4-[(2-chloro-6-fluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide, N-cyclopropyl-1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide, 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-N,4-dimethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-ethyl-N,N-dimethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxamide 1-(4-[(2,6-difluorophenyl)carbamoyl]-2-fluoro-5-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}phenyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylic acid methyl ester, 5-Fluoro-4-{3-[1-hydroxyethyl]-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}-N-(2-methylphenyl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide (mixture of stereoisomers) and 4-{4-ethyl-5-oxo-3-[(1S)-2,2,2-trifluoro-1-hydroxyethyl]-4,5-dihydro-1H-1,2,4-triazol-1-yl}-5-fluoro-N-(2-methoxy-4-methylpyridin-3-yl)-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide (mixture of stereoisomers).
7. Use of the compound of claim 6 or its tautomer, salt or tautomer salt in the preparation of a medicament for treating brain cancer or respiratory tract cancer, wherein the compound is N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide.
8. The use according to any one of claims 1 to 7, wherein the brain cancer is selected from the group consisting of brainstem and hypophtalmic gliomas, cerebellar and cerebral astrocytomas, medulloblastomas, ependymomas, and neuroectodermal and pineal tumors.
9. The use according to any one of claims 1 to 7, wherein the cancer of the respiratory tract is selected from small cell and non-small cell lung cancer, and bronchial adenoma and pleuropulmonary blastoma.
10. The use according to claim 9, wherein the respiratory tract cancer is small cell lung cancer.
